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TIIVISTELMÄ
Tämä tutkimus on osa Kansanterveyslaitoksen Mielenterveyden ja Alkoholitutkimuksen
osaston Mielialahäiriöprojektia. Tutkimus koostuu 441 espoolaisen ja vantaalaisen henkilön
yleisväestöotoksesta ja 269 vakavaa masennusta sairastavan vantaalaisen psykiatrisen avo-
hoito- ja sairaalapotilaan etenevästä kohorttitutkimuksesta (Vantaa Depression Study, VDS).
Yleisväestötutkimusta varten Väestörekisteristä seulottiin 900 henkilön otos (300
Espoosta, 600 Vantaalta), iältään 20-70 vuotiaita, joille lähetettiin kysymyslomakkeisto,
joka sisälsi sosiodemograafisten kysymysten lisäksi asteikot mm ahdistuneisuuden (Beck
Anxiety Inventory, BAI), masennuksen (Beck Depression Inventory, BDI) ja temperamentti-
ja persoonallisuudenpiirteiden (Temperament and Character Inventory − Revised, TCI-R ja
Eysenck Personality Inventory, EPI) mittaamista varten. Kaikkiaan 441 henkilöä vastasi
(94 palautti ainoastaan lyhennetyn version, ilman TCI-R lomaketta) ja antoi suostumuksensa
tutkimukseen.
Vantaa Depression Study:ssa 806 aikuispotilasta, iältään 20-59 vuotta, seulottiin depres-
siivisten oireiden osalta ja 542 haastateltiin puolistrukturoidulla haastattelumenetel-
mällä (SCAN). Tutkimukseen valikoitui 269 potilasta, jotka täyttivät ajankohtaisen vakavan
masennustilan oirekriteerit. Heidät haastateltiin puolistrukturoiduin haastattelumene-
telmin myös muiden psykiatristen häiriöiden poissulkemiseksi. Poissulkukriteereinä
olivat kaksisuuntainen mielialahäiriö (tyyppi I ja II), skitsoaffektiivinen häiriö,
skitsofrenia ja muut psykoosit sekä orgaaninen tai kemiallisen aineen aiheuttama mieli-
alahäiriö. Nyt kyseessä olevaan tutkimukseen sisältyvät ne 193 potilasta (naisia 139,
miehiä 54), jotka osallistuivat sekä 6 kk että 18 kk seurantoihin ja joiden masennus pysyi
unipolaarisena seuranta-aikana. Potilaiden persoonallisuudenpiirteitä arvoitiin EPI:n avulla.
Yleisväestössä temperamentti- ja persoonallisuudenpiirteet liittyivät sekä masennus- että
ahdistuneisuusoireisiin. Korkeat vaikeuksien välttämis (Harm Avoidance, HA)- ja matalat
itseohjautuvuus (Self-Directedness, SD)-pisteet yhdistyivät kohtalaisesti, kun taas
matalat extraversio (E)- ja korkeat neurotisismi (N)-pisteet vahvasti koettuihin
12
masennusja ahdistuneisuusoireisiin. Temperamentti- ja persoonallisuudenpiirteet,
erityisesti korkeat HA-, matalat SD- ja korkeat N-pisteet ennustivat myös jossain määrin
vastaajan itseilmoittamaa, psykiatrisista syistä tapahtunutta terveyspalvelujen käyttöä ja
vastaajalla todettuja mielenteveyshäiriötä. Lisäksi korkeat HA-pisteet assosioituivat
vastaajan sukulaisilla todettuihin mielenteveyshäiriöihin.
Masennuspotilailla N-pisteet alenivat huomattavasti ja E-pisteet nousivat jonkinverran
masennuksesta toipumisen myötä. Masennus- ja ahdistuneisuusoireiden muutos seurannan
aikana ennusti vain 1/3 siitä, mitä alkutilan N-pisteet ennustivat 18 kk:n N-pisteistä.
Verrattuna N-pisteisiin, E-pisteet eivät näyttäneet olevan tilariippuvaisia ahdistuneisuus-
oireista ja muutos masennusoireissa seurannan aikana selitti vain 1/20 osan siitä, mitä
alkutilan E-pisteet ennustivat 18 kk:n E-pisteistä. Sairastettu masennusjakso, yhden
vuoden seurannan aikana, ei näyttänyt muuttavan persoonallisuutta. Masennuspotilailla
havaittiin selkeästi korkeammmat N-pisteet ja lievästi matalammat E-pisteet kuin
yleisväestön edustajilla, senkin jälkeen kun masennus- ja ahdistuneisuusoireet oli vakioitu.
Masennuspotilailla ilmeni positiivinen annos-vaikutus − suhde N-pisteiden ja sekä I että
II-akselin komorbidien sairauksien esiintyvyyden ja lukumäärän välillä. Negatiivinen
vastaava suhde ilmeni puolestaan E-pisteiden ja komorbidin sosiaalisen fobian ja klusteri
C:n esiintyvyyden välillä.
Tutkimus vahvisti käsitystä, että ahdistuneisuus- ja erityisesti masennustilat muodostavat
jatkumon lievemmistä oireista vakavampaan tautitilaan. Masennuspotilailla löydökset
tukevat sen lisäksi olettamusta, että korkeat N-pisteet ja jossain määrin myös matalat E-
pisteet saattavat olla haavoittuvuustekijöitä vakavalle masennukselle ja että korkeat N-
ja matalat E-pisteet altistavat vakavaa masennusta sairastavat potilaat komorbideille
psykiatrisille sairauksille.
Asiasanat: masennus, ahdistuneisuus, vakava masennus, ahdistuneisuushäiriö,
komorbiditeetti, persoonallisuudenpiirteet, persoonallisuus
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1. ABSTRACT
This study is part of the Mood Disorders Project conducted by the Department of Mental
Health and Alcohol Research, National Public Health Institute, and consists of a general
population survey sample and a major depressive disorder (MDD) patient cohort from Vantaa
Depression Study (VDS). The general population survey study was conducted in 2003 in the
cities of Espoo and Vantaa. The VDS is a collaborative depression research project between
the Department of Mental Health and Alcohol Research of the National Public Health
Institute and the Department of Psychiatry of the Peijas Medical Care District (PMCD)
beginning in 1997. It is a prospective, naturalistic cohort study of 269 secondary-level
care psychiatric out- and inpatients with a new episode of Diagnostic and Statistical
Manual of Mental Disorders, 4th edition (DSM-IV) MDD.
In the general population survey study, a total of 900 participants (300 from Espoo, 600
from Vantaa) aged 20-70 years were randomly drawn from the Population Register Centre in
Finland. A self-report booklet, including the Eysenck Personality Inventory (EPI), the
Temperament and Character Inventory-Revised (TCI-R), the Beck Depression Inventory and
the Beck Anxiety Inventory was mailed to all subjects. Altogether 441 participants
responded (94 returned only the shortened version without TCI-R) and gave their informed
consent.
VDS involved screening all patients aged 20-60 years (N=806) in the PMCD for a possible
new episode of DSM-IV MDD. 542 consenting patients were interviewed with a semi-
structured interview (the WHO Schedules for Clinical Assessment in Neuropsychiatry,
version 2.0). 269 patients with a current DSM-IV MDD were included in the study and
further interviewed with semi-structured interviews to assess all other axis I and II
psychiatric diagnoses. Exclusion criteria were DSM-IV bipolar I and II, schizoaffective
disorder, schizophrenia or another psychosis, organic and substance-induced mood
disorders. In the present study are included those 193 (139 females, 54 males) individuals
who could be followed up at both 6 and 18 months, and their depression had remained
unipolar. Personality was investigated with the EPI.
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Temperament and personality dimensions associated not only to the symptoms of depression,
but also to the symptoms of anxiety among general population and in depressive patients,
as well as personality dimensions to comorbid disorders in MDD patients, supporting the
dimensional view of depression and anxiety. Among the general population High Harm
Avoidance and low Self-Directedness associated moderately, whereas low extraversion and
high neuroticism strongly with the depressive and anxiety symptoms. The temperament and
personality dimensions, especially high Harm Avoidance, low Self-Directedness and high
neuroticism were also somewhat predictive of self-reported use of health care services for
psychiatric reasons, and lifetime mental disorder. Moreover, high Harm Avoidance
associated with a family history of mental disorder.
In depressive patients, neuroticism scores were found to decline markedly and extraversion
scores to increase somewhat with recovery. The predictive value of the changes in symptoms
of depression and anxiety in explaining follow-up neuroticism was about 1/3 of that of
baseline neuroticism. In contrast to neuroticism, the scores of extraversion showed no
dependence on the symptoms of anxiety, and the change in the symptoms of depression
explained only 1/20 of the follow-up extraversion compared with baseline extraversion. No
evidence was found of the ’scar effect’ during a one-year follow-up period. Finally, even
after controlling for symptoms of both depression and anxiety, depressive patients had a
somewhat higher level of neuroticism (odds ratio 1.11, p=0.001) and a slightly lower level
of extraversion (odds ratio 0.92, p=0.003) than subjects in the general population.
Among MDD patients, a positive dose-exposure relationship appeared to exist between
neuroticism and prevalence and number of comorbid axis I and II disorders. A negative
relationship existed between level of extraversion and prevalence of comorbid social
phobia and cluster C personality disorders.
Personality dimensions are associated with the symptoms of depression and anxiety.
Futhermore these findings support the hypothesis that high neuroticism and somewhat low
extraversion might be vulnerability factors for MDD, and that high neuroticism and low
extraversion predispose to comorbid axis I and II disorders among patients with MDD.
Keywords: depression, depressive disorder, anxiety, anxiety disorders, comorbidity,
personality, neuroticism, extraversion
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2. LIST OF ORIGINAL PUBLICATIONS
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      European Psychiatry 2006; 21:389-395.
II   Jylhä P, Isometsä E. The relationship of neuroticism and extraversion to symptoms of
      anxiety and depression in the general population.
      Depression and Anxiety 2006; 23:281-289.
III   Jylhä P, Melartin T, Rytsälä H, Isometsä E. Neuroticism, Introversion and Major
      Depressive Disorder − Traits, States or Scars?
      Depression and Anxiety (In Press).
IV   Jylhä P, Melartin T, Isometsä E. Relationships of neuroticism and extraversion with
      axis I and II comorbidity among patients with DSM-IV major depressive disorder.
      Manuscript (Submitted).
These articles are reproduced with the kind permission of their copyright holders.
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3. INTRODUCTION
Major depressive disorder (MDD) is a complex, highly prevalent, aetiologically
multifactorial, clinically heterogeneous and often recurrent or chronic severe psychiatric
disorder with considerable impairment in occupational and psychosocial functioning and
increased rate of completed suicides. According to the WHO World Health Survey, depression
produces the greatest decrement in health compared with the chronic diseases angina,
arthritis, asthma and diabetes (Moussavi et al. 2007) and by the year 2020 will be second
only to cardiovascular illness in the total disease burden imposed on humankind worldwide
(Murray and López 1996).
In Finland the point prevalence of major depression is approximately 5%, corresponding to
about 200 000 - 240 000 Finns (Pirkola et al. 2005). Elevated suicidality has been
associated with major depression and anxiety disorders, resulting in about 750 completed
suicides in Finland annually. According to the Social Insurance Institution in Finland,
depression is also a major cause of functional and work disability. In 2005, due to MDD,
28 919 Finns were in a disability pension and 19 812 new sickness allowance spells were
begun in Finland.
Personality refers to a consistent pattern in the way an individual behaves, feels and
thinks, whereas temperament can be seen as the early appearing biological core of later
adult personality. Temperament and personality dimensions have been studied using various
self- and peer-rated questionnaires including the Eysenck Personality Inventory (EPI,
Eysenck and Eysenck 1964) and the Temperament and Character Inventory (TCI, Cloninger et
al. 1993) and its revised version, TCI-R.
The possible links between temperament and personality and mood has been examind since
Hippocrates. Epidemiological (Hasin et al. 2005) and clinical (Melartin et al. 2002)
studies have revealed that about 40-50% of patients with MDD have also a comorbid
personality disorder. Theoretically personality may be involved in the pathogenesis of the
disorder in multiple ways. Personality features may predispose an individual to, be shaped
by repeated episodes of the illness, modify the clinical picture of the depressive illness
or be an attenuated expression of the disorder (Shea and Yen 2005). Confusingly anxiety
states may also affect on the assessment of the relationship between personality and
depression (Reich et al. 1986). Thus, the investigation of the relationship between
personality and major depressive disorder is complex.
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The present thesis consists of a general population study and a clinical cohort study.
Among the general population the relationship between temperament and personality
dimensions, as measured with TCI-R and EPI, and the symptoms of depression and anxiety are
studied. The relationship between the personality dimensions of neuroticism and
extraversion, and pure MDD or with comorbid axis I or II disorder, are investigated among
patients from The Vantaa Depression Study (VDS) as compared with the general population.
VDS is a prospective, naturalistic cohort study of secondary-level care psychiatric out-
and inpatients with a new episode of DSM-IV MDD.
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4. REVIEW OF THE LITERATURE
4.1 Toward dimensional diagnostic concept of mood and anxiety
disorders
Traditionally the diagnoses in psychiatry have been categorical. A patient either meets or
fails to meet the relevant criteria for specific diagnoses. The introduction of
operationalized classification systems for mental disorders, such as DSM-III (American
Psychiatric Association 1980), DSM-IV (American Psychiatric Association 1994) and ICD-10
(World Health Organization 1992, 1993), have made a significant contribution to the
scientific development of psychiatry by utilising objective, operationalized criteria of
psychiatric diagnoses with specific thresholds and thus improving e.g. the diagnostic
reliability, teaching of students and communication among scientists and the public
(Kendell and Jablensky 2003). Likewise, categorical diagnoses have helped the clinicians
to make decisions whether to treat, type of treatment etc. (Kraemer et al. 2004). However,
the construct validity of the present DSM system is not well established (Spitzer and
Williams 1985) and by using this categorical system a lot of clinically and scientifically
important information of the patient is lost (Helzer et al. 2006).
As the processes toward developing DSM-V and ICD-11 progress, it has been increasingly
acknowledged that not only categorical, but also dimensional approaches to a diagnosis is
important for clinical work and research (Goldberg 2000; Haslam 2003; First 2006; Helzer
et al. 2006). Dimensional system takes into account that there may be clinically important
individual differences among those who fall above, and those who fall below, a categorical
diagnostic threshold (Helzer et al. 2006). These differences e.g. number of positive
symptoms, the severity of symptoms or comorbidity, may be presented on a scale ranging
from a three-point ordinal measure to a continuum (Helzer et al. 2006). There are several
potential benefits of dimensional expansion of a categorical diagnosis, including
diagnosis-specific quantitative score, increased statistical power in research, new
perspectives about the taxonomic problem of comorbidity and better understanding of public
health and epidemiological data (Helzer et al. 2006). Practicing clinicians are more or
less already accustomed to adopting a dimensional perspective (e.g. severity of illness)
in clinical practice in order to develop a treatment plan and to assess clinical progress
(van Os et al. 1996). However, as depression is a heterogeneous and an aetiologically
multifactorial disorder, the sheer enumeration of symptoms and episodes, and their
severity, does not give a full picture of depression or of the depressive patient. In
addition to a clinical diagnosis, factors including life-events, personality, values and
life goals should be incorporated into the evaluation of the patient.
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4.2 Depression as a dimensional concept
4.2.1 Depression as an emotion
Depressive affect or feeling is a normal response to disappointment, loss or other painful
events of human life. Depressive affects are self-limited and do not usually significantly
interfere with a person’s functional capacity, unless becoming longer lasting (American
Psychiatric Association 2000b). Moreover, it has been postulated that in some situations
the depressive mood might even be useful and have offered a selective advantage in humans’
evolutionary history, by disengaging former goals and reallocating resources (Nesse 2006).
4.2.2 Symptoms of depression
Depressive symptoms include, among others, mood bias toward negative emotions (depressed
mood), impaired reward function (anhedonia, lack of reactivity and loss of interest) and
psychomotor symptoms (Hasler et al. 2004). The symptoms of depression are probably
heterogeneous with respect to etiology and pathophysiology (Hasler et al. 2004).
Moreover, depression itself has been found to be dynamic in nature, evolving on a
continuous scale, ranging from no depressive symptoms, depressive symptoms, minor
depression and finally to major depressive disorder (Kendler and Gardner 1998; Kessing
2007). In addition, the symptoms of depression measured cross-sectionally might change
over time in the individual patient, fulfilling criteria for major depression, minor
depression, dysthymia and subsyndromal states (Judd et al. 1997, 1998; Vuorilehto et al.
2005).
4.2.2.1 Measures of symptoms of depression
Depressive symptoms can be measured by using not only numerous disorder specific scales,
but also by general measures. These general, non-disorder specific scales includes
diagnostic interviews and general psychiatric symptoms measures.
4.2.2.1.1 Diagnostic interviews
The primary goal of diagnostic interviews is to provide some level of structure to the
diagnostic assessment process by covering either DSM or ICD symptoms of various
psychiatric disorders, including depression. Interviews that were designed to be used
primarily in a psychiatric environment by mental health professionals, and to provide
diagnosis according to DSM IV, include the Structured Clinical Interview for DSM-IV Axis I
Disorder (SCID-I, First et al. 1995) and interviews to provide diagnosis according to both
ICD-10 and DSM-IV criteria include the Schedules for Clinical Assessment in
Neuropsychiatry (SCAN, WHO 1994). Interviews that were designed to be used primarily in
epidemiological studies by lay interviewers and to provide diagnosis according to DSM IV
include the Diagnostic Interview Schedule (DIS, Robins et al. 1981), and measures to
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provide diagnosis according to both ICD-10 and DSM-IV criteria include the Composite
International Diagnostic Interview (CIDI, Robins et al. 1988). Interviews that were
designed to be used in both clinical and epidemiological settings by lay interviewers and
to provide diagnosis according to both ICD-10 and DSM-IV include the The
Mini-International Neuropsychiatric Interview (MINI, Sheehan et al. 1998). Interviews that
were first developed for the primary care settings include the Primary Care Evaluation of
Mental Disorders (PRIME-MD, Spitzer et al. 1994) and the Symptom-Driven Diagnostic
System for Primary Care (SDDS-PC, Olfson et al. 1995).
4.2.2.1.2 General psychiatric symptoms measures
The general psychiatric symptoms measures are intended as screening instruments to
identify individuals most likely to have psychopathology, not as specific diagnostic
measures. These scales include the Mental Health Inventory (MHI, Veit and Ware 1983); the
General Health Questionnaire (GHQ, Goldberg 1972); the Symptom Checklist-90 (SCL-90,
Derogatis et al. 1973) and its revised version SCL-90-R (Derogatis 1977); Brief Symptom
Inventory (BSI, Derogatis and Melisaratos 1983) and the Patient Health Questionnaire-9
(PHQ-9, Spitzer et al. 1999), a self-report part of the PRIME-MD.
4.2.2.1.3 Specific depressive symptoms measures
To measure mood symptoms, numerous self-report and clinician-administered scales have
been developed. There are several self-report measures that are commonly used either for
screening depressive illness in the community or in the general medical population,
including the Beck Depression Inventory (BDI, Beck et al. 1961), the Zung Self-Rating
Depression Scale (Zung SDS, Zung 1965), the Centre for Epidemiologic Studies Depression
Scale (CES-D, Radloff 1977), the Hospital Anxiety and Depression Scale (HADS, Zigmond
and Snaith 1983) and the Depression Scale (DEPS, Salokangas et al. 1995; Poutanen et al.
2007). Additionally self-report rating scales for use in specific populations have been
developed, including the Edinburgh Postnatal Depression Scale (EPDS, Cox et al. 1987) as a
screening test for postpartum depression and the Geriatric Depression Scale (GDS, Yesavage
and Brink 1983) as a screening test for depression in elderly people. Some of the
self-administered mood disorders measures, including the BDI, Zung SDS and CES-D, are also
used to measure the severity of depressive symptoms.
Observer-rated depressive symptom scales designed to measure the severity of depressive
symptoms include the Hamilton Rating Scale for Depression (HAM-D, Hamilton 1960), the
Montgomery-Asberg Depression Rating Scale (MADRS, Montgomery and Asberg 1979) and
the Raskin Scale (Raskin 1988). Other observer-rated scales are used e.g. the Bech-Rafaelsen
Melancholia Scale (MES, Bech et al. 1986) and the Newcastle Depression Diagnostic Scale
(NDDS, Davidson et al. 1984) to measure the severity of melancholic states and the Bipolar
Depression Rating Scale (Berk et al. 2007) to measure depression in bipolar disorder. Of
the above mentioned observer-rated scales, the HAM-D is perhaps more commonly used than
the others.
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There are also measures having both self-report and clinician-administrated forms, these
includes the Inventory of Depressive Symptomatology (IDS, Rush et al. 1996) and the Quick
Inventory of Depressive Symptomatology (QIDS, Rush et al. 2003) derived from IDS. Both of
these inventories are less dependent on somatic factors than HAM-D and are able to detect
atypical and melancholic features of depression.
4.2.2.1.4 Beck Depression Inventory
The items of Beck Depression Inventory (BDI) were originally derived from observations of
depressed patients during the course of psychoanalytic psychotherapy (Beck and Steer
2000). Beck proposed that the symptoms of depression could be explained in cognitive terms
i.e. the biased interpretations of events were attributed to the activations of negative
representations of the self, the personal world and the future (the negative cognitive
triad) (Beck 2005).
The original 21-item version was published in 1961 (Beck et al. 1961), each item
represented by four or five statements describing symptom severity from low to high and
the subjects were asked to identify the statements that best described their feelings "at
the present time/at the time of interview". Later eight new versions have been published,
including an abbreviated version containing 13 items (Beck and Beck 1972); BDI-IA (Beck et
al. 1979a) to eliminate duplicate severity descriptors, to reword certain items and to
lengthen the time frame to the "last week, including today"; revised BDI-IA (Beck and
Steer 1987) and new revised BDI-IA (Beck and Steer 1993) with new scoring; the Beck
Depression Inventory-II (BDI-II, Beck et al. 1996) with a modification of items to reflect
DSM-IV criteria (e.g.items covering increase in appetite, increase in sleep, agitation and
psychomotor retardation), to simplify wording and to extend the time frame to 2 weeks, and
BDI for Primary Care (BDI-PC) and Fast Screen (BDI-FS, Beck et al. 1997). In addition,
many other versions exist, especially in non-English translations (Beck et al. 1988a),
e.g. the Finnish modification of the short form of the Beck Depression Inventory measuring
depression symptoms and self-esteem, called the Raitasalo’s modification of the short form
of BDI (RBDI, Raitasalo 2007). The correlation between the various forms and versions of
the BDI has been found to be very high (Beck et al. 1988a).
Each of the BDI-IA item sets contains four statements, each describe symptom severity
along an ordinal continuum from absent or mild (a score of 0) to severe (a score of 3).
The item sets cover areas of sadness, pessimism, sense of failure, dissatisfaction, guilt,
punishment, self-dislike, self-accusations, suicidal ideas, crying, irritability, social
withdrawal, indecisiveness, body image change, work difficulty, insomnia, fatiguability,
loss of appetite, weight loss, somatic preoccupation and loss of libido. The manual of the
new revised BDI-IA suggests the following interpretation of severity scores: 0-9, minimal;
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10-16, mild; 17-29, moderate; and 30-63 severe depression, with the cut-off score of 15
for maximal efficiency to diagnose DSM-III-R mood disorder (Beck and Steer 1993). It has
been also suggested that the cut-off point of 12/13 has the best predictive value to
diagnose ICD-10 depressive disorder (Lasa et al. 2000).
The BDI shows high internal consistency, Cronbach’s alphas ranged from 0.76-0.95 in
clinical and from 0.73-0.90 in non-clinical populations (Beck et al. 1988a). Also the
validity of BDI with other measures of depressive symptom severity has been high, as for
psychiatric patients the mean correlations between the BDI and HAM-D has been found to be
0.73 and for non-psychiatric subjects from 0.73 to 0.80 (Beck et al. 1988a). BDI has shown
a high short-term test-retest correlation (r=0.60-0.90) (Beck et al. 1988a), and also a
fairly strong correlation with anxiety scales, e.g. with Beck Anxiety Inventory (r=0.61)
(Beck et al. 2000).
4.2.2.1.5 Hamilton Rating Scale for Depression
The Hamilton Rating Scale for Depression (HAM-D) is an observer-rated depressive symptom
rating scale to measure the severity of depressive symptoms in patients with primary
depressive illness (Hamilton 1960). The quantification of symptom severity may be used to
estimate symptom severity before treatment, gauge the effect of treatment on symptoms or
detect a return of symptoms (e.g. relapse or recurrence) (Hamilton 2000). The original
scale had 21 items with e.g. items of depersonalization and diurnal variation of the
illness (Hamilton 2000). At least 20 published versions of the Hamilton depression scale
have since been developed together with structured interview guides, self-report forms and
computerized versions of the scale (Williams 2001). The 27-item (Gelenberg et al. 1990)
and 29-item (Williams 1988) versions of the scale include also items for atypical
depression. However, the 17-item version with its many modifications is the most commonly
used, covering areas of depressed mood, feelings of guilt, suicide, insomnia (early,
middle and late), work and activities, psychomotor retardation, agitation, anxiety
(psychological and somatic), somatic symptoms (gastrointestinal and general), genital
symptoms, hypochondriasis, loss of weight and insight. The HAM-D items are scored from 0
to 4 or 0 to 2. Items with quantifiable severity are scored 0 to 4; 4 indicates the
greatest severity. Some symptoms are believed to be more difficult to quantify reliably,
and these items have a range of 0 to 2. When compared with global measure of depression
severity, scores over 23 indicated very severe, 19-22 severe, 14-18 moderate, 8-13 mild
depression and 7 or under normal condition (Kearns et al. 1982). The internal consistency
has been found to be higher (≥0.8) with the structured than with the unstructured
interview (Potts et al. 1990). Correlations between the HAM-D and other clinician-rated
instruments, including MADRS, range between 0.8 and 0.9 (Hamilton 2000). HAM-D gives
more weight to somatic signs and symptoms than to cognitive symptoms (e.g. guilt), and the
17-item version does not include reverse neurovegetative symptoms (e.g. oversleeping and
overeating) (Hamilton 2000). Recently its use as a golden standard for the assessment of
depression has been questioned due to the possible flaws in its psychometric and
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conceptual properties: many scale items have been found to be poor contributors to the
measurement of depression severity or have poor interrater and retest reliability; the
format for response options has been found not to be optimal and content validity to be
poor (Bagby et al. 2004).
4.2.2.2 Epidemiology of symptoms of depression
The prevalence of depressive symptoms varies depending on the population studied and
criterion used. In a summary of ten population surveys between 1957 and 1992, it was found
that one tenth to one third of the subjects had suffered from depressive symptoms
(Lehtinen and Joukamaa 1994). In another review of 36 studies of subthreshold depression,
the prevalence of depressive symptoms varied from 2.2% to 24% in the community and
epidemiological setting and from 5.4% to 15.6% in primary care setting, depending on the
definition of the condition (Pincus et al. 1999).
The prevalence of depressive symptoms measured by BDI has been similar in different
populations. In a sample of 298 adults from the US general population 80.3% of
participants had BDI scores less than 10, 10.7% from 10 to 15, 5% from 16 to 23 and 4%
over 23 (Oliver and Simmons 1984). In a Finnish study of 2018 adults from the general
population 77% of subjects scored on the BDI below 10, 18% between 10 and 18, 4% between
19-29 and 1% above 30 (Honkalampi et al. 2000). Recently in a study among 937 Israeli
adults 78.5 % of respondents scored less than 10, 13.2% from 10 to 15, 4.5% from 16 to 23
and 3.8% 24 or above (Iancu et al. 2003).
In the National Institute of Mental Health Epidemiological Catchment Area (ECA) study
consisting of 18 571 subjects, 47% reported at least one and 23.1% at least two DSM-III
criterion of depression in their lifetime, but not meeting the criteria for MDD and/or
dysthymia (Johnson et al. 1992). In a subsample of 9 160 subjects from the ECA study,
19.6% of the general population reported one or more depressive symptoms in the previous
month (1-month prevalence) and one-year prevalence of two or more depressive symptoms was
11.8% (Judd et al. 1994). In the National Comorbidity Survey, 10.0% of 8 098 respondents
met the criteria for lifetime minor DSM-III-R depression (2 to 4 symptoms of MDD without a
lifetime history of either MDD or dysthymia) (Kessler et al. 1997a) and in the Netherlands
Mental Health Survey and Incidence Study (Cuijpers et al. 2007) 7.5% of 5 504 respondents
met the criteria for minor DSM-IV depression in the previous year (2 to 4 symptoms of MDD,
without a lifetime history of mood disorder).
4.2.2.3 Clinical impact of subthreshold symptoms of depression
Less severe constellation of depressive symptoms not meeting the criteria of MDD are often
called subthreshold disorders, but also in a number of other ways, including minor
depression and depressive symptoms threshold (Pincus et al. 1999). These categories have
been defined in various ways, e.g. subthreshold depression in five, minor depression in
nine and depressive symptom thresholds in three different ways (Pincus et al. 1999). In a
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review of subthreshold mental disorders it was found that the minimum number of symptoms
required for a diagnosis of one of the subthreshold conditions ranged usually from one to
six, the most common minimum was two; the duration of the symptoms required for the
subthreshold condition varied from none to two weeks, and out of 36 studies included in
the review, 25 had not included impairment criterion, only 4 had ruled out lifetime mood
disorder and 9 general medical condition (Pincus et al. 1999). Thus, the use of the title
of subthreshold depression is diverse.
Although not meeting the diagnostic criteria of MDD, adults with subthreshold level of
depressive symptoms have been reported to have more medical comorbidity (Coulehan et al.
1990), more days lost from work (Skodol et al. 1994; Judd et al. 1996), more mental health
visits (Skodol et al. 1994), more suicide attempts (Johnson et al. 1992), poorer
functional status (Wells et al. 1992; Judd et al. 1996; Olfson et al. 1996), poorer health
status (Wells et al. 1992; Judd et al. 1996), more social irritability (Judd et al. 1996),
more financial strain (Judd et al. 1996), more number of bed days (Wells et al. 1992),
more days with pain (Wells et al. 1992) and worse outcome of various chronic diseases
(Katon 2003) , including diabetes (Lin et al. 2004) and coronary disease (Ruo et al. 2003)
than individuals without these symptoms. From ECA study, it has been estimated, based upon
population attributable risk, which adjusts for prevalence, that there is as much or more
service burden and impairment associated with depressive symptoms than with the formal
mood disorders of major depression and/or dysthymia (Johnson et al. 1992).
4.2.2.4 Course and outcome of symptoms of depression
Subjects with depressive symptoms are a very heterogeneous group, including individuals
with partially remitted or prodromal MDD, a transient adjustment to a stressful
life-event, symptoms that are secondary to a general medical illness or a recurrent brief
depressive condition (Olfson et al. 1996; Vuorilehto et al. 2005), thus the course and
outcome of depressive symptoms depends on the population studied.
In a Zurich Cohort Study of 591 Young Adults during a 15-year follow-up approximately one
third of the subjects with subthreshold depression (1-2/9 symptoms of DSM-IV MDD)
developed MDD (Angst et al. 2000). In a Baltimore ECA study, during a 13-year follow-up,
10% of 1920 subjects with subthreshold depressive symptoms (3 or more symptoms of
DSM-III-R MDD, but not meeting criteria of MDD) developed MDD, 5% dysthymia and 8%
comorbid MDD and dysthymia (Chen et al. 2000). Among 4796 subjects in the Netherlands
Mental Health Survey and Incidence study (NEMESIS), the risk of developing DSM-III-R
MDD within 2 years was 1.8%, 4.0% and 8.0% in subjects without depressive symptoms, one
key symptom only and minor depression (one key symptom and 1-3 other symptoms in 1 year),
respectively (Cuijpers et al. 2004). During a 8-year follow-up among 1265 adolescents,
subthreshold depression (depressed mood or loss of interest for 2 weeks, but not having 5
or more DSM-IV MDD symptoms or significant distress or impairment of functioning) at ages
17 to 18 years was associated with later depression and suicidal tendencies, prognosis
being similar among sample members with subthreshold depression and major depressive
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disorder (Fergusson et al. 2005). In their review of 23 studies, Cuijpers and Smit found
that the incidence of MDD in subjects with clinically relevant depressive symptoms was
larger than in subjects without such symptoms (Cuijpers and Smit 2004). Thus, although
most individuals with depressive symptoms recover, a substantial proportion will develop
MDD or dysthymia.
4.2.3 Major depressive disorder (MDD)
4.2.3.1 Diagnosis of MDD
There are currently two diagnostic classification systems in use, the DSM-IV (American
Psychiatric Association 2000b) and ICD-10 (World Health Organization 1992, 1993;
Tautiluokitus 1996). In Finland ICD-10 is used in clinical practice as an official
classification, whereas DSM classification is usually applied in research programmes.
DSM-IV MDD is characterized by having one or more major depressive episodes (MDE’s).
Besides the required core symptom of persistent depressive mood or significant loss of
interest or pleasure being present during the same two-week episode, there must be at
least four of the following accompanied symptoms (total of five symptoms): significant
weight loss or gain, insomnia or hypersomnia, psychomotor agitation or retardation,
fatigue or loss of energy, feelings of worthlessness or excessive or inappropriate guilt,
diminished ability to think or concentrate and recurrent thoughts of death, recurrent
suicidal ideation or suicide attempt or specific plan for committing suicide. Moreover,
the symptoms must cause clinically significant distress or impairment in social,
occupational or other important areas of functioning and should not be due to the direct
physiological effects of a substance or a general medical condition or bereavement. An
episode of MDD may be classified as mild, moderate or severe, based on the number of
symptoms, the severity of the symptoms and the degree of functional disability and
distress (American Psychiatric Association 1987, 1994, 2000b).
The diagnosis of MDD in both DSM-IV and ICD-10 are almost compatible. However, ICD-10
includes also fatigue or loss of energy among the core symptoms, splits feelings of
worthlessness and inappropriate guilt into two and requires one symptom less.
In this thesis, unless otherwise specified, depression refers to unipolar DSM-IV MDD.
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4.2.3.2 Epidemiology of MDD
Major depressive disorder is a common disorder, widely distributed in the population.
Several epidemiological studies have estimated the prevalence of depression in the general
population around the world (Table 1.). Mood disorders are found to be the next common of
mental disorders after anxiety disorders (Demyttenaere et al. 2004). It is estimated that
during their lifetime, approximately 20% of the population will suffer an episode of MDD
(Kessler et al. 1994). The lifetime risk for MDD is nearly twice as high for females as
for males and is fairly low until early teens, when it begins to rise in roughly linear
fashion (Kessler et al. 1994), the median age of onset being 30 years (Kessler et al.
2005a).
Table 1. Prevalence of MDD.
       Lifetime prevalence of MDD
       NCS            17.1%    DSM III-R     (Kessler et al. 1994)      USA               N=8098
       NCS-R          16.2%    DSM-IV        (Kessler et al. 2003)      USA               N=9282
       NESARC         13.2%    DSM-IV        (Hasin et al. 2005)        USA               N=43093
       NEMESIS        15.4%    DSM-III-R     (Bijl et al. 1998)         Netherlands       N=7076
       ESEMeD         12.8%    DSM-IV        (Alonso et al. 2004)       Europea           N=21425
12-month prevalence of MDD
       ECA             5.8%    DSM-III       (Regier et al. 1993)       USA               N=18572
       NCS            10.3%    DSM-III-R     (Kessler et al. 1994)      USA               N=8098
       NCS-R           6.6%    DSM-IV        (Kessler et al. 2003)      USA               N=9282
       OHS             4.1%    DSM-III-R     (Offord et al. 1996)       Canada            N=9953
       NESARC          5.3%    DSM-IV        (Hasin et al. 2005)        USA               N=43093
       NEMESIS         5.8%    DSM-III-R     (Bijl et al. 1998)         Netherlands       N=7076
       ESEMeD          3.9%    DSM-IV        (Alonso et al. 2004)       Europea           N=21425
       FINHCS          9.3%    DSM-III-R     (Lindeman et al. 2000)     Finland           N=5993
       Health 2000     4.9%    DSM-IV        (Pirkola et al. 2005)      Finland           N=6005
a Belgium, France, Germany, Italy, Netherlands and Spain
29
In   the  Outcome  of  Depression  International  Network  (ODIN)   study in  five   European
countries, an overall prevalence of ICD-10 and DSM-IV depressive disorders (MDD,
dysthymia and adjustment disorders with depressive mood) was found to be 8.56% (Ayuso-
Mateos et al. 2001). In a critical review of 27 studies of the size and burden of mental
disorders in Europe, the estimated 12-month prevalence of MDD ranged from 3.1% to 10.1%,
with the median being 6.9% (Wittchen and Jacobi 2005).
In the Mini Finland Health Survey of 8000 adults, the 1-month prevalence of neurotic
depression using Present State Examination (PSE) interview was 4.6% (Lehtinen et al.
1990). The 6-month prevalence of DSM-III-R MDE in a computer assisted telephone interview
study of 2293 Finnish adults using UM-CIDI Short Form was found to be 4.1% (Isometsä et
al. 1997). The 12-month DSM-III-R prevalence of major depressive episode in a Finnish
Health Care Survey (FINHCS) of 5993 Finnish adults using also UM-CIDI Short Form was
found to be 9.3% (Lindeman et al. 2000), whereas in another recent Finnish study, the Health
2000, with 6005 adult participants, the 12-month prevalence of MDD using the German
computerized version of the CIDI (M-CIDI) was reported to be 4.9% (Pirkola et al. 2005).
The difference in these prevalences may be due to the methodological factors, such as
different instruments, diagnostic criteria and sampling methods (e.g. in UM-CIDI Short
Form unlike in M-CIDI, it is impossible to make differential diagnoses between unipolar,
bipolar or schizoaffective mood disorders, residual schizophrenic disorders with
superimposed MDE or organic mood disorders; the age range in FINHCS was wider than in
Health 2000, 15-75 years and over 30 years, respectively; in Health 2000 MDD, not MDE
diagnosis was used).
4.2.3.3 Aetiology of MDD
Major depressive disorder is a complex, multifactorial disorder, where the risk factors
are seen to be related and interacting with each other (Kendler and Prescott 2006). An
individual’s probability of suffering an episode of MDD is affected by factors of several
domains, including genetic risk factors (Levinson 2006), hormonal and neurobiological
influences (Manji et al. 2001; Nestler et al. 2002), low birth weight (Costello et al.
2007), poor parenting (Parker 1979), parental depression (Lieb et al. 2002), childhood
physical (Widom et al. 2007) or sexual (Kendler and Prescott 2006) abuse, childhood
parental loss (Kessler et al. 1997b; Kendler and Prescott 2006), predisposing personality
traits (Angst and Clayton 1986; Hirschfeld et al. 1989), early onset of an anxiety
disorder (Kessler et al. 1996; Young et al. 2004), low social support (Kendler and
Prescott 2006), marital difficulties (Whisman et al. 2000), history of MDD (Lewinsohn et
al. 1988), prior depressive symptoms (Cuijpers and Smit 2004), substance abuse (Kessler et
al. 1996), circadian abnormalities (Bunney and Bunney 2000) and stressful life-events
(Paykel et al. 1969; Kendler and Prescott 2006). Temperamental factors together with
genetic vulnerability and adverse life-events are likely to form one of the key domains of
liability to major depression (Kendler and Prescott 2006).
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4.2.3.3.1 Heritability of MDD
Major depression is a familial disorder and its familiality mostly results from genetic
influences (Kendler and Prescott 2006). A meta-analysis of five studies found that
first-degree relatives of individuals with MDD have a nearly threefold increased risk of
developing MDD compared with control samples (Sullivan et al. 2000). The heritability or
the proportion of variation due to genetic factors for MDD has been usually reported to be
around 37% (Sullivan et al. 2000). These estimates are grounded mostly on community based
twin studies, whereas on clinically based studies the heritability has been on the order
of 70% (McGuffin et al. 2007). However, the heritability estimate of MDD in a community
based twin study increased also to about 70%, when incorporating an index of severity,
having data at two time points and incorporating measurement error in the model (Kendler
et al. 1993a). Therefore, it has been recently concluded that the heritability of MDD
might be as high as nearly 80% (McGuffin et al. 2007). Moreover, the heritability of MDD
has been found to be greater in women than in men (Kendler et al. 2001), in a most recent
study 42% and 29%, respectively (Kendler et al. 2006c).
Current genetic studies have been focused on two phenotypes: MDD and personality traits
like neuroticism that predict increased risk for depression (Levinson 2006). The genes
that predispose to depression are not necessarily the same for females and for males
(Kendler et al. 2001) and it is likely that the genetic liability to MDD is contributed by
multiple genes, each having a small effect e.g. 5-HT transporter gene (Zhou et al. 2005),
glucocortcoid receptor gene (van Rossum et al. 2006), brain-derived neurotrophic factor
gene (Kaufman et al. 2006), and their possible interactions (Kim et al. 2007). Other
possible new candidate genes may be involved to newer hypotheses about the mechanisms of
depression e.g. sleep, circadian rhythms and inflammation (Levinson 2006).
4.2.3.3.2. Childhood experiences and MDD
The risk for adult MDD has been significantly correlated with a history of having
experienced poor parenting (Kendler and Prescott 2006). Among female twins the lifetime
risk for MDD, and also for other internalizing disorders, is associated with coldness and
authoritarianism of both mothers and fathers and overprotectiveness of mothers, e.g.
moving from an average level of maternal coldness, measured by the Parental Bonding
Instrument (Parker et al. 1979), to 1 sd above the mean, increased the lifetime risk for
depression by above 30% (Kendler and Prescott 2006). In their study of what aspects of
parenting received in childhood were associated with adult major depression, Kendler and
Prescott found no evidence of shared family environment affecting the risk for MDD;
instead it was hypothesized that poor parenting increased the risk for MDD through
individual specific environment i.e. individuals may react to parenting in different ways
guided in part by genetically influenced characteristics e.g. temperament (Kendler and
Prescott 2006).
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Other childhood experiences including parental loss and childhood sexual abuse, have also
been found to increase the risk for MDD and other adult psychopathology, parental death
increasing specifically the risk of adult MDD (Kendler and Prescott 2006).
The childhood adversities increasing the risk for adult depressiveness have been found to
be partly mediated by adult risk factors, supporting a pathway hypothesis from childhood
adversities to depressiveness through adult risk factors (Korkeila et al. 2005). Evidence
has also been found to support the vulnerability hypothesis i.e. the consequences of an
unfavourable childhood background might be worse if combined with adult adverse
life-events (Korkeila et al. 2005). Futhermore childhood adverse life-events have been
found to associate with adult depression-prone personality characteristics (Korkeila et
al. 2004).
4.2.3.3.3 Adult adverse life-events, social support and MDD
Adult adverse life experiences and poor social support have been found to associate with
depression (Paykel et al. 1969; Brown and Harris 1978). In their study among female twins,
Kendler and Prescott (2006) found that 13/15 categories of stressful life-events (SLE)
were associated with an increased risk of major depression, including personal events
(assault, major financial problems, serious housing problems, job loss, serious
difficulties at work, serious illness, serious marital problems, divorce/separation, loss
of confidant), network events (interpersonal conflict with an individual in the network,
crisis experienced by someone in the network, illness or death of someone in the network),
but not robbery or legal problems. Men were more likely to have depressive episodes
following divorce, separation and work difficulties, whereas women were more sensitive to
events in their proximal social network events (Kendler and Prescott 2006). Most of the
events were associated with an increase of 2 to 7 times the baseline risk, the highest
being observed for the rarest event, assault, which had an OR of 17.9 for MDD. The risk
for major depression increased further if the number or severity of events increased. Of
four psychological dimensions of life-events (entrapment, danger, loss and humiliation),
high ratings of loss and humiliation were associated with increased risk for depression
among individuals with high-threat events (Hazard ratios 1.70 and 1.45, respectively) and
the combination of high ratings of humiliation and loss created the highest risk for
depression (Kendler and Prescott 2006).
Low social support (combined measure of social integration, emotional support and
instrumental support) has also been found to increase the risk for developing future
episodes of major depression, even after controlling for the history of past depressive
episodes (Kendler and Prescott 2006).
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In VDS, 91% of the patients reported life-events, on average 4.1±3.0 events per preceding
year. Although life-events were distributed evenly between the time preceding depression,
the prodromal phase, and the index MDE, 76% of the patients attributed their depression to
some event (Leskelä et al. 2004).
Recent findings support bidirectional models of person environment interrelationships. Not
only can the causal relationship between environmental adversity and an individual be from
environment to person, but also from person to environment (Kendler and Baker 2007).
Individual differences in personality, which result partly from genetic influences, have
been found to impact on the way in which humans structure the world around them, and to
make them more or less likely to experience stressful life-events and to have poor quality
interpersonal relationships, which in turn ’feed back’ to them, influencing their risk for
subsequent psychiatric illness (Kendler et al. 2003b).
Consistent with diathesis-stress theories of depression that hypothesized life stress
being an important component in the aetiology of depression, but requiring also other
vulnerability factors to explain onset conditions (Monroe and Hadjiyannakis 2002), several
gene-by-environment interactions have been reported. In gene-environment interaction the
genetic risk influences the overall liability to illness and alters the individual’s
sensitivity to the pathogenic effects of the environment (Kendler and Prescott 2006).
Caspi et al. (2003) reported that individuals with one or two short allele of the 5-HTT
promoter polymorphism, showed more depressive symptoms, diagnosable depression and
suicidality in relation to stressful life-events or childhood abuse than individuals
homozygous for the long allele. Since that, the result of the genetic mediation by
5-HTTLPR of vulnerability to adverse environment has been replicated at least by fifteen
studies, whereas not at least by two, possibly due to the sample age composition, selected
samples or use of unreliable measures of environment (Uher and McGuffin 2007). Also other
gene-environment interactions have been reported e.g. serotonin receptor 2A gene may be
involved in the development of depression by influencing the ability of individuals to use
environmental support (Jokela et al. 2007) and dopamine transporter gene, genotype A2/A2,
may be involved in the development of depressive symptoms in individuals with adverse
life-events (Elovainio et al. 2007). Other possible interactions are e.g. an interaction
between life-events and neuroticism, where neuroticism has a greater impact on the risk of
MDD at high rather than low levels of stressful life-events (Kendler et al. 2004).
4.2.3.3.4 Integrative models for MDD
Attempts to create intergrative models for the risk factors for MDD have been made e.g. in
Virginia Adult Twin Study of Psychiatric and Substance Use Disorders (VATSPSUD) for both
women and for men (Kendler and Prescott 2006). These models predicted depressive episodes
in the year before the most recent interview. Eighteen risk factors were organized into
five developmental tiers reflecting childhood (genetic risk factors, disturbed family
environment, childhood sexual abuse, childhood parental loss), early adolescence
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(neuroticism, low self-esteem, early-onset anxiety, conduct disorder), late adolescence
(low educational attainment, lifetime traumas, low social support, substance misuse),
adulthood (divorce, history of MDD) and the preceding year (marital problems, total
difficulties of severe life-events). The final model for women and men accounted for
52.1% and 48.7%, respectively, of the variance in liability to develop an episode of MDD.
For both female and male, the overall result suggested that there would be three broad
patterns of risk factors to MDD characterized by internalizing and externalizing symptoms
and adversity/interpersonal difficulties and their cross-influences. Low self-esteem and
childhood parental loss were more potent variables in the model for men than in women. The
results suggested that, from an aetiological perspective, MDD is largely the same disorder
in men and in women.
4.2.3.4 Pathogenesis of MDD
The pathogenesis of MDD is not known precisely, however there are several hypotheses. The
monoamine hypothesis proposes that mood disorders are caused by a deficiency in serotonin
or noradrenaline systems (Thase et al. 2002). However, it has been found that in its
original form the hypothesis is inadequate, therefore the hypothesis has evolved to
include e.g. adaptive changes in receptors to explain the delay in onset of the
antidepressant effect (Hirschfeld 2000). Moreover, monoamine depletion studies have
demonstrated decreased mood in subjects with a family history of MDD and in drug-free
patients with MDD in remission, but not in healthy subjects, and thus failed to
demonstrate a causal relation between dysfunction in the monoamine systems of serotonin
and noradrenalin and MDD (Ruhe et al. 2007). More recently the hypothesis has evolved into
the direction of a chemical or molecular hypothesis of depression, which presumes that
mood disorders are produced by long-term changes in the production or activity of
molecules e.g. neuropeptides, growth factors and their receptors and intracellular
signalling molecules in the brain (Manji et al. 2001; Castren 2005).
Stress promotes adaptation, but a perturbed diurnal rhythm or failed shut-off of mediators
e.g. glucocorticoids and growth hormone, after stress leads over time to allostatic load
(wear and tear on the body) (McEwen 2003). Abnormal, excessive activation of the
hypothalamic-pituitary-adrenal (HPA) axis is observed in approximately half of individuals
with depression (Nestler et al. 2002). It has been suggested that not only the overall
production of cortisol, but also enhanced corticotrophin releasing factor (CRF) carry the
responsibility for HPA-axis hyperactivity (Nestler et al. 2002). In addition to directly
causing neuronal atrophy and hippocampal volume reduction, life stress and glucocorticoids
also reduce cellular resilience and neurogenesis (Sapolsky 2000; Manji et al. 2001). The
excessive amount of glucocorticoids may also be partly responsible for the decreased level
of brain-derived neurotrophic factor (BDNF) and thus the deficiency in neutotrophic
support (Nestler et al. 2002). It has also been suggested that the elevation of amygdala
activity caused by depressive illness may be the first step that leads to overactivation
of systems involved in physiologic and behavioural coping (McEwen 2003).
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The brain-derived neurotrophic factor hypothesis of depression postulates that loss of
BDNF is directly involved in the pathophysiology of depression, and its restoration may
underlie the therapeutic efficacy of antidepressant treatment. However, critical views
have been recently presented for reassessing this hypothesis and suggested that maybe the
role of BDNF lies more in the genesis of depressive symptoms than at the core of disease
pathology (Groves 2007).
Many brain regions have been implicated in regulating emotions and thus also postulated to
mediate the symptoms of depression (Nestler et al. 2002). Magnetic resonance imaging (MRI)
studies have demonstrated that small hippocampal volumes associate with recurrent MDD, and
when compared with control subjects, MDD patients have had smaller volumes of the orbital
frontal cortex and anterior cingulated cortex (Videbech and Ravnkilde 2004; Campbell and
MacQueen 2006). MRI studies have also revealed decreased white matter volumes in the left
anterior cingulated gyrus and right middle frontal gyrus among elderly MDD patients (Bell-
McGinty et al. 2002), whereas patients with familial MDD have shown enlarged middle genu
area of corpus callosum (Lacerda et al. 2005). Increased rate of white matter
hyperintensities, possily implicating impairment of white matter tracts connecting the
cortex with the limbic areas, has been constantly found in frontal lobes and basal ganglia
in elderly MDD patients (Videbech 1997; MacFall et al. 2001). Recently, white matter
abnormalities have been revealed also in first-episode, treatment-naïve young adults in
frontal, temporal and parietal lobes with a modern MRI technique, diffusion tensor imaging
(DTI) (Ma et al. 2007). Functional neuroimaging techniques i.e. functional magnetic
resonance spectroscopy (fMRI), positron emission tomography (PET) and single-photon
emission computerized tomography (SPECT) have shown changes among MDD patients in
several brain areas, including regions of orbital and medial prefrontal cortex, the amygdala
and related parts of the striatum and thalamus (Drevets 2000). Different brain regions
probably correlate with discrete symptom domains of major depression and together compose
the overall syndrome of MDD (Milak et al. 2005).
Most recently the network hypothesis has proposed that problems in information processing
within neural networks, rather than changes in chemical balance, might underlie
depression, and that antidepressant drugs induce plastic changes in neuronal connectivity
e.g. by increasing the expression and signalling of BDNF, which gradually lead to
improvements in neuronal information processing and recovery of mood (Castren 2005).
4.2.3.5 Course and outcome of MDD
It has been stated that the optimal outcome of treatment of MDD would be remission with an
absence of both symptoms and functional impairments for at least 4 weeks, however this
definition is not yet universally accepted (Keller 2003).
The results of several epidemiological (Eaton et al. 1997; Spijker et al. 2002; Kessler et
al. 2003; Hämäläinen et al. 2004) and clinical studies (Solomon et al. 1997; Furukawa et
al. 2000; Kennedy et al. 2003; Holma et al. 2007) evaluating the duration of MDE have
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varied depending on the methodology used and population concerned. The median duration of
MDE in the ECA (Eaton et al. 1997), the NEMESIS (Spijker et al. 2002) and the Finnish
Health Care Survey (Hämäläinen et al. 2004) study was 8-12 weeks, 3 months and 5 weeks,
respectively. In the NCS-R study (Kessler et al. 2003) the mean duration of MDE was 16
weeks. In recent studies in clinical settings the median duration of MDE has been 3 months
(Furukawa et al. 2000), 20 weeks (Solomon et al. 1997), 7 months (Kennedy et al. 2003) and
11 months (Holma et al. 2007). Overall, in clinical settings the duration of MDE seems to
be somewhat longer than in epidemiological general population studies. Factors associated
with MDE, such as number of prior episodes, longer pretreatment duration, severity and
comorbid psychiatric disorders have been found to predict non-recovery or longer time to
remission (Melartin et al. 2004).
Major depressive disorder appers to be a chronic illness, with high rates of recurrences
and chronicity, but is also variable. Factors like, the severity of MDD and comorbidity,
especially social phobia, have been found to predict the probability of, shorter time to
and number of recurrences over a 5-year follow-up (Holma et al. 2007). In a prospective
12-year National Institute of Mental Health Collaborative Depression Study, patients were
symptomatically ill 59% of weeks and the symptom severity commonly alternated over time in
the same patient (Judd et al. 1998). Approximately 80% of individuals who have experienced
MDE will have at least one more episode of MDD during their lifetime (Angst 1986; Mueller
et al. 1996) and a chronic course of MDE lasting over two years will have about 20% and
over 5 years 12 % (Keller et al. 1992). More recently, over the 5-year follow-up in VDS,
29.3% had no recurrences, whereas 30.0% experienced one, 12.9 % experienced two and 27.9%
experienced three or more recurrences (Holma et al. 2007).
An increased rate of suicidal ideation, suicide attempt and completed suicide is
associated with MDD. In a recent meta-analysis of completed suicides, 43.2% of victims had
an affective disorder, the risk of having a depressive disorder was higher in females than
in males (Arsenault-Lapierre et al. 2004). In the Finnish psychological autopsy study of
completed suicides during one year, 59% of victims had depressive disorder (Henriksson et
al. 1993). The prevalence of suicidal ideation ranges from 47% to 69% in patients with MDD
(Asnis et al. 1993; Bronisch and Wittchen 1994; Zisook et al. 1994), the estimated risk of
a non-fatal suicide attempt after the first lifetime episode of MDD is about 40% (Malone
et al. 1995) and an inpatient with MDD has about a 20-fold risk of completed suicide
(Harris and Barraclough 1997). In a recent Finnish study almost 60% of the depressed
secondary-level care psychiatric out- and inpatients reported suicidal ideation, 15%
attempted suicide at the baseline and 8% during the 18-month follow-up period (Sokero
2006).
4.2.3.6 Comorbidity of MDD
The term comorbidity is used to indicate the occurrence of two or more distinct disorders
in a person in a defined period of time (Klerman 1990). The concept of comorbidity has its
origin in general medicine (Feinstein 1970), but has also been increasingly applied in
36
psychiatry not only to indicate the co-occurence of psychiatric and a general medical
diagnosis (Stordal et al. 2003), but also of two or more psychiatric diagnoses (Melartin
et al. 2002; Kessler et al. 2005b). In psychiatry the concept of comorbidity has been
supported by DSM-III (American Psychiatric Association 1980) and DSM-IV (American
Psychiatric Association 1994) with a multiaxial classification system. Recently the
concept of comorbidity has been criticized for being perhaps an artefact produced by the
categorical diagnostic classification system (Maj 2005) and arguments for a dimensional
approach has been made (Korszun et al. 2004; Watson 2005).
There is increasing evidence of the clinical significance of comorbidity including
treatment response and overall clinical outcome. Comorbidity has been found to be one of
the major factors associated with poor outcome of MDD by increasing the risk of relapse or
recurrence (Alnaes and Torgersen 1997), chronicity (Mueller et al. 1994), suicide (Hansen
et al. 2003), residual symptoms (Paykel et al. 1995) and psychosocial impairment (Rytsälä
et al. 2005). However, several factors may influence the comorbidity findings, including
assessment method used for diagnosis, the time frame of assessment for each disorder (e.g.
lifetime or current) and overall study design (Wittchen 1996).
4.2.3.6.1 MDD and axis I comorbidity
Comorbid psychiatric disorders are common among individuals with MDD in general
population (Kessler et al. 1996; 2003; Hasin et al. 2005), in psychiatric setting
(Melartin et al. 2002) and also in primary care (Vuorilehto et al. 2005) studies.
Several general population studies have evaluated the prevalence of comorbid disorders
among individuals with MDD. In NCS-R study (Kessler et al. 2003), about 80% of respondents
with 12-month DSM-IV MDD had at least one axis I comorbid disorder, anxiety disorders
being the most common (67.8%), followed by substance use disorder (27.1%). In NESARC
study (Hasin et al. 2005) with lifetime DSM-IV MDD the most common comorbid axis I
disorder was any anxiety disorder (41.4%), followed by any alcohol use disorder (40.3%).
In a Finnish Health 2000 study, 32% of respondents with 12-month DSM-IV MDD had at least
one comorbid disorder, anxiety disorder being the most common (25%), followed by alcohol
use disorder (9%) (Pirkola et al. 2005). Regarding lifetime comorbidity, there is evidence
that an anxiety disorder is significantly more likely to precede MDD than the reverse
(Merikangas et al. 2003).
Comorbid disorders tend to be more common in clinical than in epidemiological studies,
probably due to more serious course of illness associated with patients in clinical
settings (Kessler et al. 1994). In a review of current axis I comorbidity of MDD patients
in psychiatric settings, the reported prevalence of comorbid disorders varied widely: all
in all, about half of the patients had a current anxiety disorder and about one fifth a
current substance use disorder (Melartin et al. 2002). In VDS with current MDD about 70%
of cases had at least one current axis I comorbid disorder, anxiety disorders being the
most common, 57%, and substance use disorder the second common, 25% (Melartin et al.
37
2002). In a recent study (Rush et al. 2005) of 1376 outpatienst with DSM-IV MDD assessing
the concurrent comorbidity of MDD with Psychiatric Diagnostic Screening Questionnaire,
61.8% of cases had at least one comorbid disorder, social anxiety disorder (20.8%) being
the most common, followed by GAD (18.8%), OCD (13.4%), PTSD (12.4%), bulimia (11.9%),
any alcohol use disorder (11.9%), panic disorder (11.1%) and agoraphobia (9.4%).
There are only a few studies of psychiatric comorbidity among primary care patients. MDD
patients in primary care or psychiatric out-patient settings have not been found to differ
markedly in current axis I comorbidity (Vuorilehto et al. 2007). In Primary Care-VDS
(PC-VDS) of 137 patients with DSM-IV MDD, 59% had at least one current comorbid axis I
disorder, any anxiety disorder being the most common, 50% (GAD 20%, social phobia 16%,
panic disorder 9% and simple phobia 9%), followed by substance use disorder (16%) and
somatoform disorder (14%) (Vuorilehto et al. 2005).
4.2.3.6.2 MDD and axis II comorbidity
By definition, personality traits defining personality disorders must be distinguished
from characteristics that emerge in response to depression (American Psychiatric
Association 2000b), which makes the assessment of comorbidity of MDD and personality
disorders difficult, especially in cross sectional studies, during a major depressive
episode.
There is only a little information of the prevalence of MDD with comorbid axis II
disorders in the general population. In ODIN study (Casey et al. 2004), conducted in five
European countries, and in NESARC study (Hasin et al. 2005), 22% and 38% of individuals,
respectively, with MDD had personality disorder. The most common comorbid personality
disorders in ODIN study were cluster C personality disorders, whereas in NESARC study
obsessive-compulsive personality disorder (18.3%), followed by paranoid (15.1%), schizoid
(10.2%), avoidant (9.6%), antisocial (8.1%), histrionic (5.3%) and dependent (2.2%)
personality disorders (borderline, schizotypal and narcissistic were not included in the
study).
In a review of current axis II comorbidity of MDD patients in psychiatric settings, the
reported prevalence of comorbid personality disorders varied widely (18%-86%): overall,
about half of the patients had a current personality disorder (Melartin et al. 2002). In a
study of 859 out-patients, 51.3% with a current DSM-IV MDD had at least one personality
disorder, cluster C disorders being the most common (27.3%), especially avoidant
personality disorder (20.3%), followed by cluster B (14.1%) and cluster A (7.3%)
personality disorders (Zimmerman et al. 2005). In VDS, 44% of patients with current MDD
had at least one personality disorder, cluster C personality disorders being the most
common (32%), followed by cluster A (19%) and B (14%) personality disorders (Melartin et
al. 2002).
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MDD patients appear to differ little in axis II comorbidity between primary care and
psychiatric out-patient settings. Comorbid personality disorders have been found to be
present in about half of MDD patients in primary care or psychiatric out- or inpatient
settings, although the clusters might be unevenly distributed; cluster A personality
disorders have been found to associate more with psychiatric care, whereas cluster B
disorders more with primary care treatment (Vuorilehto et al. 2007). In PC-VDS, 58% of
DSM-IV MDD patients had a comorbid axis II disorder, cluster B (35%) and C (35%)
personality disorders being the most common, followed by cluster A (7%) personality
disorder (Vuorilehto et al. 2005).
There are some studies of the long-term stability of personality disorders. In a study of
142 outpatients with MDD, the 10-year stability of categorical personality disorder
diagnosis was found to be relatively poor and not higher than that of anxiety disorders
(Durbin and Klein 2006). However, the relative stability of personality disorder
dimensional scores was greater than that for categorical diagnosis, generally reaching a
moderate level, and approached the long-term stability of normal-range personality traits.
4.2.3.7 Treatment of MDD
In order to improve the detection and treatment of MDD, several sets of evidence-based
treatment guidelines have been published during the last decade. These guidelines cover
the basics and objectives for the management of depression with various regimes, including
pharmacotherapy, psychotherapy, combination of pharmaco- and psychotherapy,
electroconvulsive therapy (ECT) and bright light therapy (Schulberg et al. 1998; Crismon
et al. 1999; American Psychiatric Association 2000a; Anderson et al. 2000; Suomen
Psykiatriyhdistys 2000; Bauer et al. 2002a, b; National Institute of Clinical Excellence
2004). Other treatments that have been used for MDD are among others exercise (Ernst et
al. 2006) and sleep deprivation (Wirz-Justice 2006). New treatments for MDD currently
being evaluated include brain stimulation (transcranial magnetic stimulation, deep brain
stimulation and vagus nerve stimulation) (Eitan and Lerer 2006; Ressler and Mayberg 2007)
and intravenous injection of ketamine (Zarate et al. 2006). Other targets for future
agents include neuropeptide Y, vasopressin V1b, nicotinic cholinergic, delta-opiate,
dopamine D1, cytokine, and corticotrophin-releasing factor 1 receptors, as well as, GABA,
intracellular messenger systems, and transcription, neuroprotective and neurogenic factors
(Manji et al. 2003; Mann 2005).
There are three phases of treatment: the acute, continuation and maintenance phases. In
the acute phase, the aim of the treatment is full remission, in the continuation phase,
the prevention of relapse, and in the maintenance phase, the prevention of recurrence
(Suomen Psykiatriyhdistys 2000). The most used treatments for MDD in Finland are
antidepressant treatment with or without augmenting and adjunctive medications;
psychotherapy and ECT.
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4.2.3.7.1 Antidepressant treatment
The more severe the depression is, the more important the antidepressants are for the
treatment of MDD. In severe or psychotic depression antidepressant treatment is always
indicated, whereas in mild or moderate cases of depression, effective psychotherapy, alone
or combined with pharmacotherapy, are also possible alternatives (Suomen Psykiatriyhdistys
2000). Since most antidepressants have similar effectiveness, the choice of medication
depends on the history of responses to medication, medication tolerability, adverse
effects and likelihood of adherence, concurrent with other medical conditions and drug
therapies and also cost of medication (Suomen Psykiatriyhdistys 2000). The decision to
increase the dose, change the medication, or add another medication or therapy should be
made, if there is not a clear response after 6 to 8 weeks treatment with the initial
medication with adequate dose (Suomen Psykiatriyhdistys 2000), although recently stricter
time limits of 3 to 4 weeks have been suggested (Trivedi et al. 2007). In a recent STAR-D
study (National Institute of Mental Health) of 2876 out-patients, 37% remitted after the
first antidepressant, 50% after two treatment steps and the theoretical cumulative
remission rate after four active treatment steps during 8 months was 67% (Rush et al.
2006). An association between treatment response and marker alleles of both the GRIK4
(Paddock et al. 2007) and 5-HTR2A (McMahon et al. 2006) has been detected, indicating that
the individual variation in antidepressant treatment outcome seems to have at least
partial genetic basis. Altogether about 2/3 of those MDD patients who use antidepressant
medication will respond and about half will be nearly symptom free after 6 to 8 weeks
treatment (Suomen Psykiatriyhdistys 2000).
The continuation phase should generally last four to nine months after the induction of
remission in order to prevent relapses, and after that, maintenance phase treatment should
be considered after 3 or more lifetime episodes to prevent recurrences (Suomen
Psykiatriyhdistys 2000). The factors that influence on the decision whether to use
maintenance phase treatment include severity of the episodes (presence of suicidality,
severe functional impairments and psychotic features), the risk of recurrence (residual
symptoms between episodes, presence of comorbid conditions and number of prior episodes),
possible side effects and patient preference (American Psychiatric Association 2000a).
4.2.3.7.2 Psychosocial treatment
Psychosocial treatment consists of specific psychotherapy and social support. This
treatment should be considered regularly when substantial psychosocial stressors,
interpersonal difficulties, or coexisting developmental or personality disorders are
present (American Psychiatric Association 2000a). Specific psychotherapies that are used
in the treatment of MDD include cognitive and cognitive-behavioural therapy, interpersonal
psychotherapy, brief psychodynamic psychotherapy and certain problem-solving therapies
(Roth and Fonagy 2005). In the acute phase treatment of mild or moderate depression,
psychotherapy can be used alone or in combination with antidepressants. In the
continuation and maintenance phase treatment, psychotherapy alone or in combination with
antidepressants may reduce the risk of a relapse or recurrence (Suomen Psykiatriyhdistys
2000).
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4.2.3.7.3 Electroconvulsive treatment (ECT)
Electroconvulsive treatment was developed 70 years ago and since then it has been used as
a treatment for mental disorders. It has been found to be effective treatment for severe
and psychotic depression and should be considered for MDD patients who have medication
resistance or when rapid relief of depressive symptoms is needed e.g. severe suicidality
(Suomen Psykiatriyhdistys 2000). In a recent review and meta-analysis on the efficacy of
ECT, it was concluded that ECT is an effective short-term treatment for depression, and is
probably more effective than drug therapy; bilateral ECT being moderately more effective
than unilateral, and high dose ECT more effective than low dose (The UK ECT review group
2006).
4.3 Anxiety as a dimensional concept
4.3.1 Anxiety as an emotion
Feelings of fear and mild anxiety appear in everyday life. As an affect, anxiety is
usually self-limited and does not significantly interfere with a person’s functional
capacity. Anxiety is often considered as a secondary emotion in response to the primary
emotion of fear (Belzung and Philippot 2007). A prerequisite for the feeling of anxiety is
thought to be the ability to keep in mind and to summon up prior emotional responses
through the frontal cortex (Belzung and Philippot 2007). Also other brain regions
including amygdala have been found to have a critical role in the processing of fearful
and anxious stimuli (Stein et al. 2007). Moreover, it has been found that the individual
variation in response to emotional stimuli is partly moderated by genetic factors e.g. the
amygdala response to emotional face processing by functional variation in the serotonin
transporter gene (Hariri et al. 2002).
4.3.2 Symptoms of anxiety
Not only depression, but also anxiety can be understood on a continuous scale, ranging
from no anxiety symptoms, anxiety symptoms, subthreshold anxiety disorder and finally
anxiety disorder. When enough signs and symptoms are clustered together, a diagnosis of
anxiety disorder can be made. There seems to be also fluctuations across threshold and
subthreshold levels over time among those who experience anxiety (Merikangas et al. 2003).
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4.3.2.1 Measures of symptoms of anxiety
Anxiety symptoms can be measured by using general measures i.e. diagnostic interviews,
general psychiatric symptoms measures and disorder specific scales. Diagnostic interviews
applied to measure not only depression, but also anxiety symptoms are presented in
4.2.2.1.1., wheras general psychiatric symptoms measures applied to measure not only
depression, but also anxiety symptoms are presented in 4.2.2.1.2.
4.3.2.1.1 Specific anxiety symptoms measures
Of anxiety disorder measures, only few assess general anxiety, including 21-item Beck
Anxiety Inventory (BAI, Beck et al. 1988b) and the 14-item Hamilton Anxiety Rating Scale
(HARS, Hamilton 1959). However, there are several scales developed to detect the symptoms
of a specific anxiety disorder, including the Fear Questionnaire (FQ, Marks and Mathews
1979) for common phobia symptoms; the Anxiety Sensitivity Index (ASI, Reiss et al. 1986)
and the Panic Disorder Severity Scale (PDSS, Shear et al. 1997) for panic disorder
symptoms; the Mobility Inventory (MI, Chambless et al. 1985) for agoraphobia symptoms; the
Social Phobia and Anxiety Inventory (SPAI, Turner et al. 1989), the Brief Social Phobia
Scale (BSPS, Davidson et al. 1991) and the Liebowitz Social Anxiety Scale (LSAS, Liebowitz
1987) for social phobia symptoms; the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS,
Goodman et al. 1989b; Goodman et al. 1989a) and the Padua Inventory (PI, Sanavio 1988) for
obsessive-compulsive symptoms; the Clinician-Administered PTSD Scale (CAPS, Blake et al.
1990), the Impact of Event Scale (IES, Horowitz et al. 1979), the Post-traumatic Stress
Diagnostic Scale (PDS, Foa et al. 1997) and the Mississippi Scale (MSS, Keane et al. 1988)
for post-traumatic stress disorder symptoms and the Penn State Worry Questionnaire (PSWQ,
Meyer et al. 1990) for the symptoms of pathological worry.
4.3.2.1.2 Beck Anxiety Inventory
The self-report Beck Anxiety Inventory was specifically developed as a measure to
discriminate between anxiety and depression, although the correlation between BAI and e.g.
BDI is substantial (r=0.61) (Beck et al. 2000). The BAI is well suited for monitoring
change with treatment and may be a useful screening tool for unselected individuals (Beck
et al. 2000). Each item in the scale is rated from 0 to 3, the total score ranges from 0
to 63. The recent guidelines suggest the following interpretation of severity scores: 0-9,
normal; 10-18, mild to moderate; 19-29, moderate to severe and 30-63 severe anxiety (Beck
et al. 2000). The BAI has high internal consistency (Cronbach’s alphas reported in five
studies ranged from 0.9 to 0.94) and has demonstrated moderate to high correlations with
other scales e.g. with HARS (r=0.51) (Beck et al. 2000). BAI does not assess avoidance
symptoms nor symptoms of generalized anxiety disorder (GAD), including worry, difficulty
to concentrate, irritability or sleep disturbance (Beck et al. 2000).
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4.3.2.2 Epidemiology of symptoms of anxiety
The symptoms of anxiety are common. In a primary care study with 1 001 patients,
subthreshold symptoms of anxiety were as or more common than their respective DSM-IV axis
I disorders: panic (10.5% vs. 4.8%), anxiety (6.6% vs. 3.7%), obsessive-compulsive (5.8% vs.
1.4%) (Olfson et al. 1996). Of general population studies, in the Epidemiological
Catchment Area Program study (1980) and the Midlife development in the United States
Survey (1996) the lifetime prevalence for panic attacks was found to be 5.3% and 12.7%,
respectively (Goodwin 2003). In a Canadian community survey (1996) of social phobia, 39.6%
of 1956 respondents had at least one, and most (27.8%) 1-3 out of 12 different DSM-IV
social fears or avoidance during the last year; with the fear of eating while being
observed being the least common (4.2%), and the fear of giving a speech in public the most
common (15.1%) (Stein et al. 2000). In a French study of social phobia, 67.1% of 12 873
respondents from the general population had at least one strong fear in social situations
and 26.9% of respondents fear or avoidance most or some of the time during their whole
lifetime (Pelissolo et al. 2000). In a German study of generalized anxiety disorder, 7.8%
and 4.1% of 4181 respondents from the general population reported a period of at least one
month and 3 months in the past 12 months, respectively, when they felt themselves most of
the time worried, tense or anxious (Carter et al. 2001). In a more recent study of
obsessive-compulsive spectrum disorders among 591 young adults, the one-year prevalence
for OCD, Obsessive-Compulsive Syndrome (1 symptom criteria and moderate distress) and
obsessive-compulsive symptoms was 0.7%, 2,5% and 3.9%, respectively (Angst et al. 2004).
Thus, the prevalences of anxiety symptoms and subthreshold anxiety disorders tend to be
higher than the prevalence of a corresponding anxiety disorder.
Comorbidity between subthreshold conditions and between subthreshold and threshold
conditions is common. In a 15-year longitudinal study of 591 general population young
adults, 25% had subthreshold anxiety at least once during the five interviews, and of
those, in at least one interview 32% had also subthreshold depression and 22% DSM-III-R
MDD (Angst et al. 1997) In a more recent study of 1704 randomly selected adolescents,
16.5% had subthreshold anxiety and of those 38.3% had also subthreshold depression and
25.9% DSM-III-R MDD (Lewinsohn et al. 2004).
The prevalence of anxiety symptoms can be measured also by using symptom scales e.g. BAI.
In such an Australian study among 326 students, 42% had BAI scores less than 9, 35% scored
from 10 to 18, 17% from 19 to 29 and 6% over 30 (Creamer et al. 1995).
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4.3.2.3 Clinical impact of subthreshold symptoms of anxiety
Less severe constellation of anxiety symptoms not meeting the criteria of any anxiety
disorder, are often called subthreshold disorders, analogous to subthreshold depressive
disorders (Pincus et al. 1999). Compared to subthreshold depressive disorders,
subthreshold level of anxiety disorders are less studied and the information of these
conditions is more sparse (Olfson et al. 1996; Magruder and Calderone 2000).
An increased rate of impairment and disability has been found to associate with
subthreshold symptoms of anxiety. In a study of 201 primary care patients with
subthreshold level of anxiety, Ormel et al. (1993) found that 40% of patients had at least
mild impairment in their social, and 30% in their occupational role. Moreover, among
patients with subthreshold level of comorbid anxiety and depressive symptoms, 43% had at
least mild impairment in their social role, and 57% in their occupational role. In
addition, anxiety symptoms with comorbid depressive symptoms have been found to associate
strongly with functional somatic symptoms (Haug et al. 2004).
4.3.2.4 Course and outcome of symptoms of anxiety
Anxiety symptoms with or without comorbid depressive symptoms tend to be persistent and
long lasting. In a study of 201 primary care patients, during 3  -year follow-up, only 29%1/2
of those who had baseline subthreshold symptoms of anxiety recovered fully and 36% of
those who had baseline subthershold comorbid symptoms of depression and anxiety recovered
fully (Ormel et al. 1993). In another 20-year longitudinal study 77 out of 591 young
adults had obsessive-compulsive symptoms, but not OCD; of those 77 the course of
obsessive-compulsive symptoms was chronic for 50%, recurrent for 35.7% and only 14.3% had
a single episode (Angst et al. 2004).
There is indication, that the emergence of subthreshold or threshold depressive states
among those with subthreshold or threshold anxiety states is far more common than the
converse (Merikangas et al. 2003). In a 15-year longitudinal study of 591 young adults,
anxiety states tended to develop either into depression alone or into anxiety with
depression, whereas depression tended to be more stable than anxiety alone over time, the
patterns of stability were similar also for subthreshold states (Merikangas et al. 2003).
4.3.3 Anxiety disorders
Anxiety disorders are among the most prevalent psychological disorders and also the burden
of illness associated with these disorders is often considerable. Persons having anxiety
disorder tend to have a high degree of comorbid conditions, especially depression,
impairment, health care visits and disability (Fehm et al. 2005; Goodwin et al. 2005; Lieb
et al. 2005).
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Most common anxiety disorders included in DSM-IV and also discussed later are Agoraphobia,
Panic Disorder Without Agoraphobia, Panic Disorder With Agoraphobia, Social Phobia,
Specific Phobia, Generalized Anxiety Disorder (GAD), Obsessive Compulsive Disorder (OCD)
and Post-traumatic Stress Disorder (PTSD). Other anxiety disorders also included in DSM-IV
are Panic Attack, Acute Stress Disorder, Anxiety Disorder Due to a General Medical
Condition, Substance-Induced Anxiety Disorder and Anxiety Disorder Not Otherwise
Specified.
Panic Attacks can occur in the context of any anxiety disorder as well as other mental
disorders e.g. MDD and it is not a codable disorder. Symptoms of Acute Stress Disorder are
experienced during or immediately after the trauma, last for at least 2 days, and either
resolve within 4 weeks after the conclusion of the traumatic event or the diagnosis is
changed to Post-traumatic Stress Disorder. Anxiety Disorder Not Otherwise Specified
includes disorders with prominent anxiety or phobic avoidance that do not meet criteria
for any specific Anxiety Disorder or Adjustment Disorder (American Psychiatric Association
2000b).
4.3.3.1 Epidemiology of anxiety disorders
The prevalence rates of anxiety disorders have been found to vary considerably between
studies. In a review of 41 separate studies, several factors were found to be associated
with heterogeneity among prevalence rates, including diagnostic criteria and diagnostic
instrument used, sample size of the study, country studied and response rate (Somers et
al. 2006). The prevalences, age of onset and female-male − ratio of Panic Disorder,
Agoraphobia, Social Phobia, Specific Phobia, Generalized Anxiety Disorder, Obsessive
Compulsive Disorder and Post-traumatic Stress Disorder and any anxiety disorder are
presented in Table 2.
4.3.3.2 Etiology of anxiety disorders
The etiology of anxiety disorders includes a multiplicity of factors, such as genetic and
other biological, psychological and social determinants, which are mediated by a range of
risk and protective factors (Hettema et al. 2001; Fricchione 2004; Jenike 2004; Katon
2006; Schneier 2006).
Hypothesis of a common underlying factor for both anxiety and depressive disorders has
also been proposed (Krueger 1999a). In a 15-year longitudinal study of depression and
anxiety (GAD and panic disorder) among 591 young adults, the major finding was the
longitudinal stability of comorbid anxiety and depression disorders, suggesting a common
underlying diathesis for at least part of these disorders (Merikangas et al. 2003). Also
genetic studies have revealed the relatedness of anxiety and depressive disorders. When
studying more than 5600 members of twin pairs, Kendler et al. (2003a) found that when
dividing common psychiatric and substance use syndromes into two broad groups of
internalizing and externalizing disorders, anxiety disorders (GAD, panic disorder and
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specific phobias)  and  major  depressive  disorder  belonged  both  to  internalizing disorders.
Within the internalizing disorders, two genetic factors, anxious-misery (MDD, GAD and
panic disorder partly) and fear (animal and situational phobia and panic disorder partly)
could be detected to predispose to disorders, and genetic factors were found to be largely
responsible for the pattern of this comorbidity (Kendler et al. 2003a). Later exposure to
unique environmental experiences may explain why one disorder vs. another develops in
genetically vulnerable individuals (Kendler et al. 2003a).
4.3.3.3 Clinical characteristics of anxiety disorders
The central clinical characteristics of Panic Disorder, Agoraphobia, Social Phobia,
Specific Phobia, Generalized Anxiety Disorder, Obsessive Compulsive Disorder and
Post-traumatic Stress Disorder are presented in Table 3.
Table 2. The prevalences, age of onset and female-male − ratio of essential anxiety disorders.
Anxiety Disorder    Prevalence rate (%)                                                 Age of onset  Female : Male5
                         World:                       Europe:        Finland: 
                         Pooled prevalences of 41 studies.    Wittchen and   Pirkola et al.
                         Somers et al. 2006                   Jacobi 2005    2005
                         12-month           Lifetime          12-month       12-month
                         (95% CI)           (95% CI)          median
  Panic Disorder         0.99 (0.55-1.5)    1.2 (0.7-1.9)     1.8            1.9              early to middle 20s1   2-3.5:1
  Agoraphobia            1.6  (1.0-2.3)     3.8 (2.5-5.6)     1.3            1.2                                     2-4:1
  Social Phobia          4.5 (3.0-6.4)      3.6 (2.0-5.6)     2.3            1.0              12-17 years2           1.2-2.6:1  
  Specific Phobia        3.0 (0.98-5.8)     5.3 (3.4-7.9)     6.6                             childhood or early     2-4:1
                                                                                              adolescence6
  GAD                    2.6 (1.4-4.2)      6.2 (4.0-9.2)     1.7            1.3              < 25 years3            1.5-2:1
  OCD                    0.54 (0.28-0.86)    1.3 (0.86-1.8)    0.7                             22 - 364               1:1
  PTSD                   1.2 (0.09-3.4)     2.1 (0.4-4.9)                                     can occur at any age7   2:17
  Any anxiety disorder   10.6 (7.5-14.3)    16.6 (12.7-21.1)                  4.2                                     2:1
1 Katon 2006, 2 Schneier 2006, 3 Fricchione 2004, 4 Jenike 2004, 5 Somers et al. 2006, 6 Harvey and Rapee 2002, 7 Keane et al. 2006
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4.3.3.4 Course and outcome of anxiety disorders
Some  main  features of  clinical course and outcome of Panic Disorder, Agoraphobia, Social
Phobia, Specific Phobia, Generalized Anxiety Disorder, Obsessive Compulsive Disorder and
Post-traumatic Stress Disorder are presented in Table 4.
Table 3. The central clinical characteristics of Panic Disorder, Agoraphobia,
Social Phobia, Specific Phobia, GAD, OCD and PTSD in DSM-IV.
Anxiety Disorder    Clinical picure of anxiety                    Avoidance behaviour
  Panic Disorder         Recurrent, also spontaneous panic attacks,    Without agoraphobia, no.
                         with or without agoraphobia.                  With agoraphobia, yes.
  Agoraphobia            Fear of developing "panic-like symptoms",     Avoidance of places or situations from
                         without having Panic Disorder.                which escape might be difficult.
  Social Phobia          Anxiety in feared social situations.          Avoidance of social and performance
                                                                       situations.
  Specific Phobia        Anxiety, if exposured to feared object        Avoidance of phobic situations.
                         or situation.
  GAD                    Chronic anxiety and difficulty to             No avoidance behaviour.
                         control the worry.
  OCD                    Obsessions and compulsions.                   Avoidance of the content of obsessions.
  PTSD                   Re-experience of the traumatic event,         Avoidance of stimuli associated with the
                         symptoms of increased arousal, numbing        trauma.
                         of general responsiveness.
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Table 4. Some main features of course and outcome of Panic Disorder, 
Agoraphobia, Social Phobia, Specific Phobia, GAD, OCD and PTSD. 
Anxiety Disorder    Clinical course              Outcome
  Panic Disorder1        Usually relapsing-remitting disorder.        Approximately 20% of patients have a
                                                                      chronic course. Coexisting MDD,
                                                                      agoraphobia and personality disorder
                                                                      predicts more persistant symptoms of
                                                                      anxiety.
  Agoraphobia8           Often continuous, lifelong.                  May persist for years and be associated
                                                                      with considerable impairment.
  Social Phobia2        Often continuous, lifelong.                  May attenuate in severity or remit
                                                                      during adulthood and fluctuate with life
                                                                      stressors and demands.
  Specific Phobia9       Often continuous, lifelong.                  Phobias that persist into adulthood
                                                                      remit only infrequently (around 20% of
                                                                      cases).
  GAD3                  Chronic, but fluctuates, often worsens       Chronic, about 40% in remission at five
                         during times of stress.                      years. Low remission rate associates
                                                                      with personality disorder and
                                                                      poor-quality family relationships.
  OCD4,7                 Often long delay in diagnosis. The           May remit, but can be relapsing or
                         symptoms wax and wane over time.             chronic. Up to 40% of patients who
                                                                      present to psychiatrists fail to respond
                                                                      to treatment.
  PTSD5,6                Often Acute Stress Disorder precedes.        50% in remission at 2 years, 30% having
                         Symptoms usually begin within 3 months       the disorder at 6 years.
                         after the trauma and may reactivate in
                         response to reminders of the original
                         trauma, life stressors or new traumatic
                         event.
1 Katon 2006, 2 Schneier 2006, 3 Fricchione 2004, 4 Heyman et al. 2006, 5 Bisson 2007, 6 Keane et al. 2006,
7 Jenike 2004, 8 Pollack et al. 2002, 9 Craske et al. 1996
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4.4 Dimensions of temperament and personality
4.4.1 Definition of the concepts
The  term  temperament  refers  to  individual  differences in  general  mood  or  qualities  of
emotional responses that appear early in life, remain fairly stable, are inherited and are
based in biological processes (Bates 2000; Pervin et al. 2005). The pattern of
self-regulation is also an essential part of temperament (Rothbart 1989; Bates 2000).
Thus, temperament can be seen as the early appearing biological core of later adult
personality. There exist several theories of temperament with different emphasis and
number of temperament dimensions. Adult temperament theories include the theories of
Strelau (1993) and Cloninger (1993) and child temperament theories include the theories of
Thomas and Chess (1977), Buss and Plomin (1975), Kagan (1986) and Rothbart and
Derryberry (1981).
In contrast to temperament, many aspects of personality do not have their basis in
inherited biology. Personality can be conceptualized as a large entity of individual
differences including values, motives, attitudes, needs, coping mechanisms, capabilities,
attainments and self-esteem. Thus, personality develops from the temperament through
experiences, maturation and interaction with environment. (Pervin et al. 2005)
In the trait theories of personality it is assumed that individuals possess broad
predispositions, called traits, to respond in particular ways, i.e. personality traits
refer to consistent pattern in the way an individual behaves, feels and thinks. The traits
provide a way to summarize how one person differs from another and to make predictions
about the person’s future behaviour (Pervin et al. 2005). According to the trait theories,
at its simplest level, behaviour can be considered in terms of specific responses that can
futher be linked together as habits, and habits grouped as traits. Finally various traits
may be linked together to form higher-order factors or dimensions. To identify traits and
higher-order factors, a statistical technique of factor analysis is used, where the
correlations among a set of trait terms in language are analysed in order to determine
those variables that increase or decrease together (Pervin et al. 2005). Several trait
theories of personality have been developed including the 16-factor model (Cattell 1965),
the three factor model (Eysenck and Eysenck 1975) and the five factor model (Costa Jr. and
McCrae 1992).
In adulthood, there is convergence between temperament and personality trait constructs.
Substantial measurement overlap between temperament and personality measures has often
been found (Zuckerman and Cloninger 1996; De Fruyt et al. 2000) and the term temperament
has sometimes been used synonymously with personality or personality dimension (Eysenck
1991), and it has been suggested that temperament characteristics may be understood as
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early-appearing personality traits (Buss and Plomin 1984). However, until more
longitudinal studies from infancy to adulthood has been taken place, the question how
temperament and personality dimensions relate to each other remains open.
Recently, a comprehensive framework of personality psychology has been proposed for
understanding the whole person (McAdams and Pals 2006). According to this proposal,
personality consists of five big principles that suggest a framework for integrating
personality traits with those self-defining features of psychological individuality,
constructed in response to situated social tasks and the human need to make meaning in
culture. In this model, personality is conceived as an individual’s unique variation on
the general evolutionary design for human nature, expressed as a developing pattern of
dispositional traits, characteristic adaptations and self-defining life narratives,
complexly and differentially situated in culture and social context
4.4.2 Personality dimensions and their measurement
Although there has been a long debate on the sufficient number of personality traits
during the last decades, no consensus exists. However, almost all major theories of
personality include two broad personality dimensions, neuroticism and extraversion,
describing negative and positive trait entities, respectively (Watson et al. 1999).
Nowadays more and more support among trait theorists is emerging around the five-factor
model, consisting of Neuroticism, Extraversion and three additional factors
(Agreeableness, Conscientiousness and Openness to new experience), each factor having six
facets. Support for this model comes from factor analyses of large sets of trait terms in
the language, cross-cultural research testing the universality of trait dimensions and the
relation of trait questionnaires to other questionnaires and ratings (Pervin et al. 2005).
Several five-factor solutions and questionnaires exists, perhaps the most widely used is
NEO-PI-R (Table 5.) (Costa Jr. and McCrae 1992).
Several scales have been developed to measure personality dimensions. The questionnaires
are usually used as self-rated, but can also be used as observer- or peer-rated (Pervin et
al. 2005). These questionnaires include the 57-item Eysenck Personality Inventory (EPI,
Eysenck and Eysenck 1964), the Cattell’s 16 Personality Factors Questionnaire (16 PF,
Cattell 1965), the 567-item Minnesota Multiphasic Personality Inventory (MMPI, Dahlstrom
et al. 1975), the 135-item Karolinska Scales of Personality (KSP, Schalling 1986), the
276-item Multidimensional Personality Questionnaire (MPQ, Tellegen et al. 1988) the
51-item Munich Personality Test (MPT, von Zerssen et al. 1988), the 10-item Positive and
Negative Affect Schedule (PANAS, Watson et al. 1988), the 89-item Zuckerman and
Kuhlman’s Personality Questionnaire (ZKPQ, Zuckerman et al. 1993) and the 240-item
Five-Factor Personality Inventory-Revised (NEO-PI-R, Costa Jr. and McCrae 1992). While
the overall composition of these personality trait inventories vary markedly, all
include and measure the essentially similar dimensions of neuroticism and extraversion
(Clark et al. 1994; Enns and Cox 1997).
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Eysenck Personality Inventory (form A and B) (Eysenck and Eysenck 1964), its forerunner
the Maudsley Personality Inventory (Eysenck 1959) and its successor Eysenck Personality
Questionnaire (Eysenck and Eysenck 1975) and its revised version EPQ-R (Eysenck and
Eysenck 1991) have been developed by factor analysis and all measure two major dimensions
of personality, extraversion-introversion and neuroticism (alternatively called emotional
stability versus instability). A third dimension, called Psychoticism (P), was added into
EPQ and EPQ-R. Individuals high on P dimension tend to be solitary, intensive, uncaring
about others and opposed to accepted social custom (Eysenck and Eysenck 1975). In
addition, a fourth factor, called Lie scale, was included in EPI, EPQ and EPQ-R to detect
individuals "faking good" (Eysenck and Eysenck 1964). Corresponding scales on EPI form A
and B, as well as on EPI and on EPQ correlate highly and are assumed to measure identical
dimensions of personality (Eysenck and Eysenck 1964; Eysenck and Eysenck 1975). Several
validation studies of N and E dimensions have been done around the world (Barrett et al.
1998), and also in Finland using EPQ (Eysenck and Haapasalo 1989).
4.4.2.1 Neuroticism
Neuroticism (N) is characterized by proneness to anxiety, emotional instability and
self-consciousness. A high neuroticism scorer is someone who tends towards anxiety and
depression, worries, has bad sleep and psychosomatic disorders, allows emotions to affect
judgement and is preoccupied with things that might go wrong, whereas low N scorer
recovers quickly after an emotionally upsetting experience and is generally calm and
unworried (Eysenck and Eysenck 1964). The core of neuroticism and other similar
dimensions, including negative emotionality (NE, Tellegen et al. 1988) and negative
affectivity (NA, Watson et al. 1988) is believed to be sensitivity to negative stimuli
(Clark et al. 1994). N/NE/NA have also been linked with an aversive motivational system
(the behavioural inhibition system), which is believed to increase non-specific arousal
and attention to threat-related stimuli and inhibit behaviour (Clark et al. 1994).
Moreover, it has been hypothesized that neuroticism is a reflection of individual
differences in the activation thresholds of the sympathetic nervous system (fight/flight
response) (Eysenck 1990).
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Table 5. The Big Five trait factors, facets and factor definitions.
Factor    Factor definition              Facets
  Neuroticism (N)        Assesses adjustment vs. emotional            Anxiety, Self-consciousness, Depression,
                         instability. Identifies individuals e.g.     Vulnerability, Impulsiveness, Angry
                         prone to psychological distress.             Hostility.
  Extraversion (E)       Assesses quantity and intensity of           Gregariousness, Activity Level,
                         interpersonal interaction; activity          Assertiveness, Excitement Seeking,
                         level; need for stimulation and capacity     Positive Emotions, Warmth.
                         of joy.                                      
  Openness (O)           Assesses proactive seeking and               Fantasy, Aesthetics, Feelings, Ideas,
                         appreciation of experience for its own       Actions, Values.
                         sake; toleration for and exploration of      
                         the unfamiliar.                              
  Agreeableness (A)      Assesses the quality of one’s                Straightforwardness, Trust, Altruism,
                         interpersonal orientation along a            Modesty, Tendermindedness, Compliance.
                         continuum from compassion to antagonism      
                         in thoughts, feelings, and actions.          
  Conscientiousness (C)   Assesses the individual’s degree of          Self-discipline, Dutifulness,
                         organization, persistence, and               Competence, Order, Deliberation,
                         motivation in goal-directed behaviour.       Achievement Striving.
The  distribution  of  neuroticism scores  in  the  population approximates to a normal curve,
women scoring usually higher on N than men (Eysenck and Eysenck 1964). Neuroticism and
extraversion dimensions have been found to have a negative correlation with each other
(Eysenck and Eysenck 1964), especially amongst high N scorers (Buckingham et al. 2001). A
negative correlation between N and age has also been reported (Eysenck and Eysenck 1964;
Eysenck and Eysenck 1975). Both test-retest correlation (r=0.8-0.9) and internal
consistency (alpha from 0.84 to 0.85) have been found to be good (Eysenck and Eysenck
1964; Eysenck and Eysenck 1975). EPI or EPQ N score correlates with N or similar scores
from other inventories, including NEO-PI-R-N (r=0.77) and ZKPQ-N-Anxiety (r=0.80) (Aluja
et al. 2002) as well as PANAS-Negative Affect Scale (r=0.58)(Watson et al. 1999). In the
Finnish validation study of EPQ, internal consistency of N was found to be good
(Cronbach’s alpha 0.84), females scored higher on N than males (mean 12.25, sd 4.87 vs.
10.13, sd 5.02) and N correlated negatively with E (r=-0.20 for females; r=-0.22 for
males)(Eysenck and Haapasalo 1989).
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4.4.2.2 Extraversion
Extraversion involves positive emotionality, energy and dominance. A typical extravert is
sociable, likes parties, has many friends, needs to have people to talk to and does not
like reading or studying by him/herself, whereas a typical introvert is a quiet, retiring
sort of person, introspective, fond of books rather than people, is reserved and distant
except to intimate friends (Eysenck and Eysenck 1964). The core of extraversion and other
similar dimensions including positive emotionality (PE, Tellegen et al. 1988) and positive
affectivity (PA, Watson et al. 1988) is believed to be affective, reflecting a tendency to
experience positive mood states. E/PE/PA has also been linked to behavioural activation
system and to the behavioural facilitation system (Clark et al. 1994). Poor regulation of
the behavioural facilitation system has been found to associate, on the low end of E/PE/PA
dimension, with low energy and activity levels, withdrawal, decreased cognitive capacity,
anhedonia and depressed mood (Clark et al. 1994). Moreover, it has been hypothesized that
extraversion reflects cortical arousal, introverts being chronically overaroused (anxious)
and extraverts underaroused (bored) (Eysenck 1990).
The distribution of extraversion scores in the population approximates to a normal curve,
men scoring usually higher on E than women (Eysenck and Eysenck 1964). A negative
correlation between E and age has been found (Eysenck and Eysenck 1964; Eysenck and
Eysenck 1975), slightly stronger among males than females (Eysenck and Eysenck 1975). Both
test-retest correlation (r=0.80-0.97) and internal consistency (alpha from 0.84 to 0.86)
have been found to be good (Eysenck and Eysenck 1964; Eysenck and Eysenck 1975). EPI or
EPQ E score correlates with E or similar scores from other inventories, including
NEO-PI-R-E (r=0.77) and ZKPQ-Surgency (r=0.74) (Aluja et al. 2002), as well as
PANAS-Positive Affect Scale (r=0.51) (Watson et al. 1999).
In the Finnish validation study of EPQ, internal consistency of E was found to be good
(Cronbach’s alpha 0.86), males scored slightly higher than females (mean 10.58, sd 4.80
vs. 10.01, sd 4.86) (Eysenck and Haapasalo 1989).
4.4.3 Temperament dimensions and their measurement
Several scales have been developed to measure temperament dimensions. The questionnaires
are usually used as self-rated, but can also be used as observer- or peer-rated (Pervin et
al. 2005). Inventories measuring temperament in adults include the 27-item Emotionality,
Activity and Sociability-Inventory (EAS, Buss and Plomin 1975), the 54-item Revised
Dimensions of Temperament Survey (DOTS-R, Windle and Lerner 1986), the 240-item
Temperament and Character Inventory-Revised (TCI-R, Cloninger 1994), the 20-item Formal
Characteristics of Behaviour-Temperament Inventory (FCB-TI, Strelau and Zawadzki 1993)
and the 110-item Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Interview
(TEMPS, Akiskal and Mallya 1987; Akiskal et al. 1998).
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4.4.3.1 Cloninger’s temperament and character dimensions
A unified biosocial theory of personality consisting of neurobiologically based dimensions
of temperament and characterological aspects of personality was proposed by Cloninger.
This theory is based on information from several sources: family studies, longitudinal
development research, psychometric descriptions of personality structure,
neuropharmacological and neuroanatomical studies of conditioning and learning in man and
animals (Cloninger 1986, 1987). The Tridimensional Personality Questionnaire (Cloninger
1987) was design to test the three temperament dimension of Novelty Seeking (NS), Harm
Avoidance (HA) and Reward Dependence (RD). After a new temperament dimension of
Persistence (P), originally scored as a component of RD, and three character dimensions of
Self-Directedness, Cooperativeness and Self-Transcendence were added to the scale, the
name was changed as the Temperament and Character Inventory (Cloninger et al. 1993). Later
a revised version, TCI-R, has also been published, with a five-point Likert scale, which
allows better estimates of the subscales, 51 items rewritten, and 3 subscales added to P
and 1 to RD (Pelissolo et al. 2005).
The psychometric properties of the various forms of the instrument have been evaluated in
several countries, including TPQ in USA (Cloninger et al. 1991), England (Otter et al.
1995), Yugoslavia (Svrakic et al. 1991) and Finland (Miettunen et al. 2004); TCI in USA
(Cloninger et al. 1993), Sweden (Brandstrom et al. 1998), the Netherlands (Duijsens et al.
2000), France (Pelissolo and Lepine 2000) and Finland (Miettunen et al. 2004) and TCI-R in
Italy (Fossati et al. 2007), Spain (Gutierrez-Zotes et al. 2004), France (Pelissolo et al.
2005), Belgium (Hansenne et al. 2005) and in Finland among adolescents (Lindgren 2002).
TCI and TCI-R scales can be used interchangeably (Pelissolo et al. 2005; Fossati et al.
2007).
4.4.3.1.1 Temperament dimensions
The different temperament dimensions are defined in terms of basic stimulus-response
characteristics. Novelty Seeking is thought to be related to the behavioural activation
system (Cloninger 1987), to predict facility in incentive activation (Cloninger 1987), is
linked to the brain’s dopamine-system (Cloninger 1987) and the suggested associated basic
emotional state is anger (Svrakic et al. 1996; Puttonen et al. 2005). Individuals high in
NS tend to be quick-tempered, excitable, exploratory, curious, enthusiastic, exuberant,
easily bored, impulsive and disorderly. NS has four subscales called Exploratory
Excitability, Impulsiveness, Extravagance and Disorderliness (Cloninger 1994).
Harm Avoidance is thought to be related to the behavioural inhibition system (Cloninger
1987), to predict facility in the formation of conditioned signals of punishment
(Cloninger 1987), is linked to to brain’s serotonin-system (Cloninger 1987) and the
suggested associated basic emotional state is fear (Svrakic et al. 1996; Puttonen et al.
2005). Individuals high in HA tend to be cautious, careful, fearful, tense, apprehensive,
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nervous, timid, doubtful, discouraged, insecure, passive, negativistic or pessimistic even
in situations that do not worry other people. HA has also four subscales called
Anticipatory Worry, Fear of Uncertainty, Shyness, and Fatiguability and Asthenia
(Cloninger 1994).
Reward Dependence is thought to be related to the maintenance system (Cloninger 1987), to
predict facility in the formation of conditioned signals of reward, particularity of
verbal signals of social approval (Cloninger 1987), is linked to the release of
noradrenalin in the autonomous nervous system (Cloninger 1987) and the suggested
associated basic emotional state is disgust/love (Svrakic et al. 1996; Puttonen et al.
2005). Individuals high in RD tend to be tender-hearted, loving and warm, sensitive,
dedicated, dependent and sociable. RD has four subscales called Sentimentality, Openness,
Attachment and Dependence (Cloninger 1994).
Persistence is linked to perseverance in behaviour despite frustration and fatigue and
involves individual differences in the ability to convert a signal of punishment into a
signal of eventual reinforcement (Cloninger 1987). Individuals high on P tend to be
industrious, hard-working, persistent and stable. P has four subscales called Eagerness,
Work Hardened, Ambitious and Perfectionist (Cloninger 1994).
The distribution of temperament scores in the population approximates to a normal curve.
In a meta-analysis of 32 studies estimating gender differences in temperament dimensions,
it was found that women scored higher in RD and HA, no difference was found in NS and P
(Miettunen et al. 2007). NS has been found to correlate negatively (Cloninger 1994;
Brandstrom et al. 2001), whereas HA positively with age (Brandstrom et al. 2001). Both
test-retest reliability (NS: r=0.91-0.93; HA: r=0.81-0.89; RD: r=0.83-0.86,; P: r=0.83-
0.90) and internal consistency (NS: alpha=0.80; HA: alpha=0.92; RD: alpha=0.84 and
P: alpha=0.92) have been found to be good using TCI-R (Pelissolo et al. 2005). A negative
correlation has been found between NS and both HA (r=-0.38) and P (r=-0.22), whereas a
positive correlation between NS and RD (r=0.21) (De Fruyt et al. 2000).
Temperament dimensions have been found to correlate with various other scales, including
EPQ (HA and N: r=0.59; HA and E: r=-0.53; NS and E: r=0.44) and ZKPQ (HA and N-Anxiety:
r=0.66; NS and Impulsive Sensation: r=0.68) (Zuckerman and Cloninger 1996), as well as
NEO-PI-R (HA and N: r=0.54; HA and E: r=-0.57, NS and E: r=0.43; RD and E: r=0.45)
(De Fruyt et al. 2000) .
In a Finnish study using TPQ and TCI, females scored higher than males in HA, NS and RD,
whereas males scored higher than females in TCI-P (Miettunen et al. 2004).
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4.4.3.1.2 Character dimensions
Three character dimensions were added to the TCI questionnaire to assess individual
differences in self-concept about goals and values and to distinguish individuals with
personality disorder. As a result of differences in character development, individuals
with the same temperament may behave differently (Cloninger 1994).
Self-Directedness (SD) is supposed to be based on the concept of the self as an autonomous
individual, and from the concept are derived feelings of personal integrity, honour,
self-esteem, effectiveness, leadership and hope (Cloninger 1994).
Co-operativeness (C) is supposed to be based on the concept of the self as an integral
part of humanity or society, and from this concept are derived feelings of community,
compassion, conscience and charity (Cloninger 1994).
Self-Transcendence (ST) is supposed to be based on the concept of self as an integral part
of the universe and its source, and from this concept of the self are derived feelings of
mystical participation, religious faith and unconditional equanimity and patience
(Cloninger 1994).
The distribution of character scores in the population approximates to a normal curve. No
clear and consistent gender differences have been found in character scores.
Compared to males, females score usually higher (Cloninger 1994; Pelissolo et al. 2005) or
not (Pelissolo and Lepine 2000) on C; lower (Pelissolo and Lepine 2000), higher (Pelissolo
et al. 2005) or neither (Cloninger 1994) on SD and higher (Pelissolo and Lepine 2000) or
not (Cloninger 1994) on ST. Age has been found to correlate positively (Cloninger 1994;
Pelissolo et al. 2005) or not (Pelissolo and Lepine 2000) with SD; positively (Cloninger
1994; Pelissolo et al. 2005) or not (Pelissolo and Lepine 2000) with C and positively
(Pelissolo et al. 2005) or not (Cloninger 1994; Pelissolo and Lepine 2000) with ST. Both
test-retest reliability (SD: r=0.82-0.93; C: r=0.88-0.90; ST: r=0.82-0.87) and internal
consistency (SD: alpha=0.88; C: alpha=0.81; ST: alpha=0.85) have been found to be good
using TCI-R (Pelissolo et al. 2005).
Character dimensions have been found to correlate with other scales, including NEO-PI-R
(SD and N: r=-0.63; SD and E: r=0.29; C and E: r=0.20; ST and E: r=0.25) (De Fruyt et al.
2000) and also with other TCI dimensions (SD and HA: r=-0.47, C and RD: r=0.54; C and SD:
r=0.57) (Cloninger 1994).
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4.4.4 Heritability of temperament and personality dimensions
Personality traits have been found to be substantially influenced by genes (Bouchard and
Loehlin 2001). In a review of four twin studies, the broad heritabilities of self- or
peer-reported measures for extraversion and neuroticism were found to be 0.49 and 0.41,
respectively (Bouchard and Loehlin 2001). In addition there is evidence of gender-specific
heritability for N (Fanous et al. 2002). The genetic factors have been shown to account
also for the variability of Cloninger’s temperament dimensions, as heritablities for HA,
NS, RD and P have been found to be 0.41, 0.39, 0.35 and 0.30, respectively (Gillespie et
al. 2003). The remaining percentage of the variability of the personality dimensions
probably comprises causes such as gene-environment interactions, chance factors in
development and errors of measurement (Bouchard and Loehlin 2001).
Temperament and character may not differ greatly in heritability. Contrary to theoretical
expectations the familial aggregation for the character dimensions has also been
substantial, as the heritabilities for SD, C and ST have been found to be 0.35, 0.27 and
0.44, respectively (Gillespie et al. 2003).
Molecular genetic studies of personality have mostly concerned the possible links between
Novelty Seeking/Extraversion and type 4 dopamine receptor (DRD4) gene and Neuroticism/
Harm Avoidance and serotonin transporter (5HTTLPR) gene (Ebstein 2006). The results of the
association between NS and DRD4 polymorphism have been inconsistent (Schinka et al. 2002;
Ebstein 2006) indicating that there might be unknown moderators like the childhood
environment (Keltikangas-Järvinen et al. 2004). The effect size of the association
between 5HTTLPR gene and anxiety-related personality traits has been found to be small,
but significant in most (Ebstein 2006), but not all (Willis-Owen et al. 2005) studies.
Moreover, it has been found that the individual variation in the level of neuroticism is
partly moderated by genetic factors e.g. the amygdala response to emotional face
processing has been found to be moderated by functional variation in the serotonin
transporter gene (Hariri et al. 2002).
4.4.5 Stability of temperament and personality dimensions
The stability of personality in the population level has been evaluated by using
mean-level and rank-order consistency (Matthews et al. 2003). Mean-level consistency
reflects whether groups of people increase or decrease on trait over time, whereas
rank-order consistency refers to the relative placement of individuals within a group
(Matthews et al. 2003).
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In a meta-analysis (Roberts and DelVecchio 2000) of 152 longitudinal studies from
childhood to old age investigating the rank-order consistency of personality traits, it
was concluded that traits are quite consistent over the life course although trait
consistency increased from 0.31 in childhood, to 0.54 during the college years, to 0.64 at
age 30 and then reached a plateau around 0.74 between ages 50 to 70.
In another meta-analysis (Roberts et al. 2006a) of 92 studies determining mean-level
change in personality traits among individuals from 10 years to 101years, the results
showed that of the six trait categories (Extraversion, divided into social vitality and
social dominance; Agreeableness; Conscientiousness; Emotional stability and Openness) four
demonstrated significant change in middle and old age. Social dominance, conscientiousness
and emotional stability increased, especially from age 20 to 40, whereas social vitality
and openness increased in adolescence but decreased in old age. Agreeableness increased
only in old age. In an internet study of 132,515 adults from 21-60 years studying
mean-level change of personality, it was also found that C and A increased throughout
early and middle adulthood and neuroticism declined among women but did not change among
men (Srivastava et al. 2003). Thus, although population studies demonstrate high
rank-order consistency of personality traits after the age of 30 years, they
simultaneously also demonstrate significant mean-level change until old age, suggesting
that change in basic personality configurations is more quantitative than qualitative.
Recently the attention of personality development research has turned to the causes of
personality change. It has been hypothezised that personality changes are not only the
result of endogenous biological mechanisms unaffected by environmental influences (McCrae
et al. 2000), but also of dynamic transactions between individual characteristics and the
environment (Roberts et al. 2005). The social investment theory suggests that personality
maturation during adulthood takes place as individuals assume and commit to adult social
roles (Roberts et al. 2005) and personality change can take place even in middle adulthood
(van Aken et al. 2006). According to this model, taking adult responsibilities in the
domains of work, family, religion and volunteerism is associated with increase in
conscientiousness, agreeableness and emotional stability (Roberts et al. 2005), although
there are also individuals who show personality trait change opposite of the normative
pattern, confirming that individual differences in change are the rule, not the exception
(Roberts et al. 2006b). Another new theory concerning the causes of personality change is
narrative appoach i.e. how individuals create meaning and purpose in their lives through
the construction of life stories (McAdams 2001). Changes and new developments in how
individuals interpret their lives may trigger corresponding changes in patterns of
thinking, feeling, and behaving - i.e. personality traits - over time (Pals 2006).
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4.4.6 Personality disorders and temperament and personality dimensions
DSM-IV has 10 personality disorders and additionally Personality Disorder Not Otherwise
Specified. In DSM-IV personality disorder has been specified as an enduring pattern of
inner experience and behaviour that deviates markedly from the expectations of the
individual’s culture, is pervasive and inflexible, has an onset in adolescence or early
adulthood, is stable over time, and leads to distress or impairment. Personality disorders
can be grouped into three clusters based on descriptive similarities. Cluster A includes
the Paranoid, Schizoid and Schizotypal Personality Disorders. Individuals with these
disorders often appear odd or eccentric. Cluster B includes the Antisocial, Borderline,
Histrionic and Narcissistic Personality Disorders. Individuals with these disorders often
appear dramatic, emotional or erratic. Cluster C includes the Avoidant, Dependent and
Obsessive-Compulsive Personality Disorders. Individuals with these disorders appear
anxious or fearful (American Psychiatric Association 2000b).
The diagnostic system used in DSM-IV and ICD-10 represents the categorical perspective of
personality disorders, suggesting that these disorders are qualitatively distinct clinical
syndromes. The term "dimensional approach" has been used at least in two distinct ways
i.e. either each separate personality disorder (PD) is conceptualized as a continuum, or
that the fundamental dimensions underlying the disorders are not the PD’s themselves but
the personality traits that compose the disorders. This latter type of dimensional
perspective assumes that personality disorders represent maladaptive variants of
personality traits that emerge imperceptibly into normality and into one another (Skodol
et al. 2005; Clark 2007). Moreover, personality clusters may be viewed as dimensions
representing spectra of personality dysfunction on a continuum with axis I disorders
(Clark 2007). Recently, a prototype matching approach to personality disorder diagnosis
has been developed, in which each PD is presented by experts in its ideal or "pure" form,
whereby the diagnosticians rate the overall similarity between the patient and the
prototype by using e.g. the facets of the Five-Factor Model (Lynam and Widiger 2001) or a
5-point rating scale and considering the prototype as a whole rather than counting
individual symptoms (Westen et al. 2006).
Of personality dimensions, neuroticism has been found to associate positively with all
personality disorders (Deary and Peter 1998; Brieger et al. 2000; Duggan et al. 2003;
Saulsman and Page 2004; Moran et al. 2006). Low extraversion, on the other hand, has also
been found to have an association with all personality disorders (Duggan et al. 2003), or
with only some of cluster A or C (Deary and Peter 1998; Brieger et al. 2000; Saulsman and
Page 2004; Furnham and Crump 2005) or borderline personality disorders (Saulsman and Page
2004). In contrast, extraversion has been found to have a positive association with
histrionic and/or narcissistic personality disorders (Deary and Peter 1998; Brieger et al.
2000; Saulsman and Page 2004; Furnham and Crump 2005).
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Of  TCI dimensions, low SD and C has been found to associate with the number of personality
disorder symptoms and the presence of any personality disorder (Svrakic et al. 1993), or
C, all but histrionic personality disorder symptoms (Svrakic et al. 2002). High ST has
been found to associate with the symptoms of histrionic, narcissistic, borderline,
schizotypal and paranoid personality disorders (Svrakic et al. 2002), whereas low ST with
symptoms of schizoid personality disorder (Svrakic et al. 1993). Thus, ST might be able to
distinguish between schizoid and schizotypal personality disorders (de la Rie et al.
1998). Patients with cluster A personality disorder have been found to have low RD and
high HA (Svrakic et al. 1993, 2002; Farabaugh et al. 2005), with cluster B disorder high
NS (Svrakic et al. 1993; Farabaugh et al. 2005) or high NS and HA (Svrakic et al. 2002)
and with cluster C disorder high HA (Svrakic et al. 1993; Farabaugh et al. 2005) or both
high HA and NS (Svrakic et al. 2002).
Overall, personality dimensions seem to associate with personality disorders. However,
e.g. the TPQ scores in relation to PD’s have been found to explain only a part of the
variance, suggesting that personality traits are one contributing factor among others to
PD’s (Farabaugh et al. 2005).
4.5 Temperament and personality dimensions and affective
      disorders
The relationship between personality and affective disorders is complex. Personality
features may have a common cause with affective disorders, may predispose an individual to
affective disorders, be shaped by repeated episodes of the illness, modify the clinical
picture of the illness, be an attenuated expression of the disorder or be state-dependent
concomitants of affective disorders (Shea and Yen 2005; Brandes and Bienvenu 2006).
The association between affective disorders and personality has been studied extensively.
In these studies personality functioning has been conceptualized in numerous ways,
including research on sociotropy/autonomy and dependency/self-criticism derived from
cognitive and psychoanalytic theories of affective disorders, respectively; on personality
disorders; on personality traits derived from factor-analytic approaches; and on
Cloninger’s temperament and character dimensions (Shea and Yen 2005; Brandes and
Bienvenu 2006).
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4.5.1 Temperament and personality dimensions and depression
4.5.1.1 Neuroticism
A positive correlation between the dimension of neuroticism and depressive symptoms
(Fergusson et al. 1989; Saklofske et al. 1995) as well as depressive disorders (Katz and
McGuffin 1987; Farmer et al. 2002; Bienvenu et al. 2004; Cuijpers et al. 2005) has been
demonstrated in numerous cross-sectional studies over the decades. Neuroticism has been
found to be markedly affected by current mood state (Coppen and Metcalfe 1965; Kendell and
DiScipio 1968; Hirschfeld et al. 1983b; Kendler et al. 1993b; Shea et al. 1996; Ormel et
al. 2004; Fanous et al. 2007) and to increase after an episode of depression in some
(Hirschfeld et al. 1989; Kendler et al. 1993b; Fanous et al. 2007) but not all (Duggan et
al. 1991; Shea et al. 1996; Ormel et al. 2004) reports. In addition high N has been found
to predict poorer course and outcome of depression over follow-up periods ranging from 6
months to 18 years (Hirschfeld et al. 1986; Duggan et al. 1990; Kendler et al. 1997;
Mulder 2002; Melartin et al. 2004), even after controlling for the severity of baseline
depression (Duggan et al. 1990).
The view that high neuroticism is a risk factor for depression is supported by several
prospective studies, in which neuroticism has been measured in the premorbid phase. In
such studies, not only future depressive episodes have been found to be predicted by
neuroticism (Hirschfeld et al. 1989; Boyce et al. 1991; Kendler et al. 1993b, 2006a;
Fanous et al. 2007) or neuroticism-like traits (Nyström and Lindegård 1975; Angst and
Clayton 1986; Rorsman et al. 1993) but also first onset depressive episodes by neuroticism
(Hirschfeld et al. 1989; Boyce et al. 1991; Kendler et al. 1993b, 2006a) or
neuroticism-like trait (Rorsman et al. 1993). Recent epidemiological twin studies have
suggested that a set of genetic risk factors influence both neuroticism and liability to
depression (Kendler et al. 2006a; Kendler and Prescott 2006). Thus neuroticism seems not
to be a risk mediator for depression, but rather an indicator i.e. the genetic risk for
depression does not "run through" neuroticism itself. In addition, the genetic correlation
between N and MDD in males and in females has been found to be +0.47 and +0.46,
respectively, suggesting that substantial proportions of the genetic vulnerability to
depression does not reflect in neuroticism (Kendler et al. 2006a). Overall, the evidence
for supporting the vulnerability, spectrum or common-cause, state and pathoplasty models
for N and depression are the most consistent, whereas the evidence for the
complication or scar model is less consistent.
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4.5.1.2 Extraversion
Extraversion has been reported to have a negative correlation with depressive symptoms
(Saklofske et al. 1995) as well as depressive disorders (Farmer et al. 2002; Cox et al.
2004) in cross-sectional studies. Although low extraversion has been suggested to be a
vulnerability factor for depression (Hirschfeld et al. 1983a; Kendler et al. 2006a) and
high extraversion to even exert some protective effects against depression (Farmer et al.
2002), the premorbidly started prospective epidemiological studies among male conscripts
(Angst and Clayton 1986) and among twins (Kendler et al. 1993b; Fanous et al. 2007), as
well as two prospective clinical studies (Hirschfeld et al. 1989; Boyce et al. 1991) have
not proved this to be a risk factor. Confusingly, in longitudinal studies, extraversion
has been found to be affected by mood states (Kendell and DiScipio 1968; Hirschfeld et al.
1983a; Farmer et al. 2002) or not (Shea et al. 1996; Fanous et al. 2007). There are only a
few (Kerr et al. 1974; Van Londen et al. 1998) studies examining the prognostic impact of
E on depression, and the results have been inconsistent; in some studies low E has been
associated with poorer outcome (Kerr et al. 1974), whereas in some not (Van Londen et al.
1998). Overall, the role of extraversion as a risk factor for depression is more obscure
than that of neuroticism.
4.5.1.3 Temperament and character dimensions
Harm Avoidance has been consistently shown to associate positively with depressive mood in
non-clinical (Peirson and Heuchert 2001) and in clinical (Hansenne et al. 1999)
cross-sectional studies and to predict future depressive symptoms in longitudinal
non-clinical (Elovainio et al. 2004; Cloninger et al. 2006) studies, especially subscales
HA3 (Shyness) and HA4 (Fatiguability and Asthenia) (Elovainio et al. 2004), but also to be
altered by a depressed state (Joffe et al. 1993). Moreover, high HA has been able to
predict familial vulnerability to major depression in a sib-pair study (Farmer et al.
2003). While NS does associate with some psychopathologic variables correlated with
depression (Grucza et al. 2003), particularly the subscale NS 1 (Exploratory Excitability)
(Hansenne et al. 1998), overall NS still appears to correlate negatively with depression
per se (Farmer et al. 2003). High RD has been found to protect against the development of
depression (Farmer et al. 2003) or to associate positively with depression (Ampollini et
al. 1999), particularly with restless sleep and subjective symptoms of depression, when
combined with high P (Grucza et al. 2003). The subscales NS2 (Impulsiveness) and RD1
(Sentimentality) as well as P has also been reported to increase the risk of depressive
symptoms independently (Elovainio et al. 2004).
Of the character dimensions, low SD has been consistently found to associate with
depression (Bayon et al. 1996; Farmer et al. 2003). Moreover, both low SD and HA have been
reported to associate with a poor response to antidepressant medication in most (Joffe et
al. 1993; Sato et al. 1999), but HA not in all (Newman et al. 2000) studies.
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4.5.2 Temperament and personality dimensions and anxiety
4.5.2.1 Neuroticism and extraversion
Compared to depression, there are fewer studies on the relationship between anxiety and
personality dimensions of neuroticism and extraversion. Fairly consistently high N has
been recognized to associate with anxiety in prospective epidemiological twin (Hettema et
al. 2004; Kendler et al. 2007), other non-clinical (Loo 1979; Moffitt et al. 2007) and
clinical studies (Reich et al. 1986). Likewise, low E has been found to associate with
anxiety in non-clinical (Loo 1979; Stewart et al. 2004) and clinical studies (Reich et al.
1986). Moreover, both N and E have been shown to be affected by anxiety state at least in
panic and agoraphobic patients (Reich et al. 1986). Of specific anxiety disorders,
individuals with social phobia or agoraphobia have tended to be both high in N and low in
E (Bienvenu et al. 2004, 2007); with panic disorder, OCD or GAD high in N and overall
average in E (Bienvenu et al. 2004), moreover low E has been reported not to be a
vulnerability factor for GAD (Moffitt et al. 2007). Individuals with specific phobia have
tended to be only slightly higher in N and lower in E than subjects without anxiety or
depressive disorder (Bienvenu et al. 2004).
Although high neuroticism-like traits in late adolescence have been shown to predict the
onset of anxiety disorders by young adulthood (Krueger 1999a) and in peacekeepers, the
onset of post-traumatic stress disorder (Bramsen et al. 2000), as well as high N and low
E in survivors of severe burns to predict the onset of PTSD during the following year
(Fauerbach et al. 2000), the question whether these personality traits act as risk factors
for anxiety remains open. Personality traits in these cases could have been either earlier
manifestations of genetic and/or environmental influences that also affect the risk for
anxiety disoders (Hettema et al. 2004) or prodromal symptoms of anxiety disorders (Brandes
and Bienvenu 2006). Overall, high N and low E are found to be at least risk indicators for
certain anxiety disorders, and both N and E be affected by anxiety state.
4.5.2.2 Temperament and character dimensions
Most consistently high HA and low SD have been associated with anxiety in clinical (Lyoo
et al. 2001; Marteinsdottir et al. 2003) and non-clinical samples (Jiang et al. 2003;
Matsudaira and Kitamura 2006). In addition, a negative correlation has been found between
anxiety symptoms and either C in students (Jiang et al. 2003) or P, ST and C in patients
with social phobia (Marteinsdottir et al. 2003), or NS in OCD patients (Lyoo et al. 2001),
whereas a positive correlation has been reported between anxiety and RD in panic disorder
patients (Ampollini et al. 1999). Moreover, HA, NS, SD and C have been found to be
state-dependent on anxiety symptoms (Allgulander et al. 1998).
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4.5.3 Temperament and personality dimensions and comorbid
         disorders of MDD
4.5.3.1 Neuroticism and extraversion
In epidemiological (Bienvenu et al. 2001; Weinstock and Whisman 2006), twin (Jardine et
al. 1984; Andrews et al. 1990; Khan et al. 2005; Hettema et al. 2006; Kendler et al. 2007)
and clinical (Bronisch and Hecht 1990; Cuijpers et al. 2005) studies, neuroticism appears
to associate positively with the comorbidity of depressive and anxiety disorders, and has
been found to be a risk factor for this comorbidity (Kendler et al. 2007) and explain even
to one fourth of it (Khan et al. 2005). Also the comorbidity of depression and alcohol
dependence (Khan et al. 2005) has been found to associate with high neuroticism, as well
as depression and antisocial personality disorder (Khan et al. 2005) or any personality
disorder (Davidson et al. 1985; Brieger et al. 2000).
Likewise, low extraversion has been found to associate with the comorbidity of depressive
and anxiety disorders (Bienvenu et al. 2001; Cuijpers et al. 2005), but to explain only a
very small proportion of it (Khan et al. 2005). A negative association has also been found
between extraversion and the comorbidity of depression and alcohol dependence (Khan et al.
2005), and of depression and antisocial personality disorder (Khan et al. 2005) or any
personality disorder (Brieger et al. 2003). Moreover, the number of comorbid anxiety
disorders among MDD patients has been found to associate with high neuroticism and low
extraversion (Cuijpers et al. 2005).
4.5.3.2 Temperament and character dimensions
There are only a few studies on the relationship of TCI dimensions with axis I and II
comorbidity among MDD patients. In these studies, MDD with comorbid GAD has been found
to be associated with high HA, whereas social anxiety disorder to high HA, low NS and
RD (Ongur et al. 2005). MDD with the presence of comorbid OCD or panic disorder has
been related to low NS , while simple phobia with low RD (Ongur et al. 2005). MDD patients
with comorbid axis II disorder have been associated with high HA and also with somewhat
high NS (Battaglia et al. 1996).
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4.5.4 Temperament and personality dimensions as possible endophenotypes
         for MDD
The term endophenotype has been described as an internal, measurable component unseen by
the unaided eye along the pathway between disease and distal genotype (Gottesman and Gould
2003). Most often endophenotypes are used in genetic analysis of disease, but also in
diagnosis and classification (Gottesman and Gould 2003). An endophenotype may be
neurophysiological, biochemical, endocrinological, neuroanatomical, cognitive or
neuropsychological (including configured self-report data) in nature (Gottesman and Gould
2003). It has been suggested that an endophenotype for psychiatric disorder has to meet
certain criteria, including specificity (the endophenotype is more strongly associated
with the disease of interest than with other psychiatric conditions), state-independence,
heritability, family association, cosegregation (the endophenotype is more prevalent among
the ill relatives of ill probands compared with the well relatives of the ill probands)
and biological and clinical plausibility (Tsuang et al. 1993). Several putative
endophenotypes for MDD have been suggested, including anhedonia-related endophenotypes,
like RD; and increased stress sensitivity - related endophenotypes, like HA and N (Hasler
et al. 2004).
4.6 A conclusion of previous literature
Although several studies have investigated the associations between personality dimensions
and the symptoms of depression and anxiety, there are also several limitations in these
studies. Only few (Bienvenu et al. 2004; Cox et al. 2004) studies have been undertaken in
the general population to explore the association between neuroticism and extraversion and
symptoms of anxiety and depression and none have explored anxiety with both dimensions.
Moreover, although a few published studies have employed the revised version of TCI
(Lindgren 2002; Gutierrez-Zotes et al. 2004; Hansenne et al. 2005; Pelissolo et al. 2005;
Fossati et al. 2007), none have explored the association between the dimensions of TCI-R
and symptoms of depression and anxiety in the adult general population.
The view that high neuroticism is a risk factor for depression has been supported mainly
by prospective epidemiological studies (Kendler et al. 2002, 2006 a, c; Ormel et al.
2004). However, the extent to which the findings of an epidemiological study can be
generalized to clinical samples is often uncertain, as compared to subjects of an
epidemiological study; patients from clinical samples tend to have more severe,
long-lasting and recurrent depressive episodes, commonly comorbid with personality
disorders. There are few premorbidly started clinical studies conducted among primiparous
women (Boyce et al. 1991), family members of patients with depression (Hirschfeld et al.
1989; Shea et al. 1996) and car owners (Nyström and Lindegård 1975) or male conscripts
(Angst and Clayton 1986) with neuroticism-like traits, but none among depressed patients
from the general population. Moreover, the role of extraversion is more obscure than that
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of neuroticism, as extraversion has been found to be (Hirschfeld et al. 1983a; Kendler et
al. 2006a) or not to be (Angst and Clayton 1986; Hirschfeld et al. 1989) a risk factor for
depression. There are also contradictory findings, whether the scores of neuroticism and
extraversion change (Hirschfeld et al. 1989) or not (Shea et al. 1996; Ormel et al. 2004)
after an episode of depression. Finally, the state of anxiety, which also might influence
the scores of neuroticism (Bienvenu et al. 2001; Cuijpers et al. 2005) and of extraversion
(Reich et al. 1986) has only rarely (Reich et al. 1987) been explicitly controlled.
In the former studies, the information on the associations between neuroticism and
extraversion and axis I or II comorbid disorders among patients with MDD has been
fragmentary. Knowledge of this comorbidity derives mostly from studies exploring MDD and
either comorbid axis I or II disorders separately, but not both axes concurrently.
Moreover, only one earlier study of MDD and comorbid disorders, evaluating MDD and
comorbid general anxiety disorder (GAD) (Kendler et al. 2007), has been longitudinal and
controlled for the possible confounding state-effect of depression. Little is also known
about whether the levels of neuroticism and extraversion differ between patients with pure
MDD and those with comorbid axis I or II disorder.
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5. AIMS OF THE STUDY
This  study  investigated  the  relationship  between  the  TCI  dimensions,  neuroticism  and
extraversion and symptoms of depression and anxiety among 441 participants from the
general population survey, and also between neuroticism and extraversion and MDD in
a cohort of 193 secondary level care MDD patients as compared with the general population.
The specific aims of the study were as follows:
I   To investigate among the general population, 1) whether Harm Avoidance would have
    a positive and Self-Directedness a negative correlation with both depressive and anxiety
    symptoms, 2) whether these dimensions would predict the use of health care services for
    mental disorders, and 3) whether Harm Avoidance but not Self-Directedness would be
    associated with self-reported family history of mental disorders.
II  To investigate among the general population, 1) whether neuroticism would have a
    positive and extraversion a negative correlation with depressive and anxiety symptoms,
    and 2) whether both dimensions would be related to the use of health care services
    for psychiatric reasons.
III To investigate, 1) whether neuroticism and extraversion would be affected by depression
    (the ’state effect’), 2) and/or be shaped by the recurrence or relapse of depressive
    episodes (the ’scar effect’) and finally, 3) whether these dimensions would act as risk
    factors for depression (’trait effect’).
IV  To investigate among MDD patients, 1) whether a dose-exposure relationship would exist
    between standardized levels of neuroticism and extraversion and the type and number of
    comorbid  axis  I  and  II  disorders, and  2) to investigate the standardized scores of
    neuroticism and extraversion among pure MDD and with comorbid axis I or II disorders.
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6. METHODS
6.1 General study design
This study is part of the Mood Disorders Project conducted by the Department of Mental
Health and Alcohol Research, National Public Health Institute. The general population
survey study was conducted in 2003 in two adjacent cities of Espoo and Vantaa, combined
population 408 270 in 2003. The Vantaa Depression Study (VDS) is a collaborative
depression research project between the Department of Mental Health and Alcohol Research
of the National Public Health Institute and the Department of Psychiatry of the Peijas
Medical Care District (PMCD). Vantaa is the fourth largest city in Finland, with a
population of 169 000 in 1997, and provides psychiatric services to all of its citizens
free of charge. The research protocol for the general population survey study was approved
by the Ethics Committee of Helsinki University Central Hospital, and that for VDS by the
Ethics Committee of the PMCD.
Due to the study design, the publications had different general population survey samples
and MDD patient compositions as presented in Table 6.
Table 6. Composition of general population survey samples and MDD patient
cohort in the original publications.
              Genaral population survey              Vantaa Depression Study
  Study I                Participants, who returned the whole         
                         questionnaire, N=347                         
  Study II               Participants, who returned the whole         
                         questionnaire and the shortened version      
                         of it, N=441                                 
  Study III              Participants aged 20-60 years, N=388         Patients followed up at both 6 and 18
                                                                      months, remained unipolar, N=193
  Study IV               Participants aged 20-60 years, N=388         Patients followed up at both 6 and 18
                                                                      months, remained unipolar, N=193
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6.2 General population survey
A random  sample of 900  subjects  (300 from Espoo, 600 from Vantaa) was randomly drawn
from the National Population Register Centre. Each was mailed a self-report booklet that
included sociodemographic characteristics and, among other measures, the 21-item Beck
Anxiety Inventory, (BAI, Beck et al. 1988b); the 21-item Beck Depression Inventory (BDI,
Beck et al. 1961); the 240-item Temperament and Character Inventory-Revised (TCI-R,
Cloninger 1994); the 57-item Eysenck Personality Inventory (EPI-form B, Eysenck and
Eysenck 1964) and additional questions on whether a physician had ever diagnosed a mental
disorder, the respondent had used health services for a mental health problem during the
past 12 months, or if a mental disorder had been diagnosed in relatives. Written informed
consent was obtained from all participants after details of the study were described.
Due to the design of the Mood Disorders Project, participants from Espoo were 20-60 years
old and from Vantaa 20-70 years. After three weeks, the questionnaire was mailed again to
non-responders. Finally, a shortened version (without TCI-R) was sent to those who had
still failed to respond. Of the 441 responders, 347 returned the whole questionnaire and
94 only the shortened version, no sociodemographic differences existed between the first
and second mailing groups. Non-responders were younger than responders (mean age 41.4
years, sd 12.5 vs. 45.0 years, sd 12.5, t=-4.387, p<0.001) and were more often male (62.3%
vs. 48.8%, χ2=16.7487, df=1, p<0.001), but no difference was present in the area of
residence within the city. Responders differed slightly from the age-matched general
population of the same area. They were older (45.0 years vs. 40.7 years, χ2=27.5374, df=7,
p=0.001), more often married or cohabiting (married or cohabiting 60.6% vs. 49.5%, single
18.2% vs. 36.8%, divorced 18.5% vs. 12.2%, widowed 2.7% vs. 1.5%, χ2=2.71, df=3,
p<0.001), more often employed (employed 86.8% vs. 78.7%, student 4.2% vs. 7.8%,
unemployed 5.3% vs. 4.9%, pensioned 7.9% vs. 8.5%, χ2=60.9139, df=4, p<0.001) and had
a slightly higher level of education (university degree 17.3% vs. 20.1%, polytechnic or
equivalent degree 34.9% vs. 15.8%, vocational education 25.4% vs. 39.4%, no professional
education 22.4% vs. 24.7%, χ2=114.854, df=3, p<0.001). No gender difference was present.
Studies III and IV included only participants aged 20-60 years (N=816). In this age group
no sociodemographic differences existed between the first and second mailing groups.
Non-responders were younger than responders (mean age 39.6 years, sd 10.8 vs. 42.7 years,
sd 11.0, t=-3.126, p<0.001) and were more often male (58.3% vs. 48.5%, χ2=16.12, df=1,
p<0.001), but no difference was present in the area of residence within the city.
Responders differed slightly from the age-matched general population of the same area.
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They were somewhat older (42.7 years vs. 39.8 years, χ2=18.35, df=4, p<0.01), differed in
marital status (married or cohabiting 60.6% vs. 49.7%, single 19.4% vs. 36.9%, divorced
18.1% vs. 12.4%, widowed 1.8% vs. 1.0%, χ2=53.88, df=3, p<0.001) and had a slightly higher
level of education overall (university degree 17.3% vs. 19.0%, polytechnic or equivalent
degree 36.4% vs. 26.4%, vocational education 25.4% vs. 29.5%, no professional education
20.9% vs. 22.0%, χ2=16.51, df=3, p<0.001). No gender or work status difference was
present.
The sociodemographic characteristics of the respondents of the general population survey
in study I and II are shown in Table 7, and in study III and IV in Table 8.
6.3 MDD patient cohort
6.3.1 Screening
The first phase of patient sampling for the VDS involved screening all patients aged 20-60
years (N=806) in the PMCD for a possible new episode of DSM-IV MDD between 1 February
1997 and 31 May 1998 (Melartin et al. 2002). During that period, all patients (N=806) aged
20-59 years, who were 1) seeking treatment at, 2) being referred to, or 3) already
receiving care and currently showing signs of deteriorating clinical state in the
Department of Psychiatry, but without a clinical diagnosis of ICD-10 schizophrenia or
bipolar I disorder, were screened for the presence of depressive symptoms. The screening
instrument included the five screening questions regarding depression from the WHO
Schedules for Clinical Assessment in Neuropsychiatry (SCAN), version 2.0 (Wing et al.
1990). The Scale for Suicidal Ideation (SSI, Beck et al. 1979b) was also completed in
order to disclose the individuals with moderate to severe suicidal ideation plans. If the
following criteria matched the patients after either 1) a positive response to any of the
SCAN screening questions, 2) clinical suspicion of depression by the interviewing
personnel, or 3) a score of six or more in the SSI irrespective of any depressive
symptoms, she/he was fully informed about the study project and her/his participation
requested. Of the 703 eligible patients, 542 (77.1%) agreed and gave their written
informed consent. The non-participating did not differ significantly (p>0.05) in age or
gender from those who consented.
6.3.2 Baseline evaluation
6.3.2.1 Diagnostic measures
In the second phase, a researcher using SCAN 2.0 (Wing et al. 1990) interviewed the 542
consenting patients. Patients were examined whether or not the current mood episode
fulfilled the criteria for DSM-IV MDD, using also melancholic and atypical features
specifiers. All psychiatric and medical records in the PMCD, including a standardized set
of laboratory test, were also available at the interview. Patients with current alcohol or
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other substance abuse were interviewed after two or three weeks of abstinence, in order to
eliminate substance-induced mood disorders. On this basis, 269 of the 542 patients were
subsequently diagnosed with DSM-IV MDD and included in the study. The diagnostic
reliability of SCAN 2.0 was excellent (κ=0.86, 95% CI 0.58-1.0) (Melartin et al. 2002).
The researcher made the decision during the interview whether or not to include the
patient in the study, after which an entire SCAN interview was conducted to achieve a full
picture of Axis I comorbid disorders. In addition, the Structured Clinical Interview for
DSM-III-R Personality Disorders (SCID-II)(Spitzer et al. 1989) was used to assess
diagnoses on Axis II.
6.3.2.2 Exclusion criteria
Patients with a diagnosis of DSM-IV bipolar I or II disorder, organic or substance-
induced mood disorder, schizoaffective disorder, schizophrenia or another non-affective
psychosis were excluded from the study, even if they fulfilled the symptom criteria of
current MDE. Excluded were also the cases with a history of MDD if the current episode did
not fulfill the criteria of the disorder.
6.3.2.3 Observer and self-report scales
The cohort baseline measurements included among the other observer scales: 17-item
Hamilton Rating Scale for Depression (HAM-D, Hamilton 1960) to assess the severity of
depression and Social and Occupational Functioning Assessment Scale of DSM-IV (SOFAS,
Goldman et al. 1992) to assess the level of functioning.
The self-report scales included among other scales the 57-item Eysenck Personality
Inventory (EPI form B, Eysenck and Eysenck 1964) for neuroticism and extraversion, the
21-item Beck Depression Inventory (BDI, Beck et al. 1961) for the severity of depression
and the 21-item Beck Anxiety Inventory (BAI, Beck et al. 1988b) for the level of anxiety.
6.3.3 Follow-up procedure
Of the 269 individuals with a current MDD initially included in the study, 193 could be
followed up at both 6 and 18 months, and their depression had remained unipolar (the
diagnosis switched to bipolar in 13/269 patients, 5%) (Melartin et al. 2004). Patients who
dropped out from the follow-up were younger (36.1 years, sd 10.1 vs. 41.0 years, sd 11.1,
t=-3.352, p=0.001) and had scored slightly higher on the baseline BAI scale (24.4, sd 10.6
vs. 21.5, sd 10.6, t=-2.055, p=0.04), but did not differ significantly (p>0.05) in other
sociodemographic variables or in BDI, neuroticism or extraversion scales. The majority
(170/193, 88.1%) were receiving antidepressants at normal adult doses.
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6.3.3.1 Outcome measures, personality dimensions and life-chart methodology
The outcome of MDD was investigated at 6 and 18 months by repeated SCAN 2.0 interviews,
observer- and self-report scales, including the life-chart, the HAM-D, the BAI, and the
BDI and medical and psychiatric records. The personality dimensions of neuroticism and
extraversion were evaluated at 6 and 18 months by the EPI.
A detailed life-chart was created based on DSM-IV criteria and definitions. Time after the
first baseline interview was divided into three periods: state of full remission (none of
the 9 MDE criteria symptoms), state of partial remission (1-4 of the 9 symptoms) or state
of MDE (5> of the 9 symptoms). Recurrence was defined as a return of symptoms after at
least two consecutive months of partial or full remission, and relapse as a return of
symptoms fulfilling criteria for major depressive episode (MDE), following a period with
symptoms below the MDE threshold of less than two months.
The sociodemographic characteristics of the patients of the VDS cohort are shown in Table 8.
6.4 Statistical methods
Several parametric and non-parametric statistical methods were used. Univariate analyses
included Student’s t-test, Pearson’s chi-square test, one-way analysis of variance
(ANOVA), Mann-Whitney test, Kruskal-Wallis test, Pearson’s correlation coefficient,
Spearman’s rho (rs) and Fisher’s exact test. Cronbach’s alpha was applied to assess
internal consistency. SPSS software, version 11.5, was used.
6.4.1 Study I and II
In the first and second study, two multiple regression analyses were performed, one with
BDI (scores divided into six categories: 0, 1 to 4, 5 to 9, 10 to 16, 17 to 29, and 30 to
63) and one with BAI (scores divided into six categories: 0, 1 to 4, 5 to 9, 10 to 18, 19
to 29 and 30 to 63) as dependent factor, and gender, age, education and the seven TCI
dimensions (in the first study) or neuroticism and extraversion (in the second study) as
independent factors. The BDI and BAI scores were transformed because of the skewness of
their distribution.
6.4.2 Study III
In the third study to examine the ’state effect’, the scores of neuroticism and
extraversion were compared between three different time points (baseline, 6 months and 18
months). To investigate whether the scores of neuroticism and extraversion would change
after an episode of depression, the ’scar effect’, a subgroup of patients were separated
who had a recurrence or relapse(s) of depression between, but not at, the 6- and 18-month
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follow-ups and compared the scores of neuroticism and extraversion at these two time
points. To examine the ’trait effect’, of each subject in the VDS cohort, was determined
at an index interview (at baseline or at the 6-month or 18-month follow-up), conducted
when the HAM-D scores were at a minimum. The scores of neuroticism and extraversion from
the index interview were then compared with scores for the total general population group
and also with the no self-reported lifetime mental disorder group.
Several multiple regression analyses were performed to investigate the ’state effect’ and
the ’trait effect’, all including age, gender, education, marital status and work status
as independent variables or covariates. In addition, BDI and BAI change scores (18-month
follow-up and baseline) and either baseline neuroticism or extraversion scores, were also
included as independent variables in the final linear regression model to investigate the
’state effect’, with 18-month follow-up, neuroticism and extraversion as a dependent
variable. BDI, BAI, neuroticism and extraversion scores (baseline score from the no
self-reported lifetime mental disorder general population group and index interview score
from the VDS cohort) also served as covariates in the final logistic regression model to
investigate the ’trait effect’; belonging to the VDS cohort, the general population or the
self-reported lifetime mental disorder group served as the dependent variable. To
estimate which dependent variable of the regression model investigating the ’state effect’
contributed the most, the part correlation coefficients were squared to get the partial
R-squares. All the tests were made also separately for females and males.
6.4.3 Study IV
In the fourth study among VDS patients, an axis I comorbid diagnoses assigned at any time
point (baseline or 6-month or 18-month follow-up) by SCAN 2.0 (Wing et al. 1990) was
included in the analysis. For axis II diagnoses, an index interview (baseline or 6-month
or 18-month follow-up), conducted when the HAM-D scores were at a minimum (mean±SD
was 5.7±5.7), was determined. Personality disorder diagnoses made at this time point
were used in the analysis.
To investigate the prevalence of a comorbid axis I or II disorder (categorical),
specifiers of MDD and SOFAS (Social and Occupational Functioning Scale) in VDS patients
by different levels of neuroticism and extraversion of the general population, the scores
of neuroticism from the general population were divided into four levels [very high ( > +2
sd), high (from +1 - +2 sd), normal (from -1 sd - +1 sd) and low (< -1 sd)] as well as the
scores of extraversion [high (> +1 sd), normal (from -1 sd - +1 sd), low (< -1 sd- > -2
sd) and very low (<-2 sd)].
Several multiple linear and logistic regression analyses were performed to investigate the
relationship of neuroticism and extraversion to the comorbidity of MDD with axis I and/or
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II disorders, all including age, gender, HAM-D and either the scores of neuroticism or
extraversion or both as independent variables or covariates, with the number of positive
items of each personality disorder or whether or not axis I or II disorder was present as
a dependent variable.
To compare the level of neuroticism and extraversion between patients with pure MDD or
with comorbid axis I or II disorders, the mean scores of neuroticism and extraversion of
the depressive patients were converted into standardized scores (Z-scores), the mean
score of neuroticism and extraversion from the general population being zero.
Table 7. Sociodemographic characteristics of the general population sample for
the study I (N=441) and study II (N=347).
                                          Female                     Male                          Total   
Characteristic             Study I        Study II       Study I Study II     Study I        Study II
                                 N    (%)       N    (%)       N    (%)       N    (%)       N    (%)       N    (%)
  Total                          226  (51.2)    184  (53.0)    215  (48.8)    163  (47.0)    441  (100)     347  (100)
  Marital statusa
      Single                      42  (18.7)     32  (17.4)     38  (17.8)     26  (16.0)     80  (18.2)     58  (16.7)
      Cohabiting                  37  (16.4)     31  (16.8)     47  (22.0)     34  (20.8)     84  (19.1)     65  (18.7)
      Married                     86  (38.2)     71  (38.6)     96  (44.9)     75  (46.0)    182  (41.5)    146  (42.1)
      Divorced                    54  (24.0)     44  (23.9)     27  (12.6)     22  (13.5)     81  (18.5)     66  (19.0)
      Widowed                      6  (2.7)       6  (3.3)       6  (2.8)       6  (3.7)      12  (2.7)      12  (3.5)
  Educationb
      University                  40  (17.9)     33  (18.1)     35  (16.7)     25  (15.7)     75  (17.3)     58  (17.0)
      Polytechnic or equivalent    89  (39.7)     73  (40.1)     62  (29.7)     51  (32.1)    151  (34.9)    124  (36.4)
      Vocational school           38  (17.0)     33  (18.1)     72  (34.4)     55  (34.6)    110  (25.4)     88  (25.8)
      No professional education    57  (25.4)     43  (23.7)     40  (19.1)     28  (17.6)     97  (22.4)     71  (20.8)
  Work statusc
      Employed                   195  (88.3)    160  (87.5)    180  (85.3)    126  (78.7)    375  (86.8)    286  (83.4)
      Student                      9  (4.1)       7  (3.8)       9  (4.3)       6  (3.8)      18  (4.2)      13  (3.8)
      Unemployed                  11  (5.0)       7  (3.8)      12  (5.7)       9  (5.6)      23  (5.3)      16  (4.7)
      Disability pension          12  (5.4)       9  (4.9)      22  (10.4)     19  (11.9)     34  (7.9)      28  (8.1)
  Self-reported mental            38  (16.8)     31  (16.8)     19  (8.8)      15  (9.2)      57  (12.9)     46  (13.3)
      disorder, lifetimed
  Self-reported contact with      26  (11.6)     21  (11.5)     15  (7.0)      10  (6.1)      41  (9.4)      31  (9.0)
  health care for psychiatric
  reason in last 12 months
  Family history of mental        82  (36.6)     69  (37.9)     35  (16.6)     28  (17.4)    117  (26.9)     97  (28.3)
       disordere
      First degreef               50  (22.1)     40  (21.7)     21  (9.8)      16  (9.8)      71  (16.1)     56  (16.1)
      Spouse                       6  (2.7)       5  (2.7)       3  (1.4)       3  (1.8)       9  (2.0)       8  (2.3)
      Other relativeg             32  (14.2)     31  (16.8)     11  (5.1)       9  (5.5)      43  (9.8)      40  (11.5)
                                 Mean (sd)      Mean (sd)      Mean (sd)      Mean (sd)      Mean (sd)      Mean (sd)
  Age (years)                     44.9 (12.4)     44.0 (12.6)     45.2 (12.6)     45.7 (12.8)     45.0 (12.5)     44.8 (12.8)
Study I                                                  Study II
a χ2=10.671, df=4, p=0.031, missing data 2/441           b missing data 6/347
b χ2=18.151, df=3, p<0.001, missing data 8/441           c missing data 4/347
d χ2=6.229,  df=1, p=0.013                               d χ2=4.393,  df=1, p=0.036
e χ2=22.147, df=1, p<0.001, missing data 6/441           e χ2=17.737, df=1, p<0.001
f χ2=12.454, df=1, p<0.001                               f χ2=9.079,  df=1, p=0.003
g χ2=10.239, df=1, p=0.001                               g χ2=10.872, df=1, p=0.001
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Table 8. Sociodemographic characteristics of a general population sample (N=388),
total and divided by self-reported lifetime mental disorder, and unipolar depressive 
patients in the Vantaa Depression Study (N=193).
                                     General             General             General             MDD
                                     population, no      population self-    population,         patients
                                     self-reported       reported lifetime   total (N=388)       (N=193)
                                     lifetime mental     mental disorder
                                     disorder (N=338)    (N=50)
  Characteristic                     N        (%)        N        (%)        N        (%)        N        (%)
  Gendera1,a2
     Female                          167      49.4        33      66.0       200      51.5       139      72.0
     Male                            171      50.6        17      34.0       188      48.5        54      28.0
  Marital statusb1,b2
    Single                            63      18.8        12      24.0        75      19.4        38      19.7
    Cohabiting                        71      21.0         7      14.0        78      20.2        35      18.1
    Married                          142      42.3        14      28.0       156      40.4        69      35.8
    Divorced                          54      16.1        16      32.0        70      18.1        44      22.8
    Widowed                            6       1.8         1       2.0         7       1.8         7       3.6
  Educationc1,c2
    University                        61      18.3         5      10.4        66      17.3        17       8.8
    Polytechnic                      123      36.8        16      33.3       139      36.4        53      27.5
    Vocational school                 80      24.0        17      35.4        97      25.4        45      23.3
    No professional education         70      21.0        10      20.8        80      20.9        78      40.4
  Work statusd1,d2
    Employed                         294      87.2        38      76.0       332      85.8       129      68.6
    Student                           16       4.7         2       4.0        18       4.7        16       8.5
    Unemployed                        18       5.3         2       4.0        20       5.2        34      18.1
    Pensioned, psychiatric reason      0       0           5      10.0         5       1.3         7       3.7
    Pensioned, somatic reaseon         9       2.7         3       6.0        12       3.1         2       1.1
                                     Mean     sd         Mean     sd         Mean     sd         Mean     sd
  Age, years                          42.7    11.0        42.3    11.1        42.7    11.0        41.0    11.1
Significance: no self-reported lifetime mental disorder vs. self-reported lifetime mental disorder
a1 χ2= 4.801,   df=1,  p=0.028
b1 χ2= 10.003,  df=4,  p=0.04,  missing data 2/338
c1  missing data 4/338, 2/50
d1 χ2= 36.102,  df=4,  p<0.001, missing data 1/338
Significance: normal population vs. unipolar depressive patients
a2 χ2=22.232,   df=1, p<0.001
b2  missing data 2/388
c2 χ2=27.347,   df=3, p<0.001,  missing data 6/388
d2 χ2=36.062,   df=4, p<0.001,  missing data 1/388, 5/193
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7. RESULTS
7.1 The dimensions of temperament and character and symptoms
      of anxiety and depression in the general population
7.1.1 Mean scores and Cronbach’s alphas of TCI-R, BDI and BAI
The mean scores on most of the dimensions were lower in men than in women; they scored
lower on NS, HA, RD, C, ST, BDI and BAI. Women had lower scores on P, and no difference
was found on SD. The mean scores, standard deviations and Cronbach’s alphas are shown in
Table 9.
Table 9.  Mean scores and standard deviations on the TCI-R, BDI and
BAI. Comparisons between genders, and Cronbach’s alpha coefficients (N=347).
TCI-R           Female             Male               Total     
                   mean ± sd          mean ± sd          mean ± sd          α        t        p
    NSa           102.7  ± 17.6       97.9  ± 14.5      100.5  ± 16.4      0.85     2.703    0.007
    HAa            92.9  ± 20.8       84.9  ± 17.8       89.2  ± 19.8      0.89     3.809   <0.001
    RDb           107.8  ± 13.7       95.9  ± 13.7      102.3  ± 14.9      0.86     7.984   <0.001
    Pb            112.9  ± 16.8      116.6  ± 17.6      114.6  ± 17.3      0.89    -2.027    0.043
    SDb           146.5  ± 19.1      147.2  ± 16.9      146.8  ± 18.1      0.87              ns
    Ca            140.5  ± 13.1      133.0  ± 15.6      137.0  ± 14.8      0.86     4.827   <0.001
    BDIb,d          7.11 ±  8.93       4.64 ±  5.45       5.95 ±  7.60     0.92     3.635    0.003
    BAIa,e          7.42 ±  8.28       5.49 ±  6.91       6.51 ±  7.72     0.91     2.323    0.021
a   missing data    4/347
b   missing data    5/347
c   missing data    8/347
d   Mann-Whitney    U=12408.5,    Z=-2.372,  p=0.018
e   Mann-Whitney    U=12252.5,    Z=-2.628,  p=0.009
TCI-R=Temperament and Character Inventory-Revised,
NS=Novelty Seeking, HA=Harm Avoidance, RD=Reward Dependence, P=Persistance, SD=Self-Directedness, C=Co-operativeness,
BDI=Beck Depression Inventory, BAI=Beck Anxiety Inventory
76
7.1.2 Symptoms of anxiety
Most  of  the  responders  had  no or  only low  levels of anxiety. The range of scores on the
BAI was 0 to 50, median 4.0, and the distribution was skewed to the left. When subdividing
the scores into four categories, 76.4% of respondents had no anxiety (scores 0-9), 15.5%
had mild anxiety symptoms (10-18), 5.8% moderate anxiety symptoms (19-29) and 2.3%
severe anxiety symptoms (30-63).
7.1.3 Symptoms of depression
The level of deprssion was also low among the individuals of the sample. The scores on the
BDI ranged from 0 to 51, median 3.0, and the distribution was again highly skewed to the
left. After the scores of the whole sample were subdivided into four categories 77.8% of
respondents were not depressed (scores 0-9), 15.2% had mild depressive symptoms (10-16),
5.3% moderate depressive symptoms (17-29) and 1.8% severe depressive symptoms (30-63).
7.1.4 Correlations of the BDI, BAI and TCI-R
The scores on the BDI correlated most negatively with SD (rs=-0.495, p<0.001) and most
positively with HA (rs=0.555, p<0.001). Scores on the BAI also correlated most negatively
with SD (rs=-0.458, p<0.001) and most positively with HA (rs=0.560, p<0.001). The scores
of the BDI correlated also with the other dimensions of the TCI-R: NS rs=-0.145,
(p=0.007), RD rs=-0.170, (p=0.002), P rs=-0.154, (p=0.005), C rs=-0.184, (p=0.001) and ST
rs=0.096, (p=ns). The correlations between the scores on the BAI and other dimensions of
TCI-R were: NS rs=-0.063, (p=ns), RD rs=-0.143, (p=0.008), P rs=-0.136, (p=0.012), C
rs=-0.214, (p<0.001) and ST rs=0.172, (p=0.002). Age correlated significantly with NS
(r=-0.344, p<0.001), RD (r=-0.169, p=0.002) and HA (r=0.133, p=0.036). The correlation
between the BDI and BAI scores was strong, rs=0.726 (p<0.001). The correlations between
the dimensions of TCI-R were moderate.
7.1.5 Health related questions
Health care use due to a mental health problems (self-reported) during the past year
correlated with HA (rs=0.241, p<0.001), P (rs=-0.148, p=0.006), SD (rs=-0.135, p=0.013),
and the BDI (rs=0.288, p<0.001) and BAI (rs=0.289, p<0.001) scores.
Family history of mental disorder (self-reported) in a first-degree relative correlated
with HA rs=0.202, (p<0.001), P rs=-0.143, (p=0.008), and BDI rs=0.145, (p=0.007) and BAI
rs=0.139, (p=0.01) scores. However, there was no correlation with SD (rs=0.019, p=ns).
Lifetime mental disorder (self-reported) correlated significantly with scores on the BDI
(rs=0.239, p<0.001), BAI (rs=0.194, p<0.001), HA (rs=0.272, p<0.001), P (rs=-0.209,
p<0.001) and SD (rs=-0.225, p<0.001).
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7.1.6 Multivariate models
In multiple regression models with BDI and BAI scores as dependent variables, and HA, P,
SD, ST, age, education and gender as independent variables, BDI appeared to significantly
associate only with HA (β=0.511, t=8.160, p<0.001) and SD (β=-0.206, t=-3.629, p<0.001),
whereas BAI associated with HA (β=0.534, t=8.321, p<0.001), SD (β=-0.144, t=-2.484,
p=0.013) and unexpectedly also with P (β=0.124, t=2.437, p=0.015) and ST (β=0.143,
t=3.097, p=0.002).
7.2 Neuroticism and extraversion and symptoms of anxiety and
       depression in the general population
7.2.1 Mean scores and Cronbach’s alphas of EPI, BDI and BAI
The mean scores of most of the dimensions were lower in men than in women. Men scored
lower on neuroticism, liability, BDI and BAI, but no difference was found on extraversion.
The mean scores, standard deviations and Cronbach’s alphas are shown in Table 10.
Table 10.  Mean scores and standard deviations on the EPI, BDI and
BAI. Comparisons between genders, and Cronbach’s alpha coefficients (N=441).
EPI           Female             Male               Total     
                                                               Mann-
                                                     Whitney
                   mean ± sd          mean ± sd          mean ± sd          α      U-test       p
    Nab            10.18 ± 5.05        8.48 ± 5.22        9.35 ± 5.20      0.85                0.001
    Ec             13.38 ± 4.64       13.20 ± 4.40       13.29 ± 4.52      0.79                   ns
    Liea            2.05 ± 1.52        1.55 ± 1.51        1.81 ± 1.54      0.50   U=18814.0   <0.001
                                                                                  Z=-3.907
    BDIb           6.79 ± 8.44        4.77 ± 5.93        5.76 ± 7.38      0.93   U=20619.5    0.017
                                                                                  Z=-2.329
    BAIb           7.08 ± 8.04        5.53 ± 7.35        6.32 ± 7.75      0.91   U=20268.5    0.008
                                                                                  Z=-2.656
a   Missing data 4/441
b   Student’s t-test=4.471
c   Missing data 5/441
EPI=Eysenck Personality Inventory,
N=Neuroticism, E=Extraversion,
BDI=Beck Depression Inventory, BAI=Beck Anxiety Inventory
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7.2.2 Symptoms of anxiety
The  level  of  anxiety was also low among participants. BAI scores ranged from 0 to 50, the
median being 4.0 and the distribution was skewed to the left. Upon subdividing the scores
into four categories, 77.5% of respondents had no anxiety (score 0-9), 13.3% had mild
anxiety symptoms (score 10-18), 6.7% moderate anxiety symptoms (score 19-29) and 2.5%
severe anxiety symptoms (score 30-63).
7.2.3 Symptoms of depression
Most of the respondents had no or only a low level of depression. BDI scores ranged from 0
to 51, the median being 3.0 and the distribution was highly skewed to the left. After
scores of the entire sample were subdivided into four categories, 78.4% of respondents
were not depressed (score 0-9) 15.4% had mild depressive symptoms (score 10-16), 4.4%
moderate depressive symptoms (score 17-29) and 1.8% severe depressive symptoms (score
30-63).
7.2.4 Correlations of BDI, BAI and EPI
The correlation between BDI and BAI scores was strong (rs=0.727, p<0.001). N scores
correlated positively with BDI (rs=0.714, p<0.001) and BAI (rs=0.694, p<0.001) scores,
whereas E scores correlated negatively with both BDI (rs=-0.473, p<0.001) and BAI
(rs=-0.362, p<0.001) scores. N scores correlated negatively with E scores (rs=-0.442,
p<0.001). Scores on the lie scale correlated somewhat with BDI scores (rs=0.104, p=0.03)
and E scores (rs=-0.155, p=0.001), but not with BAI scores (rs=0.092, p=ns) or N scores
(rs=-0.003, p=ns).
7.2.5 Health related questions and age
Lifetime mental disorder (self-reported) correlated significantly with the scores of BDI
(rs=0.251, p<0.001), BAI (rs=0.210, p<0.001), N (rs=0.299, p<0.001) and E (rs=-0.168,
p<0.001). Health care use due to mental health problems (self-reported) during the past
year correlated with N scores (rs=0.235, p<0.001), E (rs=-0.137, p=0.004), BDI (rs=0.281,
p<0.001) and BAI (rs=0.288, p<0.001). Family history of mental disorder in first-degree
relatives (self-reported) correlated with N scores (rs=0.101, p=0.034), BDI (rs=0.128,
p=0.007) and BAI (rs=0.145, p=0.01), as well as with health care use for mental health
problems (self-reported) during the past year (rs=0.180, p<0.001) and self-reported
lifetime mental disorder (rs=0.273, p<0.001). Age correlated negatively with E scores
(r=-0.248, p<0.001) and positively with scores on the lie scale (r=0.193, p=0.001), but
not significantly with N scores (r=-0.37, p=ns). The correlation between age and BDI
scores was modest (rs=0.118, p=0.014).
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7.2.6 Multivariate models
In multiple regression models with BDI and BAI scores as dependent variables, and N, E,
gender, age and education as independent variables, BDI appeared to be significantly
associated with N (β=0.624, t=16.059, p<0.001), E (β=-0.176, t=-4.479, p<0.001) and age
(β=0.095, t=2.712, p=0.007), whereas BAI was associated only with N (β=0.676, t=16.361,
p<0.001).
7.3 Neuroticism, extraversion and MDD
7.3.1 Mean scores of neuroticism and extraversion
N scores declined and E scores increased during the follow-up period of MDD patients.
After a relapse or recurrence of depressive disorder, both of these scores remained at the
same level than before the episode. Mean scores of N were higher and those of E lower in
the MDD patient group than in the general population. The mean scores and standard
deviations are shown in Table 11.
7.3.2 Comparisons for the ’state effect’
7.3.2.1 Neuroticism and extraversion scales and gender
During the 18-month follow-up period N scores decreased (mean 17.2, sd 3.7 vs. 13.7, sd
5.6, t=10.034, p<0.001) and E scores increased (mean 10.0, sd 4.7 vs. 11.2, sd 4.5,
t=-5.078, p<0.001) significantly. No significant differences were observed between men and
women.
7.3.2.2 Neuroticism and extraversion scales and BDI and BAI scores
The positive correlation between BDI scores and N increased during the follow-up
(baseline: rs=0.267, p<0.001; 6-month follow-up: rs=0.587, p<0.001; 18-month follow-up:
rs=0.688, p<0.001), as well as the negative correlation between BDI scores and E
(baseline: rs=-0.152, p<0.05; 6-month follow-up: rs=-0.434, p<0.001; 18-month follow-up:
rs=-0.433, p<0.001). In addition, the positive correlation between BAI scores and N
increased (baseline: rs=0.375, p<0.001; 6 months: rs=0.701, p<0.001; 18 months: rs=0.713,
p<0.001) as also somewhat the negative correlation between BAI scores and E (baseline:
rs=-0.165, p<0.05; 6 months: rs=-0.403, p<0.001; 18 months: rs=-0.298, p<0.001).
80
Table 11. Mean scores and standard deviations on BDI, BAI, neuroticism and extraversion of
a general  population sample (N=388), total and divided by self-reported lifetime mental disorder,
and unipolar depressive patients. Comparisons between groups and Cronbach’s alpha coefficients 
(N=193).
                      (I) General            (II) General           (III) General          (IV) Unipolar          ANOVAa               Singificanceb
                         population, no self-   population, self-      population, total      depressive             I vs. II vs. IV        III vs. IV
                      reported lifetime      reported lifetime      (N=388)                patients  (N=193)                                
                      mental disorder        mental disorder                                                                          
                      (N=338)                (N=50)                                                                                   
                                                                                                                                
  Characteristic         Mean    sd      α      Mean    sd      α      Mean    sd      α      Mean    sd      α            F                  t
                                                                                                                                            
  BDI                                                                                                                                          
    Baselinec             4.6    5.4     0.91   13.3    13.2    0.92    5.7    7.5     0.92   27.3     8.2    0.81   581.378*** (I<II<IV)#    34.999***
    6 months                                                                                  12.6     9.6    0.92    74.659*** (I<II,IV)#     11.103***
    18 months                                                                                 11.1    10.0    0.93    53.288*** (I<II,IV)#      8.716***
    At index interviewh                                                                         9.7     9.3            43.939*** (I<IV<II)#      5.582***
  BAI
    Baselined             5.6    6.4     0.90   12.6    12.7    0.92    6.5    7.9     0.91   21.5    10.6    0.89   204.181*** (I<II<IV)#    20.816***
    6 months                                                                                  13.2     9.8    0.91    56.435*** (I<II,IV)#     10.37***
    18 months                                                                                 11.5    10.3    0.93    36.985*** (I<II,IV)#      7.911***
    At index interviewh                                                                        10.7     9.5            32.029*** (I<IV<II)#      5.623***
  Neuroticism
    Baselinee             8.7    5.0     0.85   13.8     4.8    0.87    9.4    5.2     0.86   17.2     3.7    0.73   207.575*** (I<II<IV)#    19.501***
    6 monthsf                                                                                 14.7     5.3    0.85    93.143*** (I<II,IV)#     12.47***
    18 months                                                                                 13.7     5.6    0.87    65.685*** (I<II,IV)#     10.059***
    At index interviewh                                                                        13.7     5.5            65.230*** (I<II,IV)#      9.073***
  Extraversion
    Baselineg            13.9    4.4     0.79   11.3     5.0    0.76   13.5    4.5     0.79   10.0     4.7    0.80    44.861*** (I>II,IV)#     -9.040***
    6 monthsf                                                                                 10.6     4.4    0.77    35.018*** (I>II,IV)#     -7.839***
    18 months                                                                                 11.2     4.5    0.78    24.209*** (I>II,IV)#     -6.262***
    At index interviewh                                                                        11.3     4.5            22.644*** (I>II,IV)#     -5.482***
a   ANOVA was computed between groups I, II and IV at baseline and using baseline data from groups I and II as a  reference for group IV
    at 6 months and 18 months
b   t-test was computed between groups III and IV at baseline and using baseline data from group I as a  reference for group IV at 6 months
    and 18 months
c   missing data 4/338, 1/50, 5/388
d   missing data 3/338, 1/50, 4/388
e   missing data 4/338, 4/193, 4/388
f   missing data 2/193
g   missing data 5/338, 5/388, 4/193
h   Interview, when scores on the Hamilton Depression Scale were at a minimum
*** p<0.001
#   Significant differences based on post-hoc (Tukey) group comparisons
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7.3.2.3 Correlations between neuroticism and extraversion and test-retest correlations
N  scores   correlated   negatively   with   those   on  the  E   scale  at   different  time  points
(baseline: r=-0.242, p<0.01; 6-month follow-up: r=-0.438, p<0.001; 18-month follow-up:
r=-0.426, p<0.001).The test-retest correlation for N increased during the follow-up
(baseline and 6-month follow-up: r=0.496, p<0.001; baseline and 18-month follow-up:
r=0.486, p<0.001; 6-month and 18-month follow-up: r=0.737, p<0.001), and for E decreased
slightly (baseline and 6-month follow-up: r=0.753, p<0.001; baseline and 18-month
follow-up: r=0.688, p<0.001; 6-month and 18-month follow-up: r=0.731, p<0.001).
7.3.2.4 Multivariate models for the ’state effect’
In multiple regression models (Table 12.) with 18-month follow-up N or E scores as
dependent variables, and age, gender, marital status, education, work status, change in
BDI and BAI scores between two time points (18-month follow-up and baseline), and either
baseline N or E as independent variables, 18-month follow-up N was significantly explained
by baseline N, education and change in both BDI and BAI scores and 18-month follow-up E
was explained by baseline E, age and change in BDI scores. Due to correlations between the
scores of BDI, BAI, N and E, the analyses were performed also by using HAM-D instead of
BDI, but the results remained the same.
Table 12. Multiple regression models for the ’state effect’.
                                                       Dependent variable
                                          Neuroticismb                                 Extraversionc
                                   β-                            Partial     β-                            Partial
  Independent variable          coefficient*      t          p           R2    coefficient*      t          p          R2
  Neuroticism, baseline            0.520       9.482     <0.001      0.267
  Extraversion, baseline                                                        0.656       12.333    <0.001      0.400
  BDI, change 18
  months and baseline              0.278       4.401     <0.001      0.058     -0.166       -2.800     0.006      0.020
  BAI, change 18
  months and baseline              0.201       3.261      0.001      0.032     -0.029       -0.501     0.617      0.001
*   Standardized coefficient
a   Also adjusted for age, gender, education, marital status and work status
b   18-month follow-up neuroticism, R2=0.456,F(8,175)=20.176,p<0.001
c   18-month follow-up extraversion, R2=0.523,F(8,175)=26.066, p<0.001
BDI=Beck Depression Inventory, BAI=Beck Anxiety Inventory
a
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7.3.3 Comparisons for the ’scar effect’
The  number  of  preceding  lifetime  depressive  episodes  correlated mildly with both the N
scores (rs=0.28, p<0.001) and E (rs=-0.16, p=0.031). Altogether 94 patients (67 females
and 27 males) had a recurrence or a relapse (mean duration 4.6 months, sd 4.3 months)
between the 6- and 18-month follow-ups. However, during this time, there were no
significant differences in N (16.5, sd 4.3 vs. 16.2, sd 4.8, p=ns) or E (9.6, sd 4.5 vs.
10.2, sd 4.6, p=ns) scores. The results remained the same even when the subgroups by the
lifetime number of depressive episodes (lifetime second 26% [N=24], third 33% [N=31],
fourth 15% [15] and fifth or more 26% [N=24]) were analyzed separately. No gender
differences were found.
7.3.4 Comparisons for the ’trait effect’
7.3.4.1 Neuroticism and extraversion, age and gender
Both female and male patients from the VDS scored significantly higher on the N scale and
lower on the E scale than subjects from the general population. Age correlated negatively,
with no gender differences, with the index interview E scores from the VDS cohort
(r=-0.284, p<0.001) as well as with the scores from the general population (r=-0.226,
p<0.001), but not significantly with the N scores from either group.
7.3.4.2 Neuroticism and extraversion scales and BDI and BAI scores
BDI and BAI scores correlated strongly with N scores of MDD patients at the index
interview (rs=0.626, p<0.001 and rs=0.721, p<0.001, respectively) and moderately with E
scores (rs=-0.425, p<0.001 and rs=-0.378, p<0.001). Likewise, in the general population,
the BDI and the BAI scores correlated strongly with N (rs=0.712, p<0.001 and rs=0.689,
p<0.001, respectively) and moderately with E (rs=-0.479, p<0.001 and rs=-0.373, p<0.001).
In MDD patients at the index interview and in the general population, the correlation
between BDI and BAI was strong (rs=0.672, p<0.001 and rs=0.731, p<0.001, respectively). No
significant gender differences in these correlations were found.
7.3.4.3 Logistic regression models for the ’trait effect’
In a logistic regression model after controlling for gender, marital status, work status,
education, age and BDI and BAI scores, being a depressive patient was associated with
higher N (OR 1.11, p=0.001) and lower E (OR 0.92, p=0.003) scores.
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7.4 Neuroticism, extraversion and comorbidity of MDD
7.4.1 Comorbid axis I disorders
As the level of N increased, the prevalences of any comorbid axis I disorder and anxiety
disorder, especially phobic and alcohol dependence increased, whereas as the level of E
decreased the prevalence of comorbid social phobia increased. The prevalences of different
comorbid disorders by level of N and E are shown in Table 13.
In a logistic regression model, after controlling for HAM-D, gender and age, having any
comorbid axis I or anxiety disorder, especially phobic disorder, was associated with
higher N (OR 1.08, p=0.027; OR 1.07; p=0.043; OR 1.11 p=0.002, respectively), while having
comorbid social phobia was associated with lower E (OR 0.87, p=0.007).
7.4.2 Comorbid axis II disorders
As the level of N increased, the prevalence of any comorbid axis II disorder, cluster C
personality disorder, especially avoidant personality disorder, and borderline personality
disorder increased, whereas as the level of E decreased the prevalence of any comorbid
axis II disorder, cluster C personality disorder, especially avoidant, and, as a trend,
cluster A personality disorder (p=0.07) increased. The prevalences of different comorbid
axis II disorders by level of N and E are shown in Table 13.
In a logistic regression model, after controlling for HAM-D, gender and age, having any
comorbid axis II disorder, cluster C personality disorder or avoidant personality
disorder, was associated with high N (OR 1.15, p=0.007; OR 1.32, p<0.001; OR 1.27,
p=0.002, respectively), whereas having comorbid cluster A, paranoid, cluster C or avoidant
personality disorder was associated with lower E (OR 0.84, p=0.015; OR 0.82, p=0.01; OR
0.82, p=0.001; OR 0.76, p<0.001, respectively).
In the multiple linear regression model, with the number of positive items of different
comorbid axis II disorders as a dependent variable and HAM-D, gender, and age either N or
E as independent variables comorbid paranoid (β=0.077, sd 0.021, p<0.001), borderline
(β=0.127, sd 0.024, p<0.001) and all cluster C personality disorders: avoidant (β=0.109,
sd 0.025, p<0.001), dependent (β=0.075, sd 0.019, p<0.001), obsessive-compulsive (β=0.084,
sd 0.021, p<0.001), passive-aggressive (β=0.070, sd 0.023, p<0.01) were significantly
explained by N, whereas comorbid paranoid (β=-0.059, sd 0.025, p<0.05), schizoid
(β=-0.042, sd0.017, p<0.05) and avoidant (β=-0.192, sd 0.028, p<0.001) personality
disorders were explained by E.
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7.4.3 Number of comorbid disorders
As the level of N increased, the mean number of comorbid axis I, II or both axes disorders
increased, whereas as the level of E decreased the number of comorbid axis II disorders
increased (Table 13).
In the multiple linear regression model (Table 14), with the number of comorbid disorders
(either axis I or II or both axes I and II) as a dependent variable and HAM-D, gender,
age, and either N or E as independent variables, the number of comorbid disorders in all
three models was significantly explained by N, but not by E.
7.4.4 Comparison between axis I and II comorbid disorders
Among patients with pure MDD or with any comorbid axis I or II disorder, the standardized
scores of N were +0.46, +0.90 and +1.30, respectively, and the scores of E -0.34, -0.47
and -0.84, respectively. The comorbid disorder specific standardized scores of N and E are
shown in Figure 1.
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Figure 1. Mean neuroticism (N) and extraversion (E) scores of axis I and 
II comorbid disorders of Major Depressive Disorder (MDD) patients
(N=193) in the Vantaa Depression Study converted into standardized scores.
(origo: mean scores of N and E in the general population).
 1= Any axis I disorder
 2= Any anxiety disorder
 3= Panic Disoder
 4= Phobic disorder
 5= Obsessive-Compulsive Disorder
 6= Generalised Anxiety Disorder
 7= Alcohol dependence
 8= Any personality disorder
 9= Cluster A personality disorder
10= Cluster B personality disorder
11= Cluster C personality disorder
12= Pure MDD
13= All patients
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Table 13. Prevalence (number of patients) having comorbid axis I or II disorder, atypical 
 or melancholic depression, mean number (range) of comorbid disorders, and mean scores of 
 Social and Occupational Functioning Assessment Scale of DSM-IV (SOFAS) by four levels of 
neuroticism (based on population mean and standard deviation) in Vantaa Depression Study
(N=193).
                                                          Neuroticism scorea,b
                                        Low            Normal         High           Very high
  Characteristic                        < -1 sd        -1 sd - +1 sd   +1 sd - +2 sd   >+2 sd
                                        (I)(14)        (II)(81)       (III)(66)      (IV)(30)            χ2             p
  No comorbid disorder                   14.3 (2)       21.0 (17)       4.5 (3)        0   (0)        14.335d        0.001
  Axis I diagnosish                                                                                   
     Any axis I disorder                 57.1 (8)       58.0 (47)      80.3 (53)      73.3 (22)        9.455c         0.024
     Any anxiety disorder                57.1 (8)       55.6 (45)      77.3 (51)      70.0 (21)        8.288c         0.040
     Panic disorder                      21.4 (3)       13.6 (11)      28.8 (19)      20.0 (6)                           ns
     Any phobic disorderf                28.6 (4)       37.0 (30)      59.1 (39)      63.3 (19)       12.091c         0.007
     Agoraphobia without panic            0   (0)        9.9 (8)       18.2 (12)      26.7 (8)         7.532f         0.049
     Social phobia                       14.3 (2)       14.8 (12)      30.3 (20)      33.3 (10)                          ns
     Simple phobia                       21.4 (3)       28.4 (23)      48.5 (32)      46.7 (14)        8.860c         0.031
     Obsessive-compulsive disorder        0   (0)        4.9 (4)       15.2 (10)      10.0 (3)                           ns
     Generalized anxiety disorder        14.3 (2)       13.6 (11)      16.7 (11)      13.3 (4)                           ns
     Alcohol dependence                  14.3 (2)        7.4 (6)       16.7 (11)      36.7 (11)       14.236c         0.003
  Axis II diagnosisb,g
     Any personality disorder             0   (0)       16.0 (13)      42.4 (28)      43.3 (13)       22.218d        <0.001
      Cluster A                           0   (0)        6.2 (5)       12.1 (8)       13.3 (4)                           ns
            Paranoid                      0   (0)        4.9 (4)       10.6 (7)       13.3 (4)                           ns
      Cluster B                           0   (0)        8.6 (7)       21.2 (14)      16.7 (5)                           ns
            Borderline                    0   (0)        2.5 (2)       13.6 (9)       16.7 (5)         9.683d         0.013
      Cluster C                           0   (0)        2.5 (2)       28.8 (19)      43.3 (13)       36.474d        <0.001
            Avoidant                      0   (0)        1.2 (1)       21.2 (14)      33.3 (10)       27.771d        <0.001
  Number of comorbid disorders
     Axis I disorder, mean (sd)           0.86(0.94)     0.93(1.03)     1.74(1.21)     1.87(1.70)     21.211c,e      <0.001
     Axis II disorder, mean (sd)          0   (0)        0.20(0.51)     0.74(1.09)     0.83(1.05)     24.714c,e      <0.001
     Axis I and II disorder, mean (sd)     1.00(0.96)     1.22(1.19)     2.63(1.87)     2.80(2.06)     34.614c,e      <0.001
  Subtypes of depression
     Atypical depression                  7.1 (1)       11.1 (9)       21.2 (14)      23.3 (7)                           ns
     Melancholic features                35.7 (5)       35.8 (29)      47.0 (31)      50.0 (15)                          ns
  Level of functioningb
       SOFAS score, mean (sd)l           82.1 (10.7)    79.1 (11.0)    67.5(14.5)     67.7 (12.6)   I,II>III,IVj     <0.001
a   Missing data: 2/193
b   At index interview, when scores on the Hamilton depression Scale were at a minimum.
c   df=3
d   Fisher’s exact test
e   Kruskall-Wallis  test
f   Agoraphobia without panic + social phobia + simple phobia
g   Separate personality disorders were included, if n>10
h   At any time (baseline, 6 months or 18 months)
j   ANOVA, F=14.712, df=3, post-hoc (Tukey)
k   ANOVA, F= 6.461, df=3, post-hoc (Tukey)
l   Missing data 3/193
87
                    Extraversion scorea,b
  Very low       Low            Normal         High
  < -2 sd        -2 sd - -1 sd   -1 sd - +1 sd   >+1 sd                                       Characteristic
  (I)(10)        (II)(61)       (III)(108)     (IV)(12)            χ2             p
    0   (0)        8.2 (5)       14.8 (16)       8.3 (1)                           ns       No comorbid disorder
                                                                                            Axis I diagnosish
   80.0 (8)       70.5 (43)      64.8 (70)      75.0 (9)                           ns          Any axis I disorder
   70.0 (7)       68.9 (42)      63.0 (68)      66.7 (8)                           ns          Any anxiety disorder
   10.0 (1)       19.7 (12)      21.3 (23)      25.0 (3)                           ns          Panic disorder
   60.0 (6)       54.1 (33)      44.4 (48)      41.7 (5)                           ns          Any phobic disorderf
   30.0 (3)       21.3 (13)       9.3 (10)      16.7 (2)                           ns          Agoraphobia without panic
   50.0 (5)       32.8 (20)      16.7 (18)       8.3 (1)        11.306c         0.010          Social phobia
   50.0 (5)       39.3 (24)      36.1 (39)      33.3 (4)                           ns          Simple phobia
   10.0 (1)       16.4 (10)       5.6 (6)        0   (0)                           ns          Obsessive-compulsive disorder
   20.0 (2)       16.4 (10)      13.9 (15)       8.3 (1)                           ns          Generalized anxiety disorder
   10.0 (1)       16.4 (10)      16.7 (18)       8.3 (1)                           ns          Alcohol dependence
                                                                                            Axis II diagnosisb,g
   70.0 (7)       39.3 (24)      19.4 (21)      16.7 (2)        17.221c          0.001         Any personality disorder
   30.0 (3)        9.8 (6)        7.4 (8)        0   (0)                       ns(0.07)         Cluster A
   20.0 (2)        9.8 (6)        6.5 (7)        0   (0)                           ns                 Paranoid
   10.0 (1)       11.5 (7)       14.8 (16)      16.7 (2)                           ns           Cluster B
    0   (0)       11.5 (7)        6.5 (7)       16.7 (2)                           ns                 Borderline
   60.0 (6)       31.1 (19)       8.3 (9)        0   (0)        25.727d        <0.001           Cluster C
   50.0 (5)       26.2 (16)       3.7 (4)        0   (0)        28.067d        <0.001                 Avoidant
                                                                                            Number of comorbid disorders
    1.80(1.69)     1.62(1.50)     1.19(1.11)     1.00(0.85)                        ns          Axis I disorder, mean (sd)
    1.10(0.99)     0.59(0.82)     0.36(0.88)     0.33(0.89)     16.198c,e       0.001          Axis II disorder, mean (sd)
    3.10(2.28)     2.28(1.87)     1.70(1.62)     1.42(1.24)                        ns          Axis I and II disorder, mean (sd)
                                                                                            Subtypes of depression
   30.0 (3)       14.8 (9)       16.7 (18)       8.3 (1)                           ns          Atypical depression
   50.0 (5)       45.9 (28)      38.0 (41)      50.0 (6)                           ns          Melancholic features
                                                                                            Level of functioningb
   63.6 (14.3)    69.7 (13.9)    75.6 (13.0)    82.8 (10.9)   I,II<III,IVk     <0.001            SOFAS score, mean (sd)l
Table 14. Multivariate analysis   with the number of comorbid disorders
 (all axis I or any anxiety or all axis II or both axis I and II ) as a dependent 
 variable and either neuroticism (N) or extraversion (E) separately or together as     
an independent variable in depressive patients (N=193).
 Independent  Anxiety disordersb      All axis I disordersb,c  Personality disordersd  Axis Ib,c+II disorderd
 variable
 Entered
 separately      β       t       p       β       t       p       β       t       p       β       t       p
    1) Ne      0.239   2.903   0.004   0.264   3.254   0.001   0.228   2.780   0.006   0.311   3.965  <0.001
    2) Ee     -0.123  -1.529      ns  -0.085  -1.065      ns  -0.128  -1.596      ns  -0.128  -1.639      ns
  Entered
  together
    3) Ne      0.220   2.578   0.011   0.258   3.066   0.002   0.207   2.434   0.016   0.297   3.639  <0.001
    4) Ee     -0.066  -0.804      ns  -0.018  -0.226      ns  -0.074  -0.905      ns  -0.051  -0.654      ns
a   Linear regression models, adjusted for the Hamilton Depression Scale scores, age and gender
b   At any time (baseline, 6 months or 18 months)
c   Anxiety disorders + alcohol dependence
d   At index interview, when scores on the Hamilton Depression Scale were at a minimum
e   Missing data 2/193
a
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8. DISCUSSION
8.1 Main findings
The  revised  version  of the  temperament and character  inventory (TCI-R) has been seldom
applied to investigate anxiety among subjects in the general population and this was one
of the first of such studies. Both the temperament dimension of Harm Avoidance and
character dimension of Self-Directedness were found to associate significantly with
symptoms of anxiety as well as depression. Self-reported positive family history of mental
disorders associated somewhat with Harm Avoidance, but not with Self-Directedness.
Moreover, both the dimensions were also weakly associated with health care use and
self-reported mental disorders.
There are also only few previous studies on the relationships between neuroticism and
extraversion and the symptoms of anxiety and depression in the general population. Both
the personality dimensions of extraversion and neuroticism were found to be strongly
associated with depression and anxiety. Lifetime mental disorder and self-reported health
care use for psychiatric reasons were also associated with neuroticism, the former as
strongly as BAI and BDI scores.
Among major depressive disorder patients, the scores of neuroticism were observed to
decline markedly and the scores of extraversion to increase somewhat with recovery. The
predictive value of the changes in symptoms of anxiety and depression in explaining
follow-up neuroticism was about 1/3 of that of baseline neuroticism. In contrast to
neuroticism, extraversion scores showed no dependence on the symptoms of anxiety, and the
change in the symptoms of depression explained only 1/20 of the follow-up extraversion
compared with baseline extraversion. During a 12-month follow-up period, no evidence of
the ’scar effect’ was found. MDD patients had a markedly higher level of neuroticism and a
slightly lower level of extraversion than subjects in the general population, even after
controlling for symptoms of both anxiety and depression,
In MDD patients a positive dose-exposure relationship was found between the level of
neuroticism and the number and prevalence of comorbid axis I and II disorders. Likewise, a
negative dose-exposure relationship was consistently observed between the level of
extraversion and social phobia and cluster C personality disorders, and less consistently
with cluster A personality disorders. All patients with or without comorbid disorder had
positive standardized scores of neuroticism and negative of extraversion, but the scores
were not grossly extreme in any patient group.
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8.2 Strengths and limitations of the study
8.2.1 General population survey
8.2.1.1 Representativeness of the sample
The sample was randomly drawn from the National Population Register, representing the
adult population of two larger Finnish cities. The response rate for the whole
questionnaire was rather low (38.6%) and the sample size remained moderate (N=347),
possibly due to the length of the questionnaire (30-60 minutes to complete). However, the
response rate rose somewhat (49%) and sample size increased (N=441) when the responders of
the shortened version of the questionnaire were also included. There were only minimal
differences in sociodemographic characteristics between responders and the general
population. The responders were somewhat older, a little better educated, slightly more
often married and employed. It is not known whether the results are generalizable to rural
populations, as the sample included only suburban and urban population.
8.2.1.2 Temperament and personality dimensions measured
Although no marked differences in the characteristics between responders and
non-responders emerged, and the mean scores of TCI-R and EPI among the responders were
comparable to the other general population studies using the TCI-R (Brandstrom et al.
2003; Gutierrez-Zotes et al. 2004) and EPI, (Eysenck and Eysenck 1964), the possibility
that the population could have been biased towards some temperament or character dimension
investigated (e.g. P or ST) cannot be excluded. Moreover, even though the distributions of
anxiety and depressive symptoms scores were as expected, the question of how much current
mood state affected the scores of either temperament and character dimensions or
extraversion and neuroticism remains open, due to the study’s cross-sectional design.
However, the internal consistency of the Finnish version of the TCI-R was good (Cronbach’s
alpha from 0.85 to 0.89), as well as that of the Finnish version of the N and E scales
(Cronbach’s alpha 0.85 and 0.79).
8.2.2 MDD patient cohort
8.2.2.1 Representativeness of the sample
The VDS comprised a cohort of 269 in- and outpatients with MDD, effectively representing
all psychiatric patients with a new episode of MDD in the Finnish city of Vantaa. Two
thirds of all depressed subjects in the general population of Vantaa seeking treatment
from psychiatrists are treated in the PMCD (Rytsälä et al. 2001). This study took place
during the era of modern antidepressants in 1997-1999 in a community psychiatric setting;
at baseline 78% of the patients received antidepressants at adequate levels during the
acute phase in compliance with the APA Practice Guideline (Melartin et al. 2004).
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8.2.2.2 Diagnostic measures
The patients of the study were diagnosed carefully using semi-structured interviews with
excellent reliability (kappa=0.86) for the diagnosis of MDD. However, the reliability of
comorbid disorder diagnosis remains unknown. Axis II diagnoses were assessed using the
semi-structured SCID-II interview for DSM-III-R, as the SCID-II for DSM-IV was not yet
available in February 1997. The differences between DSM-III-R and DSM-IV were taken into
account by excluding masochistic personality disorder. Passive-aggressive personality
disorder was included because it belongs to the "personality disorder not otherwise
specified" category in DSM-IV
8.2.2.3 Life-chart methodology
The Longitudinal Interval Follow-up Evaluation (LIFE) methodology was introduced in the
NIMH-CDS to investigate the outcome of depression (Keller et al. 1987). In the VDS the
course of depression was assessed during the follow-up by using a graphic life-chart
methodology similar to, but not identical to LIFE. All patient records and monthly
BDI-ratings (for the first 6 months) were available. Patients’ follow-up time was
classified into periods of DSM-IV MDE, partial or full remission.
8.2.2.4 Drop outs
Altogether 73% of the cases could be interviewed at all three time points and their
depression had remained unipolar (the diagnosis switched to bipolar in 13/269 patients,
5%). As the factors associated with dropping out were younger age and a slightly higher
score on the baseline BAI scale, but not differences in other sociodemographic variables
or in BDI, N or E, the percentage of drop outs is unlikely to have biased the findings.
8.2.2.5 Comorbid axis I and II disorders
Only current axis I diagnoses assigned at the three follow-up time points were included.
Thus, the prevalence of these comorbid disorders might have been underestimated during the
follow-up. All comorbid axis II disorders could not be analysed separately, and also it is
possible that all differences within axis I comorbidity could not be detected, both due to
the small number of cases in the subgroups.
8.2.2.6 Personality dimensions measured
The personality dimensions were measured only by EPI, as at baseline, the Finnish version
of TCI-R was not yet available. The internal consistency of EPI was good (Cronbach’s
alphas for N and E at baseline, 6 months and 18 months were 0.73, 0.85, 0.87 and 0.80,
0.77, 0.78, respectively). As there were no premorbid measurements of personality
dimensions in MDD patients, it is not possible to completely rule out the possibility that
the differences in the level of N and E found between MDD patients and the general
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population might have partly been a consequence of a post-morbid change of personality in
MDD patients. However, the majority of the MDD patients were in their lifetime first,
second or third episode at baseline, there was no evidence for a change on the N or E
scores in any of these subgroups after subsequent relapses or recurrences of MDD, and E
and N scores when HAM-D scores were at minimum were used. Thus, if post-morbid changes
would have explained the differences between the patients and the general population, then
they must have had developed immediately during the lifetime first episode. However, this
possibility is unlikely.
8.3 Temperament and personality dimensions and the dimensional
      concept of anxiety and depression
In the present study, the personality dimensions associated not only to the symptoms of
depression, but also to the symptoms of anxiety among the general population and in
depressive patients, as well as to comorbid disorders in MDD patients, supporting the
dimensional view of depression and anxiety (Helzer et al. 2006). The relationship between
the symptoms of anxiety and depression and the personality dimensions of neuroticism and
of extraversion, as well as the temperament and character dimensions of TCI-R, was studied
among the general population. There are only few previous general population studies
(Goodwin et al. 2002; Bienvenu et al. 2004; Cox et al. 2004) investigating the association
between the dimensions of N and E and anxiety and depressive symptoms, and none has
explored anxiety symptoms with both dimensions. Moreover, there are even less studies
(Grucza et al. 2003; Richter et al. 2003) investigating the relationship between the
dimensions of TCI-R and the symptoms of depression undertaken in the general population,
and none on anxiety.
The association between MDD and neuroticism and extraversion was investigated
longitudinally among a cohort of depressive patients. By having the N and E scores of the
general population, it was possible to study these two dimensions not only among the MDD
patients at different time points, but also to compare the level of N and E between the
general population and MDD patients. The relationship between N and E and MDD has been
studied in some prospective epidemiological twin (Kendler et al. 1993b, 2006a; Fanous et
al. 2007) and general population studies (Ormel et al. 2004). However, it is uncertain
whether the findings of an epidemiological study are generalizable to clinical samples, as
patients from clinical samples commonly tend to have longer-lasting, more severe and
recurrent episodes, often comorbid with personality disorders. There are some previous
longitudinal premorbidly started clinical studies among primiparous women (Boyce et al.
1991), family members of patients with depression (Hirschfeld et al. 1989; Shea et al.
1996) or male conscripts (Angst and Clayton 1986) investigating the association between
MDD and the dimensions of N and E, but as a limitation of these studies, the state of
anxiety, which also might influence on the scores of N and E (Reich et al. 1986), was not
controlled and the sample was restricted to a limited patient group.
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As all comorbid disorders were assessed in MDD patients, it was possible to study the
relationship between N and E and MDD with both axis I and II comorbid disorders to obtain
an overall picture of these associations. Former studies have explored either axis I
(Bienvenu et al. 2001; Khan et al. 2005; Hettema et al. 2006) or all (Davidson et al.
1985; Brieger et al. 2000) or only one (Khan et al. 2005) axis II comorbid disorders, but
not both axes concurrently. Moreover, only one previous study of MDD and comorbid
disorders, evaluating MDD and comorbid GAD, has been longitudinal and controlled for the
possible confounding state-effect of depression.
8.4 Temperament and personality dimensions and the symptoms
      of depression
Among the general population neuroticism and Harm Avoidance, both measuring sensitivity to
negative stimuli, were found to associate positively with the symptoms of depression
measured by BDI. These findings are consistent with earlier reports with HA and depressive
symptoms in clinical settings (Svrakic et al. 1992; Joffe et al. 1993; Hansenne et al.
1999), among students (Peirson and Heuchert 2001) and in the general population (Richter
et al. 2003), as well as with N and depressive symptoms in clinical (Kendell and DiScipio
1968; Ulusahin and Ulug 1997) and non-clinical (Hepburn and Eysenck 1989; Williams 1990;
Saklofske et al. 1995) settings, in patients and their healthy controls (Hirschfeld et al.
1983a; Farmer et al. 2002) and among the general population (Bienvenu et al. 2004).
By contrast, extraversion, a trait reflecting a tendency to experience positive mood
states and the character dimension of Self-Directedness, based on a concept of the self as
an autonomous individual, associated negatively with depressive symptoms measured by BDI
among the general population. These results accord with previous findings with E and
depressive symptoms in clinical (Kendell and DiScipio 1968; Ulusahin and Ulug 1997) and
non-clinical (Hepburn and Eysenck 1989; Williams 1990; Saklofske et al. 1995) settings, in
patients and their healthy controls (Hirschfeld et al. 1983a; Farmer et al. 2002) and
among the general population (Bienvenu et al. 2004), as well as with SD and depressive
symptoms in clinical settings (Svrakic et al. 1992; Joffe et al. 1993; Hansenne et al.
1999), among students (Peirson and Heuchert 2001) and in the general population (Richter
et al. 2003). All the association remained significant even after adjusting for education,
gender and age.
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8.5 Temperament and personality dimensions and the symptoms
      of anxiety
Both high N and high HA associated with the symptoms of anxiety, measured by BAI, even
after adjustment for gender, education and age. This finding is consistent with previous
reports with N and anxiety symptoms conducted in twins (Hettema et al. 2004), in clinical
settings (Kerr et al. 1970; Bianchi and Fergusson 1977), in students (Bull and Strongman
1971; De and Singh 1972) and in the general population (Henderson et al. 1998; Issakidis
and Andrews 2002). Also in earlier clinical studies (Pfohl et al. 1990; Ball et al. 2002;
Marteinsdottir et al. 2003) and studies among students (Pelissolo et al. 2002; Jiang et
al. 2003) a positive association between HA and anxiety has been observed. Moreover,
although P did not associate positively with the symptoms of anxiety in the univariate
analyses, in the multiple regression models the temperament dimension of P and the
character dimension of ST associated positively with the symptoms of anxiety.This finding,
however, may be due to multicollinearity problems.
Symptoms of anxiety correlated negatively with both E and SD. The negative association
between SD and the symptoms of anxiety was confirmed in the multiple regression models,
even after adjustment for gender, education and age. This finding accords with former
studies conducted among students (Pelissolo et al. 2002; Jiang et al. 2003) and in
clinical settings (Pfohl et al. 1990; Ball et al. 2002; Marteinsdottir et al. 2003).
Although E correlated negatively with anxiety symptoms, the association was not confirmed
in the multiple regression models, perhaps due to the negative correlation between N and E
scores. However, this negative finding accords fully with the view that E is related to
depression only, but not with anxiety (Clark et al. 1994).
8.6 Temperament and personality dimensions and health related
      questions
The overall clinical significance of the associations between the symptoms of depression
and anxiety and the temperament and personality dimensions measured among the general
population was supported by the data obtained from the health related questions. The BDI
and BAI scores, as well as HA and N scores correlated positively, while P negatively with
the questions on health care use for mental health problems during the past year,
self-reported mental health disorder in relatives and self-reported but physician-
diagnosed lifetime mental disorder. SD and E correlated negatively with self-reported
lifetime mental disorder and self-reported health care use for a mental health problem
during the past year. HA, but not other dimensions correlated somewhat with self-reported
positive family history of mental disorders. These preliminary findings need to be
interpreted with caution, as their validity, particularly the self-reported family
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history, is unknown. However, the prevalence of self-reported health care use in the
present study fully accords with their known prevalence in the Finnish general population
(Hämäläinen et al. 2004), and high N and HA were found to associate nearly as strongly as
the symptoms of anxiety and depression with the self-reported health care use. Moreover,
in previous studies the use of mental health services for anxiety disorders (Issakidis and
Andrews 2002) has been found to associate with high N, or for anxiety and depressive
disorders (Goodwin et al. 2002) with high N and low E.
8.7 Personality dimensions and MDD
8.7.1 Neuroticism
High N associated with the symptoms of depression and anxiety in MDD patients. Moreover, N
was found to be dependent on the change in symptoms of both depression and anxiety. As the
dispersion of the depressive symptoms increased during the follow-up, the correlations
between N and the symptoms of depression and anxiety expectedly strengthened among the
MDD patients, reaching nearly the level of the general population. The dependence on
the change in symptoms of depression is consistent with earlier clinical studies (Kendell
and DiScipio 1968; Hirschfeld et al. 1983b). However, only a few earlier studies (Bianchi
and Fergusson 1977; Clark et al. 1994) have reported the dependence of N on the change in
symptoms of anxiety. In accordance with a previous five-week study (Santor et al. 1997)
the follow-up N scores were only marginally accounted for, by the changes in depression
scores and mostly by the baseline personality dimensions. The changes in symptom state
explained only 1/3 (depression 2/9 and anxiety 1/9) of what the baseline N explained of
the follow-up N. Thus, although being relatively stable, N was found to be also
state-dependent on both depressive and anxiety symptoms.
During the 12-month follow-up, the N scores did not change in a subgroup of MDD patients
with a recurrence or relapse of depression, which is consistent with a 18-year follow-up
study (Duggan et al. 1991) and also with premorbidly started studies (Shea et al. 1996;
Ormel et al. 2004). However, this finding is contrary to some epidemiological studies
(Kendler et al. 1993b), where the level of N was increased possibly due to residual mild
symptoms of depression. Thus, in the present study N was not found to be shaped by a
relapse or recurrence of depression.
Even after controlling for symptoms of anxiety and depression and other confounding
sociodemographic factors, the scores of N were higher among MDD patients than in the
general population. This finding accords with previous reports (Hirschfeld and Klerman
1979; Angst and Clayton 1986; Ormel et al. 2004; Kendler et al. 2006a). The difference in
the proportion of subjects in the depressive group with very high N, i.e. over 2 sd above
the mean N score of the general population was 7-fold (18% vs. 2.5%) that of the general
population, which is in line with an earlier study with depressive patients and published
norms (Hirschfeld and Klerman 1979) and with a prospective general population group (Ormel
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et al. 2004). However, less than 20% of depressive patients had extreme N scores, and the
range of scores among depressive patients and the general population had a large overlap.
Overall, these findings were consistent with the view that N is a risk factor or at least
indicator for MDD.
8.7.2 Extraversion
The personality dimension of extraversion was found to be dependent on the change in
symptoms of depression and anxiety. During the follow-up the correlations between E and
the symptoms of depression and anxiety strengthened among the MDD patients, reaching
nearly the level of the general population. The dependence on the change in symptoms of
depression is consistent with most earlier clinical (Kendell and DiScipio 1968; Hirschfeld
et al. 1983b), but not all epidemiological (Kendler et al. 1993b) studies. In accordance
with a previous five-week study (Santor et al. 1997) the follow-up E scores were mostly
accounted for by the baseline E scores, and only marginally by the changes in depression
scores. The changes in symptom state explained only 1/20 of what the baseline E explained
of the follow-up E. Overall, although relatively stable, E showed to be state-dependent on
depressive symptoms, but not on anxiety symptoms.
The scores of E did not change during the 12-month period in a subgroup of MDD patients
with a recurrence or relapse of depression, which is consistent with a previous
premorbidly started study (Shea et al. 1996). Overall, E was not found to be shaped by a
relapse or recurrence of depression.
Even after controlling for symptoms of anxiety and depression and other confounding
sociodemographic factors, the scores of E were lower among MDD patients than in the
general population. This is consistent with some previous clinical (Hirschfeld et al.
1983a; Farmer et al. 2002) and general population twin studies (Kendler et al. 2006a), but
not all (Kendler et al. 1993b), where E and major depression had no significant
relationship. The difference in the percentage of subjects with very low E, i.e. less than
2 sd below the mean E score of the general population was 4-fold (10% vs. 2.5%) among
depressive patients compared with the general population, slightly less than in another
study with depressive inpatients and published norms (18% vs. 2.5%) (Hirschfeld and
Klerman 1979). Although the difference in the level of E between MDD patients and the
general population was not as pronounced as with N, it was clearly observed. The lower
level of E seen in clinical rather than in general population studies (Kendler et al.
1993b) of depression might at least be in part due to the high rate of comorbidity of
depression and personality disorders, especially cluster C (32 %, Melartin et al. 2002)
among MDD patients. Albeit not as strong as N, low E i.e. introversion, was found to be a
risk factor or indicator for MDD.
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8.8 Personality dimensions and MDD with comorbid axis I or II
      disorders
8.8.1 MDD with comorbid axis I disorders
High N was found to associate with comorbid axis I disorders. Moreover, a positive
dose-exposure relationship was found between the level of N and the number and prevalence
of comorbid axis I disorders. Only phobic disorders associated with high N, consistent
with previous reports (Bienvenu et al. 2001; Khan et al. 2005; Weinstock and Whisman
2006), whereas other internalizing (panic disorder, GAD) and externalizing disorders did
not reach statistical significance, perhaps due to too few cases. The positive association
between N and the number of comorbid axis I disorders has also been noted in earlier
studies (Bienvenu et al. 2001; Cuijpers et al. 2005). Even after adjustment for gender,
age and HAM-D scores, all the above associations remained significant.
Of comorbid axis I disorders, low E associated with social phobia. In accordance with an
earlier study (Bienvenu et al. 2001), a negative dose-response relationship was observed
between the level of E and the prevalence of social phobia. However, contrary to a
previous report investigating MDD and comorbid anxiety disorders, using NEO Five-Factor
Inventory and not controlling for the current symptoms of depression (Cuijpers et al.
2005), the number of comorbid axis I disorders was not dependent on the level of E. Even
after adjustment for gender, age and HAM-D scores, all associations remained significant.
Thus, the role of E in comorbidity seems to be more specific than that of N.
8.8.2 MDD with comorbid axis II disorders
High N associated with cluster C personality disorders, especially with avoidant
personality disorder. Moreover, a clear positive dose-exposure relationship was found
between the level of N and number and prevalence of comorbid axis II disorders. When
applying the number of positive personality disorder items, a positive correlation was
also found between the N scores and paranoid, borderline and all cluster C (avoidant,
dependent, obsessive-compulsive, passive-aggressive) personality disorders, which accords
with a previous finding (Brieger et al. 2000). As a new finding, high N was found to
associate also with the number of comorbid axis II disorders. All associations remained
significant even after adjustment for gender, age and HAM-D scores. Overall, among MDD
patients, high N was found to predict comorbidity of axis II disorders, as well as the
overall number of comorbid axis II disorders.
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A negative dose-response relationship was observed between the level of E and the
prevalence of cluster C and also, as a trend, cluster A personality disorder. In
accordance with a previous report (Brieger et al. 2003), low E associated with avoidant
and paranoid personality disorders and, when applying the number of positive personality
disorder items, also with schizoid personality disorder. Even after adjustment for gender,
age and HAM-D scores, all the associations remained significant. The role of E in axis II
comorbidity seems to be more specific than that of N.
8.8.3 Personality dimensions and pure MDD or with any comorbid axis I or
         II disorders
The scores of N and E were not extreme for patients with either pure MDD or with comorbid
axis I or II disorders, although their overall psychopathology increased as the N scores
increased, and, but to a lesser extent, as the E scores decreased. Moreover, for all of
these patient groups the pattern of these scores was the same. The standard scores of N
were positive and those of E negative, which accords with the view that high N broadly and
low E weakly are common vulnerability factors for comorbid psychiatric disorders of MDD
(Khan et al. 2005).
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9. CONCLUSIONS AND FUTURE IMPLICATIONS
9.1. Conclusions and clinical implications
Personality dimensions associated not only to the symptoms of depression, but also to the
symptoms of anxiety among general population and in depressive patients, as well as to
comorbid disorders in MDD patients, supporting the dimensional view of depression and
anxiety. Among subjects in the general population, the temperament dimension Harm
Avoidance and the character dimension Self-Directedness associated moderately, whereas
extraversion and neuroticism strongly with the depressive and anxiety symptoms. The
temperament and personality dimensions, especially Harm Avoidance, Self-Directedness and
neuroticism were also somewhat predictive of self-reported use of health care services for
psychiatric reasons, and lifetime mental disorder. Moreover, high Harm Avoidance may
associate with a family history of mental disorder.
Among MDD patients, the scores of the personality dimensions of neuroticism and
extraversion were relatively stable during a depressive episode. However, neuroticism was
strongly and extraversion less strongly dependent on the change in symptoms of depression,
as along with recovery from MDE, the scores of neuroticism decreased and those of
extraversion increased. Neuroticism, but not extraversion, was also somewhat dependent on
the change in symptoms of anxiety. Thus, it might be difficult to get an accurate sense of
a person’s long-term personality traits during the acute phase of an affective disorder.
It seems that a depressive episode does not have a negative effect on an individual’s
personality. In the medium term follow-up of this study, a relapse or recurrence of
depression did neither increase the patients’ overall level of neuroticism nor decrease
the level of extraversion, thus no scar in the personality dimensions of neuroticism or
extraversion was observed.
The overall level of neuroticism was markedly higher and the level of extraversion
slightly lower in depressive patients than in the general population, suggesting that
especially neuroticism, but also extraversion might be a vulnerability factor or at least
indicator for MDD. In clinical work, high neuroticism might be considered to be used as a
risk indicator for a possible recurrence of MDD and to help making treatment plans e.g.
when considering maintenance phase treatment for MDD.
Neuroticism and extraversion were found to be associated with the comorbidity of MDD and
axis I and II disorders. A positive dose-exposure relationship was found between the level
of neuroticism and the prevalence and number of comorbid axis I and II disorders. A
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negative dose-exposure relationship was found consistently between the level of
extraversion and social phobia and cluster C personality disorder, and less consistently
with cluster A personality disorder. Patients with pure MDD, or with any comorbid axis I
or II disorder, had positive standardized scores of neuroticism and negative standardized
scores of extraversion, but the scores were not extreme in any patient group. This finding
indicates that also other factors than neuroticism and extraversion are needed to explain
the comorbidity patterns of MDD.
9.2 Implications for future research
Most of the existing studies on the relationship between personality dimensions and
depressive and anxiety disorders have been conducted by using the two superfactors of
neuroticism and extraversion. A more specific level of analysis and increased specificity
of associations between personality domains and disorders would probably be gained by
using subcomponents of neuroticism and extraversion, and also by using more than two
personality dimensions.
Currently personality dimensions are mostly studied by using self-report questionnaires.
In order to reduce the possible effects of mood and anxiety state and response style on
the results, in future it should consider using also peer-ratings, semi-structured
interviews and other methods e.g. the experience sampling method.
Most of the current prospective longitudinal studies on the connection of personality
traits and affective disorders have been conducted among adolescents and adults. However,
mood and especially anxiety disorders have often developed already by mid-adolescence.
Thus, to truly test whether the temperament/personality dimensions predispose the
affective disorders, longitudinal studies starting already in childhood should be
conducted.
In future, when studying the comorbidity of MDD, alternative factors other than
neuroticism and extraversion are probably needed to explain the comorbidity pattern. These
factors might include not only the two personality dimensions of neuroticism and
extraversion, but also other personality dimensions, disorder-specific genetic
vulnerabilities, gene-environment interactions or distant (events or experiences from
childhood and adolescence) and/or recent (stressful life-events and low social support)
environmental risk factors.
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